var title_f2_31_2544="PE treatment algorithm";
var content_f2_31_2544=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57249&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57249&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 664px\">",
"   <div class=\"ttl\">",
"    Treatment algorithm for patients with suspected pulmonary embolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 644px; height: 739px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2544=[""].join("\n");
var outline_f2_31_2544=null;
var title_f2_31_2545="Malignant mesothelioma II CT";
var content_f2_31_2545=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant mesothelioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 321px; height: 318px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows right sided circumferential pleural thickening with thickening of the major fissure; there is extension into azygo-esophageal recess and into the anterior mediastinal, pericardial fat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2545=[""].join("\n");
var outline_f2_31_2545=null;
var title_f2_31_2546="Bar dips";
var content_f2_31_2546=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Safe and unsafe range of motion for bar dips",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 271px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Picture A depicts the appropriate and safe range of motion for a bar dip with the upper arm parallel to the ground. Picture B depicts a bar dip with an increased range of motion, increasing the risk of soft tissue injury.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Pat R Vehrs, PhD, FACSM.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2546=[""].join("\n");
var outline_f2_31_2546=null;
var title_f2_31_2547="Tetracaine (topical): Pediatric drug information";
var content_f2_31_2547=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tetracaine (topical): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?28/30/29155?source=see_link\">",
"    see \"Tetracaine (topical): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?25/3/25652?source=see_link\">",
"    see \"Tetracaine (topical): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9564873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pontocaine&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9564874\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ametop&trade;;",
"     </li>",
"     <li>",
"      Pontocaine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10535986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Topical",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10536247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/30/29155?source=see_link\">",
"      see \"Tetracaine (topical): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children: Safety and efficacy have not been established",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults: Apply 2% solution as needed; do not exceed 20 mg (1 mL) per application",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9565223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical, as hydrochloride [for rhinolaryngology]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pontocaine&reg;: 2% [20 mg/mL] (30 mL [DSC], 118 mL [DSC])",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9564880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10536144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local anesthesia for mucous membranes",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F9605761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Adverse effects listed are those characteristics of local anesthetics. Systemic adverse effects are generally associated with excessive doses or rapid absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Cardiac arrest, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, convulsions, dizziness, drowsiness, nervousness, unconsciousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Methemoglobinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremors",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, pupil constriction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Respiratory arrest",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction, anaphylaxis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10536145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tetracaine or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10536147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with cardiac disease and hyperthyroidism",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10536146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use prior to cosmetic procedures can result in high systemic levels and lead to toxic effects (eg, arrhythmias, seizures, coma, respiratory depression, and death), particularly when applied in large amounts to cover large areas and/or left on for long periods of time or used with materials, wraps, or dressings to cover the skin after anesthetic application. These practices may increase the degree of systemic absorption and should be avoided. The FDA is recommending consumers consult their healthcare provider for instructions on safe use prior to applying topical anesthetics for medical or cosmetic purposes. Use of products with the lowest amount of anesthetic with the least amount of application possible to relieve pain is also recommended.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9565140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9564892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9564893\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10536244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks both the generation and conduction of sensory, motor, and autonomic nerve fibers by decreasing the neuronal membrane's permeability to sodium ions, which results in decreasing the rate of depolarization of the nerve membrane",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F10536245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Within 3 minutes when applied to mucous membranes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: 1.5-3 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10536246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: By the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: Metabolites are renally excreted",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16052 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.69.132.100-C55D250E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2547=[""].join("\n");
var outline_f2_31_2547=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9564873\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9564874\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10535986\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536247\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9565223\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9564880\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536144\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9605761\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536145\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536147\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536146\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300124\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9565140\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9564892\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9564893\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536244\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536245\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10536246\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16052\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16052|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?26/45/27347?source=related_link\">",
"      Tetracaine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?17/36/17987?source=related_link\">",
"      Tetracaine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/18/13603?source=related_link\">",
"      Tetracaine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24148?source=related_link\">",
"      Tetracaine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/8/38019?source=related_link\">",
"      Tetracaine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/8/43138?source=related_link\">",
"      Tetracaine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/30/29155?source=related_link\">",
"      Tetracaine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?25/3/25652?source=related_link\">",
"      Tetracaine (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_31_2548="Fibroid anatomy PI";
var content_f2_31_2548=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F64122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F64122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fibroid locations in the uterus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 417px; height: 587px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These figures depict the various types and locations of fibroids. A woman may have one or more type of fibroid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2548=[""].join("\n");
var outline_f2_31_2548=null;
var title_f2_31_2549="Tinnitus PI";
var content_f2_31_2549=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F73491&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F73491&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Tinnitus (ringing in the ears)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 602px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJaAhcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKDSUALmkzRRmkMM0ZoooAM0ZooouAZozRRRcAzRmiii4BmjNFFABmjNFFFwDNGaKKLgGaM0UUwDNGaKKQBmjNFFMAzRmiilcAzRmiigAzRmiii4BmlzSUUwFzSZoooAM0uaSigBaKSigQtFGaKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopKAFpKKKTGIaKKKAFopK8/8a+Pb/TPFtl4U8LaINa1+4tTeyLJciCG3gDbd7tg8kjAGO49aAPQaK838LfFXTr2z1VfFFs3h7VNKvY9PvLWR/OVZJM+WVdR8ytg4OB09MEz/ET4p6J4N0fXrgN9v1HR5LaK4sULIwaflBuKkcpub/gOOpFAj0GjNcRe/FPwbZabZ30+sjyLzeYAltNJI4Q4dvLVC4UHuRipNT+J/gvTLSxur/xDZw299bm6tpDuIljBwSuByc8bevXjigDss0ZrK17xFpOgaK+raxex2unqFPmvnnd90AAZJOeABmsK3+JvhG40S51aDVWeztpxbTAWs3mpIeimHZ5mTzj5e1Azs6K423+Jng+fQJtbXXIV0yG4FpLLLHJGYpT0V1ZQy9e4Are8Oa9pniXS01LQ7yO9sXZkWaPO1irFTjI9QeaANSiikoAWkoooAM0UmaM0ALRSZooAWikzXmfj34sW3g34h6B4avtNL2upojyah9o2i23SGMFk28jcBk7hjPtyAem0V4/Y/GiDVfEXjPStOsraC30C0luI9Tu7lvJmMbBGJVEJCbt3zKWJC9OcDd8SfFPQfD2hwPfahbPrdxpn2+G1t45ZVf8Ad7gSQmUjJ4DPt4oA9DozXm9r8WNDtvCPh7UdfuorPVNYsVu4rKKOSZuVyeEUkLnI3HA4PPFZvgP4q3niTUfB9vc6fbW8et6bc30rrIT5RikKADPYgZ5oA9azRmuP8P8AxJ8JeIdaTStH1mO5vZA5iXypEWYJ94xuyhZMYP3SelXvFvjTQPCQtv7f1AW0lyW8mJIpJpJNoyxCRqzEDucYFAHRZpc1xWofE/whp+l6fqM+r77K/iaa3lt7aacMinDMfLQ7QDwd2MHipNS+Jng3TLHTby/8QWcFrqMLXFpK27bMi4yQQOoyBg854xmgDsaKhtZ47q2huLdw8MqCRGH8SkZB/KpaAFopM0uaACivNdK8d+ILz4uX/g6bQ9PjtrOI3b3a3rFjblsIwTZjecrlc4GTycVd0D4ueCvEGradp2k6u01xqG/7KWtJoklZc5UM6AbuDx/iMgjvaK4Ky+Lngq91q00q11dnu7q5azjzaTIhmBx5e9kC7iegzz+IzYk+KHhOPxENGbUnNyboWJlFtKbcXJ/5Ymbbs3+2fbrTHc7WlrktJ+IfhbV/Ek+gadqnn6vBcTWstuIJQUki++CSuMDB5zg4OCaPF/xC8O+ErxLTWLuYXbQm5aG2tpLh44QcGRwinaueMnFAjraK4nXfih4X0WG1nu7q7ktLi0S+W5trGeeJYHJCyM6IQoO08Hnjp0p+r/E/wfpF7Z2l/rKJcXlnHf26pBLJ5sDttR1KqQckHjrgZxjmgDs6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACkoooGFFFFABSGlpkjiNdzcDIH5nFJgKaKDSUhi5rzbxp4N8QHx7Z+NPBF5pkerJZHTbq11NX8ieEvvB3ICysD7c4HTnPo5NNJouFjxC++EOvX3hrxFcXeradJ4w1nUrfUncRutonkN+7iHV9oBb5sZ6DHcmsfCrxP4g0n4i/wBtahoseqeKk04x/ZBL5MLWuMg7huwcAZ57nA6V7Szfv09Np/pT2alcLHjfiz4d+K/EWuaX4mun0Q63FZPp91ZRX97bWzR+YXV0mi2ybueVYFT+ANaHgv4a3mheIfCd8w0q1t9HsLu2e1s3mdVaaZnGxpSWIAbkseucADgepB6y9P8AEOmah4g1XR7O58zUtKEX2yHYw8rzV3x8kYbKgngnHfFFwsYXxf8ABc3jnwza2VldJbXtlfRahbmVnWN3j3Da7IQ6ghjypBBwRXBp8LvFkWj6sNMm0fSNRvruzmn+zarqEv22KESBopbiQmRAwdQNgBwpBJyMe3b6cGouFjw22+DOrp4f1mwa70uJr/WbXU1RHmdI44sbkLOCxPoTnPt0r3jNRhqdmncLDqDSZozQAuaSkzS5oCwUUmaXNABSZozSZoAWvM/HXwyTxj4/g1TU5IX0Q6RLps8GSJSzMWDqcYGCQQfUdK9LozRcLHis3wXks7nxHFoVzawaZf8Ah0aLaxyli6yZBMkhAwcnJJHc9KdL8M/FGn3t5Jod7okkWq6BBo999tEoaFoofL3RbRyp64OPXnpXtFFFwseL6X8M/FHh7UNEvtDvdEmuIvD8eg3q3vm7VCtu82IqMnn+E46deeF8LfCHUNOTwzDqGoWrQadot5pVyYC25jO7EMmR2Dd+9ez1leKPEOmeFtCudZ126+y6bbbfNm8tn27mCL8qgk/MwHA70XCx5L8PvhNrPhzXdAk1GPRLu30ZnEN8L+/acqUK/LAz+TGTkZxkYHA6Y3/in8O9R8SeKdJ8Q6LPatdWls9pLa3V3c2qSIzbgyy25DqQc8YIPHpXqGaM0XCx4Y/wo8TJpuh6fZ3Gj2+kW0dwtzpMV9fJbrJJIWEqsG3ysAejkDOcYzWv4J+F2paBefD6a6vbKVfDdpeW9wE3ZkaYkqUyOgzznFeuZpc07isOozTQaXNADqKbS5oA8z0nwX4ntfjDqHi+fUNGexvITZNbJBKJBbq2Y8EtjzOFyeh5wBWd4Z+E19pHh74eadJqdtI/hi+nu5nVGAnEjyMAvoRvHX0r12loEeQ2nwmvoPD2gacdTti+m+K18Qu4RsPGHdvLH+183XpWMnwUv7LW7kWj6He6TNqJv0kv/tXn2+X3lQiSCNiD0Yge+ele7jrVbVtQtdI0q81LUJfJsrOF7ieTaW2RopZjgAk4APABNAHM/DnwnP4U/wCEo+0XMdx/a+u3WrJsUjy0l24Q56kbetcl8RvhZe6740fxHpEumzvcWa2dzZak1wkZ2kkOrQup6HBU5H516npN/a6vpVnqWny+dZXkKXEEm0rvjdQynBAIyCOCAatUwPB9c+DWvajawWK6no500aQ1gto6XAhspTu/eQIJME/N1csRgdcYrsfBvw9utA8X6HrE19BNHp/hSDw80aoQXkjkVzIP9k4xjrXo9FIAFLSUUxi0UUUCCiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooNACUUUUDCiiigAqvfnbZzN/dQt+QzVg1HMu+F1xnKkYpMEKCGAI6EZpDVbTXMmn27N97YAfqOtWDUFWEY1GxpzGoHahsEhkrfv4vxH6U5mqvM372A/7eP0NTPU3KsKrc15b4Ebb8cviqffSR/5KtXpynmvK/BrbfjR8WGHY6Qf/ACWahPQGtT1gtSh+ar78gH1pQ1FwsWWfG1uwPNTBqp5DAqehFSQSFkGfvDg/WmmKxZzS5qLdShqdxWJM0uajzRmi4WH5ozTM0ZouA/NGaZmjNAWHZozTc0hNAD80maZmjNFxkma8s/afOfgZ4l/7dv8A0qir0/NeW/tOn/ix3iX/ALdv/SmKhCZ6tkUZqPNLmgLEmaM0zNANFwJKM00GlzTuA6jNNFLmncQ6lpuaAaBDh1Fcx8WP+SWeMv8AsC3v/oh66cdRXMfFj/klnjL/ALAt7/6IemhB8J/+SWeDf+wLZf8AohK6k9a5b4T/APJLPBv/AGBbL/0QldQetDAWikozQAtFFFABSikopjFooooEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFJXi3xt8PaX4q+LHws0bXrX7Vptz/avmw+YybtsEbr8ykEfMoPB7Vqf8M+/DH/oWf/J+6/8AjlAHqtFeVf8ADPvwx/6Fn/yfuv8A45R/wz78Mf8AoWf/ACfuv/jlAHqhpRXlX/DPvwx/6Fn/AMn7r/45R/wz78Mf+hZ/8n7r/wCOUDPVaSvK/wDhn34Y/wDQs/8Ak/df/HKP+Gffhj/0LP8A5P3X/wAcoA9F047VniP/ACzmYD2BOR+hq0a8jHwE+Go1SWE+G8x+WrqPt1zxyQf+WlWD8APhl/0LX/k/df8Axysyj1BzVWQ9a81b4BfDQdPDX/k/c/8AxyoJPgN8Nh08N/8Ak9c//HKl2KVz0a7fbGrnojqT+dXH6V5Jc/An4dCCTy/DuH2naft1z1/7+VPD8CPhrJbxyDw395Q3/H9c+n/XSkrDdz07ODXlvgsFvjJ8WwOpXSsf+ArU5vgP8Nwf+Rc/8nrn/wCOUh+BHw32kjw5/wCT1z/8cpJoLM9HtZfMt42HcVMGrySz+CHw7dGEnh7LqxU/6bcdj/10qyPgX8OT/wAy7/5PXP8A8coVimmeqhs0JJsnKngOMj6jrXlg+BXw4/6Fz/yeuf8A45RJ8CPhy0ZCeHdrY4P265/+OUaCsz1wNTt1eRwfAz4bSJk+G8MOCPt1zwf+/lTD4DfDU/8AMt/+T1z/APHKd0TZnq+6lzXlA+Avw1/6Fv8A8nrn/wCOUv8AwoX4a/8AQt/+T1z/APHKq6DU9W3UZryr/hQvw0/6Fv8A8n7n/wCOUf8AChfhp/0Lf/k/c/8Axyi6Fqeq5o3V5V/woX4af9C3/wCT1z/8co/4UL8NP+hb/wDJ65/+OUXQanqmaM15X/woT4a/9C3/AOT9z/8AHK434h/DPwh4L1TwDqPhrSPsV5J4qsLd5PtM0mYyzMRh3I6qvOM8UXQan0Nk0Zrw3xl4S0Pxp+0TFp/iWx+22cXhUTpH5zx4kF2yg5RgejNxnHNb3/ChPhr/ANC3/wCT9z/8cpBqeqZry79pw/8AFj/En/bt/wClMVM/4UJ8NP8AoW//ACfuf/jlJ/woX4a/9C3/AOT1z/8AHKE0FmerZpM15V/woX4a/wDQt/8Ak9c//HKX/hQnw0/6Fv8A8n7n/wCOUXQ7M9VzSg15T/woT4af9C3/AOT9z/8AHK47wPYW2lfBz4z6dYReTZ2mpa1bwR7i2xEt1VRkkk4AHJOaYj6IBpQa8L+H/wAEvh7q3gTw3qOoeH/OvLvTba4nk+23C75HiVmOBIAMkngDFb//AAoL4Z/9C1/5P3P/AMcp6CPVwadmvJ/+FBfDP/oWv/J+5/8AjlKPgD8M/wDoWv8Ayfuf/jlGgHq+aXNeUj4A/DL/AKFr/wAn7n/45S/8KA+GX/Qtf+T91/8AHKYj1YdRXM/Fgj/hVnjLkf8AIGvf/RD1yH/DP/wy/wCha/8AJ+6/+OUv/DP/AMMv+hZ/8n7r/wCOU0xWOu+E5H/CrPBvP/MGs/8A0QldQ3WvKf8Ahn/4Zf8AQs/+T91/8co/4Z++GX/Qs/8Ak/df/HKdwPVs0teU/wDDP3wx/wChZ/8AJ+6/+OUf8M/fDH/oWf8Ayfuv/jlAHq1Ga8q/4Z++GP8A0LP/AJP3X/xyj/hn34Y/9Cz/AOT91/8AHKAPVqK8p/4Z9+GP/Qs/+T91/wDHK4v4j/C7wd4J1X4fal4Y0f7Dey+LNPt3k+1TS5jLMxGHcjqq84zxTEfRVLSUUDFooooEFFFFABRRRQAUUUUAFFFFABRRRQB5V8RP+S6/CP8A7i//AKSrXqleW/EKN2+OXwmdUYon9rbmA4GbVcZr1KgAopaKAGminYpMUDCkNKKKAKF4fL1G2b++rx/yI/kamNRasuYoZO8cyNn2zg/zqQms5blrYjeq0tTuary1my0V2PY0zR5N1kYyMGF2jx7A8fpinPVbTz5V/dR9pAJR9eh/kKhPUtrQvSdaQcqRQ3IpinDUyTMU+VqE6f3wJB/L+lW1fNUtZzDc2844XOxvx6f596mVqkvctBqcGquGpd1O4rEkhKN5qdQPmHqKnjlDKCpyD3qruqAsYH3LkxHqB/D70rhY1Q9PD1SjlDKCpBB71IH96q5LRb3UZqsHpwf3ouFifNGah30m+i4WJs15h8dG/wCSe/8AY36f/wC1K9I315n8cNz/APCAbVJ2+LdPY4GcD95zTi9RNaEm7/jJr/uUP/b2vTt9eWHd/wANJiTB2nwltDY4z9s6V6ZvptgkT7qN1QbqN9IdifdS7qgDUbqLhYsBq8K8OH/i2Pxx/wCwxrn/AKJFe3hq8P8ADscn/CtPjWvlvuk1fWyoxy2YRjHrVRZLR6l8Kz/xbHwh/wBgez/9EpXVA1yXwv3J8NPCSuCrLpFoCCMEHyUrqQ1FwsSg07NRA04Gi4rEgNOBqIGnA1VxWJAacDUYNKDTESZpc0wGlBp3AfSimg0uaYhaUUmaKBDq8r+Pn/NOf+xz03/2pXqYry748RvJ/wAK78tGfb4x05m2jOAPMyT7UwPU6KQUtABS0lKKYgooooAKKKKACiiigAooooAKDRR1oASobu5jtYTJK2AOgHUn0AqVmCgknAFY9un2uf7dOM9oFPRV7N9TUydikrj2kv7sEhltIiOBjdJ9fQUxUv4FxHfiU/8ATeIH9VxV7BI9Ka0VZtstWKsV9qCORNbQyL2aKTB/I/41Pb6vbySeXMJLeToFmG3P0PQ1G6stMkCSxtHMoZDwQw4pKo0PkTNgHNBrm455dHI5eaxJxg8tH9Pat+3mSeJZImDI3IIrWMlIzlFoh1NC+n3Cr97YcfXFQxSebEjjoyhqvSLuRlPcYrG0Zy2nxKxJZMofwOKme5UC09QPU71XesmaIhccVm3LGHUbSXOFJKN+NahrN1aMtbEjqpDCoZaNNxiqzOA3UU+KTzbWOTn5lB561l3S/wCkAuxVeueg/wD10NiSLd/Et1ayRtyGFZ1hcedAM58xDscHsw61ftfuOBuK54JrGvc6deNctnyJMCXjp6N/jSb6lJdDVDUFqrq4IBUgg8gjvUgbNAEm+nb6gNIGpAOIaJt0ONpPKdvwqeG4D8chh1U9ar76bIqyDnII6EUXsOxoB6USVnJPJHxKNy/3l6/iKsRyLIu5GBFO4rFvfSb6g5pCTRcViffQXqDJpCfei7CxP5lJ5lU3uo0baWy3oOTTPOkf7qbB6t1/Ki4WL++mNcoh+Zxn0qkVLH53dvbOB+lPRVT7iqPoKLhYs/a17Bz/AMANOW7j7tj6jFV9xpC5IweaLhYvpKG5BB+lSB6yiqE5K4PqDipEZl+7K2PRuadwsagepA9ZazyL1CsPbg1NHdIxAJ2t6NxTuTY0Q1PDVTV6kElVcVi0GpwNVlepA9NMVicGnA1CrU8GncmxLmnA1EDTgaoRIDTs1GDTgaaEOFLmmg0oNMQ6lptLTEOpabSimAtKKSimIWiiigAooooAKKKKACiiigAoFFJQBQ1os1skCkgzuIyR2HVv0BqVEAAVQAoGAB2qvfNnVbJD02yMPrgD+pq0vc1lLc0Ww4ClxVC5vfJk2yKQhOA/b8fSnpcA1PMth8rLDpxVaSPNWFkDUMM0mkxq6KDDAKsMqeCDVa3c6ZOXTJsnOXUc7D6/StCVMiqrjHB6VF+Vl7o2gwdAykFSMgisPSPla8Tj5bh+B6Zo0+6aymW1nbMMhxC/93/ZP9KkteL+/A/56A/+OitXLmSZmo2ui1JVZ6sydKrSVmy0R1XukDoynoRip+9MlGRUssq6O+/T9h+9ExQj05z/AFp0zrGCWIAHrUOnfu9RuoucSKJB/I1HrULSwgLnaGBYDqR/nFK+gW1JLa6juATG2cf5zUzIkqlJFBB45rN0u3Eb71UKoXaOcmtLoaSY2uxhyxnTLkRMT9lkP7sn+A/3fp6VaVsVevLdL20eKQZyPyrDsHcI8M3+thbY3v6Gh6DWpoggikNQ7sUu+lcLDjTSSKaXpjPSuMl8wjpk0xzkhlV1f1XApm+lElAEqXVypwUDD34NSfapiR+6A+rVCGFPHNNASGSdurRr9BmozEXOZHdvbOB+lSKBTxinYQ2OJV+4oX6CpAlKDTgadgGhKeFpyipAtAiLZ7UhWrGKjkoFchK00j2pzGmlqBicjvSbuzAH60pNNNAD0kZDlGP+61WI7sZw4KH36fnVImgNxg8ii4WNZZQe9SLJWKjFDmNiPY9Ksx3YXiQFfftTTJcTWV6lV6z0lBGQc1MslUmS0Xg1PBqor1Kr1aZLRYBpwNQq1SA1SZJIDTgajBpwpiH0opoNOqhDhS00UopiFFLSUtMBRRQKKBBRRRQAUUUUAFFFFABRRQKAMzUzsvrB/VmU/iKsk4jqrrP+usj2EwFWZP8AVmspbs0WyMjV7mOC2leXBQKSQe4rnNP1S4tow1yo+zk/LjlkHbPtVzxHIZbiC3HKs25/oOarvEWXpXJJ3Z1RSS1Ogs7xJo1eNwysMgg5BrQjkyK8/Dz6bN5toCY85eDsfcehrqtLv47y3SWFsg9u4PofQ1UJ9CZwtqbR5FQSx5HSnQyetTFQwyK13MtjGuohLE0T5GehHUHsag0OaRru7W4OZVKhiOh4xn9K1LuPgkdayrSMx6lLJ/fVc/hWTfKzVao3JOlV3qUtlRUT1oyCE9aR+RSnrSHpUlGef3ep27/3g0Z/n/SrVwOapaj8rQP/AHZV59MnH9auzNkVI2ihPeRW7hHOCRmpo5VkQMhBB9Kz9UgYnzo1Dvt27T+lLpcUkaN5p5Y52joKm+pVla5po+DWRqsYtr1Llc7ZMI+P0P8AKtM1FewC6spIm7giq3VidmUs0hrPs52eIByfMQlHz6jj/wCvVoP71JQ5qiY08tmmNzQMTNGab0paQyRWqVXquDUgNArIsBzTg5qBaeDTuFicPUqNVUGnBqtCsXlcVKJBWf5lHmmmTYvmQVE75qsJD3NI0gHemKxKTmmmq8l0qKSSAB3JqqdRRyREHlP/AEzUt+o4paDNBjTN1Vgt/Mv7m1Iz3kYLStZ6mnO22PHTLfzqdR6Fgtk0maptPPA2Lq2eMd3X5l/PtViKeOUHy3VsehzSGPORShyKDTDxQImRgDlSUPtVmO4kX7wDD/Z61ng1Kjkd6aYmjVhuUY4B59DVpJKxlYHG4VahcDoT+Jq0yWjVR6lVqoRyVYR6pMhouKaeDVZWqVWq7kNEwNPBqIGnA1SYiQU4UwGnA1Qh1KKQUCmIcKKQUtMQUUUUAFFFFABRRRQAUlLSUAZmuHC2n/Xwn9anlOIqj1kHyoSO0yH9afNkxVjPc1jsjjr3MmuynPyxxBfxJzVyOPcvSoblNuqXA/vIjD35artquUrlW50PYzL6DjI61iC8fSr6K4i3bJHCyxjnd7j3rqr2P5DXL6rEHiOeCrKw/A1MlZlwd1Zna6dexXduk0DbkatFHrhtPn/sq+AJxa3DYI7K56H8a6+KTIFawlcynGxak+Yc1V8nD5qyDmkNU1clOwzGBTW6U89aa3SgCB+tIelOemjpSKRm6txayE9sH9RVh/uio9RTfbSr6qaep3W0Z9VH8qgpkE2DG3OMDOfSkQgEdM0+nBRUgIacmKrXVykAAJy3oKS0uluY96AjBwQaaeoW0MPU4vsWrb8ERXHB9A3b86kVq2NWsl1GxZCSsgGVYdj61zVtLNDMba8XbMvRscOPWhqxS1RfzRml4IpMUCENJwaUimng0DHipVqAGnhsUWAnFOBqt5mBTTNjvTQFzcKcGFZL3ybsJmRv7qDJ/SpYlv7g/u4VjX1kPP5CncLdy+0iqOTVWe9jiHzOB9TViDQ5pgDdXL47qnyj/GtK30ywteViUsO5GTTSZLkkc/FeSzvi3hmk9wuB+ZqZ7LUpQMiOAHuTub/CugE0YJWLYMdQO1Zeq6lJDLHDCA0j569hQ7LcE29kNtNEgwGu3edx/fPH5dK1oYY41AijVQKy7K8m87bMwbK54GMU6a5k+29MLxtIP+eaOZITi2az5VSzsFUc5pIHSVQY3DA9KydSuTdRCNQ5GcMoODiprXEKKvCY6KD0o50Ll0NJ0UghgDWHqOiL5puLJjDL1+XofqK0/N96GulQfOwA96TaYJNbHPx3jxSiG7Xy5ex/hb6H+lWxIGqxcfY79GjfZIp9DWJc2tzpjgwlriz7g8un/wBapNLXNXvSg1St7kSIGU5U1ZVw1O4rFhWqeN6qA1Ij0CsaEb1ajkrNjerEb1aZDRqRtmrCGs6KTpVuN81aZDRaFPFRI2alU1oiGPFPFNWnCqRI4Uo60lKKoQtLSUtMGFFFFAgooooAKKKKACkpaSgDO14H+znYDJRlb8mFTsMw07UYjPZTRjqyED61Bp0nn6fE/coM/XvWUtzSL0Oe1qIx3ltcD7oJjf6Hp+tW7Qc4qTWYfMs5lAydpI+o5FQaY++GJ/7yg1z2tI3vdEt5H8hrkdXBRMDOWcAY+tdpdDKVyurpueFF6tJ/IE/0rOoXTI7mJbiBo3GQRWp4fvGms0EpPmxnY+euR/kGqLIRUNpJ9k1YAnEdyMD2cf4j+VQnZltXR2cbZFPzVS3fKirINdKd0c7VhaQ9KKQ9KQET0wU96jBpFIhuh+7bPTBqO35soiefkH8qkn+6ah0pvN06MnGQMHHtxS6lPYb3qC+ufs8O7IBxmpzwTVa/tkuYgsmeOQQcGoGjnmv5dRilMSssinblhwVPetrSU8u2Cn73c+ppltaJApCqAKcbuOB9hznrxzULzKeuiNWJsdKgvrG3v49sy4ccq44Kn60kcoYAqcg1KJM9a1UjNo5uSKeycx3X3R92X+E/X0NKsgOCCCPUVvyjeCOoPWs2TRLeQsygxsTnKEr/ACoKT7lTePWkZwBkkAe5qRvDaMeJ7j/vupIPDEAbMrSSZ67jRZjuimbmBes0f/fVPDu4/wBHt5pSfRCB+ZroLPSrO1IMcCA+uMn86vgqo4UCqUe5Dn2OXi0rUbkc+Xbj3+Y/4Vct/DUIObqWSY9wzcfl0rb3HscCm7veqSQnORFDYWlsgWKJAB2AxT2KoPlULUnJGa4rxd41sPD523jsWfOyOLBYj1PoKmc1FXYQhKbsjrGmHc1n6pcN9nZY22sRwa8qk+KlrPN8sd5GvY5H8s12fh/xNbatbCUOksePmK/eT/eFYLERnombuhKGrRPHK1sF8lsykjjqSK0GjjnuAScSr0I7VbjtIQfMjVDuHUCo9oW5JGc44Hb61STJuPWJYgcct6msfVNWtLeXynzNMP8AlmgyRUviPUTp+mSyr/rD8qf7x6Vi6bbrpWnR3MqfaL+6b92CeSe5NY1Z8rsjWnC6uyeXxBNGRu0+4RMfeK9Kmg162u5FHmhXHZuDTiNYKbmlt2H/ADzIOPpms2W2sdTn+z3afYrzsRwGPtWLqTRqqcWa2qa4lqqRW48+6k+5GvJ+p9qyjbPM2/WruWSV+Raw5Jx6BRViLSovDlvLclzNdzERxknJ5966DQNNW3hMshDXEnLv1P0FCUqrsyW401dHMNZ2PmLHbi806c/ckkBUE+ma0NA1S4W9l0vVSPtSfMrdnXsa6DV7KO9sZYXAyRlW9D2NcPdSmU6LqJz5yObaRvWqs6M12BNVYnS6lYtCTcWg56sg6P8A/XqG1uUlTdG2R0PqD6Gt+2KyRhXxgjvWNqOlSwzvPZgeYfvKejj+h96633Rzp9GWY3BHNSjmsq1uQ5KkMki/eRhgir0cuMU07iaLa5FTI5qujg1OgBpklmOSrcUlUFGKmjJBqkyWjVikqzG2azIn5q5E1apmTRdU1IKgRqlU8VqjNkgpaaKdVCFpRSUopiCiiigAooooAKKKKACkpaSgBp6Vn6d+7luYOgSUkD2b5v5k1o1mTEw6zGf4Zoyv4qc/yJ/Ks59y49hbxOtYumr5UbRf3HYfhnI/nXQXYyuawiPLvJf9oA/0rCW5tHYtzNlawrpfM1CFR/CGb9Mf1rYduKzrdPN1SZuoVMfn/wDqrGWrNY6IZNF8tZGqxk2+9P8AWQkSL9R/9aummi+U1jXahcgjg9aiasVBmrpVwJ7aKQfxKDWopyK5PwxcDbNbE8wyED6HkV1MZyK1pu6M5qzJRQelApDVshEL1HUzVERSKRBMeDVLw63/AB9Qnqkh/Wrk3Q1lWUn2LVneQ4in4J7A9v61N9TRq8TTuF2vULkAZPSr9wvmLkVmXkRkt5IwSCQQKUlYmLuNEkcmQjqxHXBrHnsZXmdsgEk/Nnn2xUtnpgtrhZE+UjO7n73+etOudUt4ZdjEk9yBnFZvzLXkW7RDHGidlAFTGUKTuBGO+KigmjlXMbAisrxBNIsBWNihPQg45p3sgSuzeidXGVII9RUOoXZtYGck4AJyADiuX02W6tNjPKzM5GUPfNak14t2xhKkqTgnHT0pqegOGpLpGuG4lUOp2N0JXn2/rWiNTZpgqxHyz/F/hVXT7KODBGTgYGe30qNrgWs7BYwFU/xMc/hVKTtqS4pvQ2zIarXt0IIGcnGO9ZN/qsghjNom6ST15xUazySWxS/ZVLEEEdqHMFDqWdL1d7uba0EqJnAZq2EnjMmzPNYtsIokVnmUopLDAwPqfzqaOW2tn8+eQANyB1J/CkmDXY1r6Qx2UpXhtuBXyf48vpdQ8TXrysW2uYwM8ADivqmcpqOnSrA33lIHbBr5Z+INoNO8Q3Xy/LKfMX8TyPzzXPjL8qsdWBS5mYkUO2Pjqa1tB1S70e9S4tZCrKeQejD0NXvDHhG+17TJru2YjZkj049awz5kF09tdIUlQ4INebKM4e+ejeM7xPevDPjC1uYUFtNGpIy1vKcbT32n0rsLW6huUyDtk/un+lfK8iuhBBPPpW3ovirVtIePy5mlgXrDIcqR7en4V00sb/MctTBPeJ7P46GbS2ZvuJOpYfp/WqvjNriGXRZLViiPGYw3oTzx+AqrZa7Z+KdHlRHO/b88bH54/f3Ge9WLTfrnhifTZWA1KwbMZPU45Bp1XeXMupNNcqs+ha07RJtRQtBqDpOn92TkH3rM1w3NuwtNciKsp/dXaDHPYmqkFxJdwLJbSPbahB8rbTggj1rd0LXV1RTpfiONDORgMw4b3H+FZqRTi07lS61Fr3wzHNK4aaynUtjuAetd9YuH0+KRPusoYflXl15YN4f1me3kZm068UhSen0rsPBmqxSacLKSUGW3+QAnllHQ10YefvNMxxEPdTRvXVwtvZzTynCIpNefnLaZpsWMM9y0x+gAH9a2de1BtXvk0uxG6ANmZx0OO1VY1STX2t4wPLtY1jH1PJP8qK0uaaS6Dox5Yts6dEV4U8wnCjPHfiksNaW6ufKWLMKkL5hPXtxUVzNEkPlucsw+6OSaqWVk4Iw7LGCG2YwTXUnY5mkzotQ0aG6AfBWQdGU4IrAuobqyc70M0X95R8w+o7/hXRLqsMKos7fOf4Ryau7YbuEOuMH1rVxUtjJScdzkra6SUZjcN/P8qvwzVJqegxTZZVKSDo6cEVklbqxYLOGmj/56KOR9RUWa3LTUjoInBFWFrHtbhXUNG4ZfUGtGCXNUmS0XY+KtRNVSNgasRmtEzNouxtVhDVKNx6jNWUNaxZk0WBThUamnitEQx9AoFFUIWiiigAooooAKKKKACkpaSgBKyfEG6OK3uV/5YTKzfQ8H+daxqnqsPn6fcR92QgflUyV0VF6iM4khBByCOKyrlB5m7v0qzp0hfToGPUoBUdyOa5pam60KjVFo67nunI6yEA/SnzHajN6AmptFjK2MZIO58ufxOaySuy27IlmX5TXP6rxmukuFwCa5TXJNqvg4OKVVaFU9WY+gTNHrO9mOyfcoHuMY/TNd/btkCvOQfIazk6eXMvP14P8AOu/snyoqKT6F1l1L9NJpc8Uxq6Gc6ENNajNHapKK8y8Vn3EQbIYZU9RWqwzVeWLIqWrmkWU7O9Nt+6uSxiz8snXb7GtCWIOu5SCDyCKzpYfbioopJ7ME2/7yPr5TH/0E9qafRkuPVFqSMjINc9f6dIZX2qSGO4EfyNdNDcQXinym+YcEEYIPuKSSLB5FTKNxxlYx9JtXt7fbJyx6mrFxFGwIcAj0NXCmKqXEBfocVNrId7sqR2drG4YLz9TgVLbWEKTGRCxyc4J4FOS1wOTSRTqJWjVssvUUWC5U1S/nhcLbqAgbaWxkk+gFXxapcRI90v7zHPb8KjlMYkEpRQw5zjnNMjuzOSUOQKewxt2ipKiR7VGM5I+6OlUbm3a5kMmdyqdqn+971oiMSTAyKGx0yOlW5PLHykqD2BpNXBOxhy3C2lsjTxgsB90c4pNOuF1G9UT28i7R8oOBuFaF7Y+egKgEjkD1qW0t5C8RaIIU6e1JJ3G2rGtCqxR9ACeuO1fPPxwgjl1q2MYALq7k47b/AP8AXX0b5O9BzXgvxm0maC5iumy0cTNE3spOVP6kfhU4q/s9DTBu1Q3PgfJbjw/JbXDhXmZxGD/ERziuf8d+HID4iQ4AE+UJHVW6isv4d6hkSaerbJlbz7d/cdRW3rzTi/s47li02WlLf5+tc/Mp0kjoScKrfc5KXwxq0EjIYlMY6OelZ8sAjlaCcBZF6+9fROm6raP4eFx5KPOsZ3AjqQK+cNYu5b7VLi5fAZ3JAHYZ4rmxFCFNJp7m9CvKo2mtjS0C/bQtXt7xDmHdslHqh6/4/hXpuoLLYXcGsWByYxiRR0dP8814wZH2FG5UivZPh9fLrPhmOC4wWVTC3rleP5baMP78XBhX91qZPrFkZJYtd0ZS0cyhpoh396qXywa3ZMbRmhv4PmwflZT61oeDdZt9DvbjRdZ+WMMRDI3QrnipPEYsotQjutOZPMU/N2DKeoz0qWmSpa2L/hhU8VeGDDqKK88fysT2I4zXJXmiy6bqxtvOOf8AllJk5A9Ca19MuJNNvnm0118uY7nQnofwp2sSveTGdVVpMcrng1V1KOu4K6lpsXfC+7TrCdcZuWBG7rWfpV4g1aa53l0kIDccqRwcj8OtQwXoERWSO5ifvgbh/jVKx068NxJLAGdN5KsmVP64pKbTSFJKzPQkiSeRZo2B4HuDVvG2uLsr68spArwzDnnCHH4j/DFdBBqrFVM9vIFP8aAkV3Rqxe5xSptE0VqZJzI65kJ6k8CtXDpCqQtjDbiM4rOj1K0/567T6MCP5086ragcTKa1jNLqQ4tm9FfKkarOwLdzTv8AR7pTtZTXGapf+fCRb+ax9UQ1zEMetW05nsmNvzn96/X8BTeKhHRsSw7eqPRLzRo/MMkLNDJ/eQ/zHQ1VV7y0/wCPiMTL/ei+9+K/4VS0LxRI5S31hBFMTtEgGFY107bGOI/mb0FUpRmrwJalHSRQs783IzBgAHB39R+FaKSLgebIT35OKyr3TZC5ngYRTY/h6N7GpNOljfPGJk4cE5INUm1uJpPY3bd1x+7U49elXo29ay4Z1yBuyfQc1eiYkjjA962izKSL6GpAaroamU1umYslFLTR0p1UIWiiimIKKKKACiiigApDS0GgBppGAIOelONIelAzC0vi3kj5HlyuoB7DNLc9KLPi6v07iYnr60tz0rkkdCMy/OLV8dTwPrWxZQ7IUQfwqBWRKBLd28PX5t5/Cuit1wgpQWo5uyILtMRE1w+sr5kuzPqfy/8A113WonEJri7pC105HYYqK5dHuY+oRH7NMAOQpI+o5H8q6rSJvNtonzncoNY80QIyR9al8KykWhgc5eByh/OueGjNZ6o6tDkUjUyJuKea6tznIzTc05qYakodQVpAadmmBE0YPao2tgas0maaC5jX1i24SwsY5l6OO/sfUVPpl/8AaAYrpPLnXqD39xWi6hxg1kalYrKO6sOVdeCp9qT01Q0+bRmjJHzx0qF04rLi1eSxUJfo0ig481B29xWzbTW15EHt5UdT6GhWewmnHc5/W/tewfZcnrkA4qroenXUN0ZbiSR9y4wx6V1TQRZyzU5Gt043DP1qfZ63K59LIpSWyuhVhwRimQ2kUCbUX8a1VMTcZFK0KsPlIp8nYnmMIxuJ+B8uaqalaXTP+6Z9rNnKfeHt9K6MQgNzipRCvcip5Lj57GJo9vLBG6TnJJ3D29q1EAFTmONcksKa0ttGpLOoHqTVKNiXK4+JucVzfjTS4r61bz4Q6MNjgj7yn/Oa2DrFpG2I90reiDNZOv6pvCSXTxWlqhDEO/zP6DA7USScbDhdSufPvhDT5rT4iRWoRmFtOyNx2zj9a6T4p6hJpXjW3kgjBRYsGM9CCa7vSX0mTW5NZ0eSJ7o/JNEwwJAPT0Nch8WoI9TMWqWytiI+XMjDDJn1H+etcM6fJRfL3ud8anPVTkuhveCdZ07VoHW3IjLrtkgJ5U+o9q8d1u2az1e9gddrRTMuPoTTbK7m0nUobu2Yq6EHjuPQ10Hj9I5ru11eAHyNQiD5/wBoDn+lc1SftqV+qN4R9nU8mcmXBrqfAesDTNWWFn2wXJGCTgLJ2z9elci2CeOKs2Wn3l+H+yQs6qcM2Qqg/UkVz0rqScTeolKNmei+N2FzrNq23ACZIPY1q+HJNm0Ekg8YPNc1bXF3dWEVtrto8c0I2xX8ZDAj0fB5+tbOjy+Rd/Z5cB14ODwfce1XVjJT5jOm048p3H9h212gfyVBPdRise+8OiMny5ZUx0w5Fd/4eCSWS9KTU9PV8lRXX7K8Uzl9taVjx7UbC7gyRc3G32kNZmnz36XxjWe5YdSVZjj2Neg6/YHyGXp3rhNVR7a2fEzEoMqo4AP0Fc8oWep0xfMtDp7K/u4GQm53DIyC27/GtWfxhaW/7uT55AOg5rzy0u7vUE8qAFQeCw6muk0fwhNLhpuB6VFltEh0lvMvSeNInc7LFW9ytRnxzCpw1gV9+BWp/wAIxHCmNo/Ksy90O3JIZSD0yKbhKO4KNN7Fe58dwAfIibvTrWZN4s1S+Oyyt52J4BVSoH4moNQ0Bk3ND84/WrGg67Jpswhu4laMHAbbyKItXsOVNJXirk9pomtagrTanI8cYH+rB5P1Pet7wj4kuLK//s7UC3lZxE8nB+hrpLLUbS4sDdDBULnHfNeWeKZ3l1c+WSsxOc/3RW0Kk4zVmYWVRNNHvKMJ03R4YH0rE1m0MEy3QyAOHC8ZFP8Ah/dyXehQGcYkA2n3966K7txLEysOCMV60Y3Vzz2+WVjLsHUKCmNp5471rwtkVzVlvtLlrSXoOY29RW7bSZAq4kyNFDVhDVSM1YQ1smZMsqacKiQ1IK0RDH0UUUxBRRRQAUUUUAFBooNACGk7UpoFA0YcIK6vfjs21sfhRecKae/y65KP78QP5VX1Z/Kgkf8AugmuWaNolXSl869nl6hSI1P06/zrpEGFArD8OwslojNnc/zHPqa3HO1DTp6K4T1djP1JtykVzxizJKSOprcnO4mq32fC9KxqLmZrB2RizRcGsuKQWGorKeI5jsk+vY/pXR3MYVTXO6psKlWG4E4xWDVjaLudVDMojLkjaBkmrWciuM0S/YRz2U7EyKDtJP3lx1rptLmM1jbuxyxQEn3xWsJXM5RsWzTKeajNUyRad9KaDThQgEzzSZp2KQrQK4immyqGGDRjFBbjmncZl3VsGzismXTIiSfLCn1XiujkINVZXjUEkgCspRRrGTMVbIKCMyYP+0aelrGgI2Zzzk1eaTd/q1LA9+g/OqV/eWdopN/exQj+6GA/U8n8BU2fcq9yGWOKJgwkkiPTEbkZ/AVMsV84zHdTxD1lcfyxmuV1PxzY2mRpkHmyDjzHGB/if0rkNU8WarqRYNMyIf4U4FZurGPW5rGjOfSx6nc6rb2Sk3+sM7j+GPaP6VkXPj7SYQcNNKR/ec/0ryeRZZc+Y7sT6moha4PSsZYmX2UbRwkftM9GufidbLuEVirr7tjP6VmXHxQlJJh020T3YFj+mK4/7NkfdqtcWjEfKtZyxFXozVYan2OlvviVrFyu2EQQD/pnHj+ea5LVNV1DUJGku7mSQn1bNKts65yDUEilSQQawnUqTXvM0jThH4USeHbieG5uDDIyuAHGD3FejaPq0fiGzkgvVBu/L2OP+e6dx/vDqK860dVGoTr6wnH1rTsfNiAkhYpIjZDL1B9a0o1HC3YmpTU/Ug8SaHLpN0IpD5lvKN9vMOjr/jS6Vr1mmknRvENnJdWCsXhkibbJCT1wfT2r1HShYeJ/DstjeBEebc0RP/LKcDkD0B4P4141eWvzOjDEiMVP1HFVUj7GXPDZmdN+0XLLdGvbWXhKdJVOo3UIMLFDJywcHgcDuKteJdLLaJpM+gF7nTthRlhXcY3B/iA7n1ripbdk6irWlavqWjyeZpl3LAc5IU8H6jpUKpFqzVvQ0dOS1TO9+FN0y6jLpuowOYZOSJFI+XoRzWnrtquk61Pbhi32WYxA+sZ5Qn3wRXL2nxN8SIB508c/Zg6A5HpmtCLVptas7m/vVVZ7i4GAOm1Vxx/ntWkpQdPlTu0ZxhNVOZqyZ6/4Pv8AdaKCa6rIdcnpXmHgqZ5F2g9K9CSRlgHritKc20jCtTtLQ53xYypE5FeVX++7uRAgyZGx9BXpXipz9mkOeMVwvhyHz9aBbnYoH61jXldnRQVonZeDPDiRRoWXkck16BFHa2sXzlVxWNcXsOj6QHYgEJu+pxXBTX2q65OTCZViJ4C9T/hW0HGirWuznlGVZ3bsjvtR1OzDECRPzrEnubSckBlJrGTwpevHmRZC3Ukk1kX2g6lZHfG0nHYEmpnOb1aNIU4LRM3bi3HVDxWRqOlJMpfG1/Ud6pWmszwSiG9Uq2cAnoa6W1uobhMEjnvWGkjb3onBPdXelT7FZvs5YBl988fhTdIVtT1SSVyTubaD7V0XinTla3ZgueOorL8BQhbpkbqrY5+tXTXvWIqW5eZHtnhm3W1sYkXoBW6WUjGawop/I03zAM7RVfT76aUjzAVcjOCOlezFqKseRKLk7mjqll56Bk4kU7lPoaisJC4w42yL1WrK38YkSF8mRuw5qw9oku2RBhuoYVdr6om9tGTQ9BVhahhDKAHHzeoHBqwoq0ZskU1KpqJakWrRLJaKB0oqyQooooAKKKKACg0UGgBKBRSUDRk3xEesW7Egb42X9azvEpIsJNvUkD8yKv6yMX1i3GN+OfqKpeIP9Sg9ZF/nXPU6m1PoamnqFjUDsKmumwlNsh+7FLeD5KPsi+0UEG5qfMQq0sYwCao6jcCNGYnAArPZGm7MzV7sRIQOWPAHqa54oSzPIcsf0qxIWmkM8udx+6D/AAiomOTXNLVnTFWRk38htytymQ0ZwSP7p/8Ar4rt/DvOm2qjtEv8q4jVRmCRMZ8zEf8A30QP616B4cg/cKB0AAFVSWoqr0LrDHFRsasXA2tiqzVozFCFsUeYKjaoXfFK5Vi0ZQBTDcpjO4VlXNyyKduM+9Yd1qt3Gx2KnHualyKVO51rXcfQMCfrVaW8P8CMfwwP1rirjXtQAJ2p+tYl9rupy5AkKD/ZFZuokXGg2ehXN1tBaadIk74PP5niufv/ABXp9oWFuvnyr/ETu5+p/pXCTvcznMru59WJNMSzdzzms3VfRG8aCXxM1tT8X6jeErE4hU/3PvfnXOTRyXEheRmZjySxyTWtDYf7NXotNzjis2nLc2jyw2ObjsN3arUWnY7V08OmY7VbTTc9qFTH7Q5NbD2pTp3H3a7SPSs/w1KNJ9v0qvZC9ocL/Zx/u0f2cx/hru/7KHpSjTF7j9KXsR+0PP5NLJzxWPqemOoJC816u+lKRwKzr3RQykbaToXQKoeNWRaDWolfPzgpXVWVq3mEY4qr4n0Z7O7iuUU4jcE/Su10vTVf7POvMcyhhWMaTWhcppK5m2UM9pJJCgK+cBJEfSRen5jI/KuDAkmu5Wk++zkt9c17rq2ih9GeaMETQDzY8eo5ryjWLVItblaJdscuJlHswz/WtqlPRXMqVRNsy5rQOmCorMubDZk4rqzACvSq9xa7l6ZrKdJNG6lY5IQ7QTiu0gSNtE0vysbBHz/vZ5zWIbUKxU9DV7RLiO0la0vCwtJjkOOsb9mHt61jGDV0+pUns+x3Hg29FvchSeDXqcTLPbgqe1eGt52nXQDEf3ldTwy9iK9C8J+IA6okrDmtaM+X3JGFaHN78S34ktzJaTDHODXC+FW2a04PVgDXrd3bx3cBZeQwryvWLOTQ9ejmCnyWOCe3WprwtqFGSasdH47cyGCLJ2MVFdL4Qs447UNgZI5Nc7rsX9qaCJrfmeJQ6j1I5qbwZriy2BjzhsYweorSElz8zIlFunZHY3usWdplXkRcf3jjNZtxf2d8hMLIxIrmdN8L/wBtXdzNqkjeaXO30xnisLWdKuNEupPsErKU6KTwwrV1ZyXNbQmNKmnyp6mh4j02GZSSoB9a5jTbmS2uWhck45B9RXS6Vqa61p+XGJF4Ye9c1q0YgvkI6jI/Dr/SuWpZ+8jpp3Xus6l3W6051bkha5jwm3la9NHj3rc0182zk9Nuf0rE8NYbxBO47cVVJ3miKitFns2lhZ7II/INWDaw2ys4wo6k1T0Jv3CitDUYmmtigXdkjI9q9lbHjvcoWM1tc6liFxvIycryMeldTCgVAq9AMCvKr/x14Z8MeIX0+5+2T6hbx+ZNBYWslw0CHndJsBC8c4znp7V6XpWqWeo6bY39pOrWt9Ek1u7fKZFdQykA4PII461rTTS1M5tN6F7bQFokljiCmV1QMdo3EDJ9B71iaN4q03Vte1zSLYypdaPLFBcGVQqs0i7lCHPPH0rSxmboFPArC03xPYah4s1jw7As41DS44ZZyyAIRKCV2nPPA54rajnhdGdJY2RCQzBgQpHXNMROOlFMhljmQPC6SIejKcj86fVCCiiigAooooAKDRQaAEoFFA70AZWv/LHbSdNsyms/xCP3MZ9JE/nWtrsfmaZP6qNw/DmsnXW3aa0oHGA/T6GueqbU+hrWLZQVJdDK1Q0yYNGpHQirszZWkneI2veKch2pXO6yxllSH+E/M/0reumwK5yRjLLK/wDtYH0FYVGbQRQuDziq2OtWpxyah28GskbmTeAvf2UK9Xl3H6LzXpWggJag+1efW8YfX4if+WcJP5nFeg6acWw+la0t7mNXVD7hsuTVZjU0x5NQVTJQxqrzKcVb4pjrUlJmJdRlqyri3JJ4rppIgc1Ulgz2qXE0Ujkri0Yg1Qk04seldm9oG7U1bAelR7O5qpnHx6USfu1dh0n/AGf0rqo7FR2FWUtVA6U1SQe0OYi0n/Zq9Bpf+zW8sKjtViKEVagiXNmNFpY9Ksppyj+GtcmONcuyqPUnFVJdUskOPNDn0Qbv5VXKkLmbI0sgB90UrWoHYUjann/VWlw+eh2gD9TUE15ddooY/wDrpMB/LNFkLmFeADoKhaH1FU57u66/a9PX23k/0qu0t8Tn7XpxXrzKw/pUNGimjVEY9KbJAjDoKzmOqohaOKC4xziGYEn8CBWbP4lktX23tncQH1ePj8+lTe25SalsO17So7mGRWQHI9KzPB7bYZNMm4ltm3xZ7pWrHr9ndr99efesfWGFvcQ6jp7KZozyP7w7is5NXuU7tWPQ1ZG07ZwSVINeL+ILZvKil2/NbSPayewByn6E/lXpmi6vb6la+bA+B0ZD1Q+hrmNZslbUbu1ONt9H8n/XVeV/PpVT95GVJ8ktTjo/mQU/HqKjtgUkaKQFWU4INaKQBxxXOtTuZkXNqH5AqlLAMFXFdH9lbpVe7sWK5xScbhzFaBzeeG7mGQ/6RZHzEY94ycEfTOD+NR6BqRV1+bpUumQn7a0B4FxE8R98jj9QK5yNJbSQnBK559qyqxukxQdm0e7+GNaSWMRs4PHc1f8AEOmw6nZspUMCK8e0LXFikXLEH1r0/QdcjmhCuwYVMJ6csiJws+aJzumXU+i3Bs77cYM4jkPTHof8adqmmsZxe6S4jl6sg+61ddqWmW+pwHgZIrlW03UdLciMebD2Unp9KTi46dCoyUtVuWNJ8TzWeI9RgkhcfxYJU/jXDeJNAs9X1K8vI/FvizzJ5GkFvBqH7tCTnai7eFHQCusl1ZYuLy1kB/3dwqAeIbKMkw2eZPUR1caso7MUqSlq4nHaT8NpYLN57nxR4qti3zbYtQ25+vy1hzeDjNelR4l8TOB/E9/k/ntr0G81C+1MGNEZFJqzpmi/ZojPc/Ko5+bvQ683pFgqMFrJHC3ngtbKwLt4r8WBiOF/tHg/htqt4Y8Dm8lZj4m8UREn70N/tJ/8dre1e5bULtliB8lTge9dP4WtVs4RLMML2Hcn0rajOpKWrMq1OCjsP0X4UyzRq0vjnx3F/wBc9Yx/7JXb+DPAn/CNanJe/wDCUeKtX8yEw+Rq2ofaIlyyncF2jDfLjPoT61d0HUo7gBFUr25NdNF0r1Iyujy5qzPHNKOufDvx74wuJPC2ra7Ya7creWt3paLIynB/dSAsCoBPB/x4w/G/h7UdT1/xFqHiPwRqerSato9tHoqW22ZdKn8oiSJm3AIRKQ28DGAcdcV9DpUyVsmZM+drjwnqFnr9rP8AEbwtqnjK3Og2tnbG0UXAt7hVAmUgsMMzDPmfr1xX8bfDO91gfE/UR4euJNTkkspNEcMd+VRA5Qg9RjBJ9K+lRThVkngfinwh4u1HUPie+j288N3qmladFaTlwnnsijzow2eCV3LzjlutchpnhTWNP0vxHLofhPVJmuNLjgm0y90hLW1kdJ4iGCLMTNIq+YewYDkknB+rBS0CPEPgB4Z1Tw/4s8VzTaZfafo97DaSWy3FpHaKzhW34hjZlTGRxnPrXuFFFMAooooAKKKKACg0UUAJRRRQBDex+baTRkZ3IR+lYSf6Ro0W45Jj2sT6jg10TDKketYOnqfss8TdY5WXp68/1rKormtNlbRpD9nTPXvWq7ZUViWh8m7miJ/i3DPoef55rXU5WueL6G0lqVLs8GuetgPKcZyQ5BrobscVgrhLmeP33j8aymaQK8qc1E6YU1ddc1E68VKRTZj2OF16UH+KIY/A13WnH9wBXC3S+Rq1nP0ViYyfr0rtdNbMYq4OzIqE0/WoKmnqEU29RLYeOlI3SnKKCKdhFdxULCrTrURT2p2LRX2jNPC1Js9aa7pEMswH1NBVwC0MyoCWIAHc1A08jgiJQi/35OB+VULi7UT/AGe1jN5d9y4+VPfFFxXL0l2ETeoCp/z0c7V/+v8AhVRNRe5fy7RJrkk8tGNiD/gRq1b6P57ibUD58vYH7q/QVcFxBDL5UZy4IXCrkA0WZLn2Kkel3UvMq20fpkGQ/mTVn+ynwQ95Io7CMKmPyFSXN35QzJIqL0yTioEuBKCyyZA60XSJ1YraTAw2ySSyA8HdKxz+tWIdF0+KPe8cYA7sM1HBIr8q2eafdSxGLZMRt9zihNCd9ixHb2W0eWAQOxXFI8dmRtaJD9VFVYrhFX92Qy/hVe+vRBbvLtLY7ChyQKLLcml6fNyIUVvVRg1A+lEAiOYup/hl+b8qzdN1G6mmPnxqqE4AXk/n+FbCysD8rUKSY2mjndU8KWdwT52nI4PPmW7bHH+Nc/ceCrQEi11G/tT/AHJ03D88V6THM/fpTHuIWk2bkL/3cjNS6cWXGrNdTyMeEdWsrzz9M1a0du+SRuHoRU93peuXHlMTafaImBDCYYBHQ16kLaCTJdI8e4FMaxsyN0ccDAdwoqPYpbF+3fU841bwtcaiDeI1vBfscyRB8ox9QexrJt9K1S1ci4s5CB3Qhh+ler/Y7JmIaCHJ/wBkUq6XpzN90Rn1U4o9im7jjiHFWPMoRFK2w/K/90jB/I1aksVaPgZrsda8MgxGSzfz+/lyndn/AHW6g1zdsHgOJA/l7tvzjDIf7rf40nT5dGaxrKWxyOoWr2ky3ESEtEQ4HrisjU7YLc+bHzDP+8X6HmvTb6xSeLcqg5FcnNYrFvtbkYhLFopD/AT2PsaynT0NFPqcZNp4dsplWHRhVjT72/0+Tk7wO4rpI9O2NhlwR2pJrJG4ZRXO6d9zRTL+h+Mo22pJKEfphq6u116KbAdkYeoNeZ3Wk25b5iu73qMaWyD91LKn+6xqOSUdgfKz1ab+z5xuljjPuapyR6RFyUjHevNZbW/AAiu5se7UiaRfTn9/eTFfQNRaT6BZLqdvqHiTSNNTEKKz9gOa5u/1O/144KmC17KOCfrS2GgxxEFYy7nqzcmun03QZpcfIQv0rSNKUtyXUjHUxtI0YF14zXZpo7G3i2KSFPIHUjFWorGLTLYyuuSO3vVnS7+aeQeYipEeFx/jXZTpqOhx1Kjlqi7ptkltEHCbAnIzVm3k1Bpw48sQHBG7Jq/DFui2vg5GD2qwkSjHBOOmTmuqMTmcie3LFFLgBvarK1ClTLWyMWPFOFNFOFUSxRS0gpaYC0UUUxBRRRQAUUUUAFFFFAAaSlNJQAViKBDrF1F0EyCQe5HB/TFbdYmtZh1PTpwOGcxN+I/xqJ7Fw3MnWAbW+huP4D8jfStSF9yA+opdWtVuLd0YcEdqzNGuDsa3l/1kJ2/UdjXI9JHStUXrnkVhaiBFcRTE4H3G/H/69dBMMrWPqcHm20ijrjI+orOaKiRYzTXSltD5luje3NSlcioTLZia3CH0+UhSWQb1x6it/wAOTi4to3U5DKDmqUyAggjiq3hycWlzJZscGNiU90PSnF2Ymro6e5GKrqas3BDqCKqr1q5bkR2JhS00U7rxVIGIcYyarSXCK21Qzt6KP61ZZBjmqz2yOSXLEf3c4FAIrSzsSQzBcfwx/M3/ANaq5Z15RFjJ/ic73rQdVQYUAD0FU5lzSY0ZWoXTxsiQ5kuJTtQuc4Pr+HWt/R7CPT7Pc3zSvyznqxrBuI0h1WynkH7sFlLHoCcYrrHCTQjyz0qodWE3ayIJ7uOOJjJL5Y9c4NZ1o1qzO9swbJyTnvUeqWjXDbZM7B2plpapA2UUDjHFRKTbBRVihqcb3F+TNIQiHCIAeRgc094neBo43xnjr1q7cwlzwayNSnmsgqwpudumelZstdjZ0mxaBt7SFievNZHiCCa9mkRZHXa2AoHb61paRcXDxKbhNhPFaM6oELFQTV2uib2ZzenW1xaQ7mcnHbJ5rQjuHeJmkjO3HOalJR8g8AVI7J5RjP3SMHFK1imzIj1qLz/KjjkJHA4wPwrTikdsOM4NRx2canKAEHkkiomv0SUxpG8gH3mUcCp1DR7Fm+uZRaOIyQxwMjsCcE/lVLS7cxyLMJWbPJJ+vStPy0eMEDhh0NJJCQoCjA9BVai8hNTuZDZOIjhjxxTLGCRQybyVYAsM9DT0tjIu1hkVcgg8tQqLgDsBTV2J2RCbbyiCnQc4ply7rEzImWAzgd60ZBHEm6eRUHuajEto5AWZDn3rSxFyjo9/M0W+4XYoOAM9fzqXXLOK5tWvbaNXYDEyD+Ne/wCIpb+z86LbE20+tWtOjFkuACyt1Gc0LswfdHEwz/Z5FQtvhb7jHuPf3qxfafFeQkgAgitLxDpaL/ql220rEhv+eUn+BrJ0m4eCXyLjgg4wazas7M6YS5lc5+SGXTSY7kNJbD7jqMtH/iPanlEkVWVlYMMhlPBHqK7K9so548gA1x99ZS6dIzwIXtydzxjqPdff2rOULGidzOk0tpbneHwD1FaVvparGFHQetWbXZNGjowZWGQR3/z6VeiQgjgkZqFFCcmZ0Gkea2QpAPQkdauLpIiUkrnBxXQ2Ea7RhQKsTQAjkVooIydRnO2VlKsgZsKmegHNdA9yLK0AWPfKQSqjvTooNvPrT5LTzHDYBOMc9q0irGcpX3KiXLXqCKaHDHBIxxTmikaURqu1QcL7mtW1tArl2OWP4AVctrUI4ZjuI6e1Wo3M3JLYtwrtUA1MgpoFSoK3SMWPUVKtNUU8VoiBwpRSClFUJiilpBS0CFooopgFFFFABRRRQAUUUUAFJS0lAxRWX4hgabTZDGP3seHQjqCORWmKSRdyEevFKSurAnZ3M6GRbq0jlXGJEDfmK53U4ms76O5QfKDtf3U9/wAK3NMUQvcWh4Eb7kHorc/z3D8KNSthNCwPQiuWSujojKzIUYSRhlIINVpozzxUWkF4y9tIclOVPtV9l5rNq5ezObt829zJC2du7j6Hp/UVfwKl1KyLASxj94o49x6VXglEi57jgjuDWLVma3uRTrWPqUMgZLm2z58fYfxDuK3ZBkVRlGCaQJlzTL9Lu1VlbqOmeQfSrq+tcp5g0y9FwM+RMwVwOzdjXURNuUVadyWrEopQeabQOtWiSQnNManCkaqEQSCoSKsPULCpZRVuI1dSGUEHgg96rRNcWRBtGLxjrEzfyPb6dK0GWomWp2KJoL2K8UggrIPvKwwRTvLAPFUJrZJSCwIcdHU4I/GnW929myrendHnAlA6f73p9ad77k2tsXhECeaSW2ikwzDkdDV3y454w8LAg9MGq7hkOCKpxsSncquRHwBS8yrg1K0Rc9Kmigx2qUmO5nGzOTiqt4Vtl3Pniuh8hj2qjf6X9pQq44NDg+g1NdSjaTJMgK9D2NS2tkkcjMuNrdjUlppptxjJPPU1dSHAoUX1ByXQhWLLA9qsrFnjFSxxgcscCkk1Cztsgku4/hUZNWo9yG+xLFa57cVQ1jUYLBSikNOeFQetNu9Wup49trCYQf4peo/AVlLbrGxkcmSZuWkbkk/0olNLSI4xb1Y23dyzT3Pzzt3b+EegqRpg/wB4A9uRTHBNMCGseZmvKizZ3DW0mHLPAT3OdtbqLDcIGhkHPvXOLkUiiSJ99s/lt3H8Jq41LbkSh2OimhzG8UqiSJxhhXG6nZEXLorE3MXKessfb6sOlbcerXEY2zQOx9UGQaqXq/bJhNIvlMq4XByc5zk1cnFrQULxZU0u+3DY55HGDVq7t0mXIFZN7BI03nQAC5AzIg6SD+8Perem36zIA3BHBB6io3OlO5kyWrWMzSRrugY5kjH/AKEPetO1KkKdwZG+6/r7fWr88KyJkVlmN7WQlF3xN9+Psfce9ZtWHJXWh0VnGMDFXxGCOQKxtMu0wuGzGeAT1X2Nb0eDito6nJLRkflYU4FSJGOKlAFOUVokRcEXFToKYoqVRVohj161OgqFanXpVoljxThTRThVokcKUUgpRTEKKWkpaYC0UUUCCiiigAooooAKKKKACg0UGgBKU0lKKBmDqpNlrFpd8eVKPIkPpk5U/n/OtKRdy4pNXtRd6fNFjLFTt9j2P51Bpdz9qsY3PDgYcejDrWElZmid0Z90n2eUTgfcPze69/8AH8KuEBlDLyDzU1zHuHSqtgPLD27H7hyv+72rO1jRO6LCxiSIgjmuf1O2aCQyxg57gd//AK9dNCMNiq2qW+6MsBUzhdDjOzsc4JA6BlOQRVaU08oYpXT+H7w9qikNcxuZmsIJYYISSPMmVePxroNGZmt/Lk/1kR2N+HesRP8ASNZhjAysKl2+p4FdFaQeXdO46Ooz9auK1FJ6WLTLTMVYYcVERWljO4qigilUU7FMCFlqMrU5FJtzQFyuUqNkq3tppWpsO5SK4pjqrKVYZBGCDVxo6jMdKw7mdDBNZsWsZdqn/lm/K/h6VeTVdoxd27g/3kG4fpSmOk8umm0Dsxy6rYk8SAfUYqQ6rar0kT86rGAHqqn8Kctug/5Zr+VPmYuVE51u2HHmD8jSHWI24RZHP+yhpiwIP4F/KpVjA6AD8KOaQrIi+2TSEbbWTHqxA/rTS9854EUY/wB4k/yq2FpdtGoaFL7Kz4M80j+oBwPyp8cEcQIjQLnrjvVoimlaVh3Kziq7rV5lqJkpNDTKRSgJVox+1Hl0uUfMVvLo8qrOylC0cocxW8s4qOSI1f20jICOlVYVzDngD43ZBHII6g1RuoX3+Zws/wDeHCv9fQ10csOe1VXh6gjI9DSsUpGdZXp3GOThhwQeoq+8YkXIqpc2OMFQSgHBH3k/xHtRazvA4jnIwfut2b/6/tT9TRTHGBo3MkIG8jDKejj0NbWmXO+NR82OnPVT6GqqgOMilRTFJ5kY5/iA/iH+NUlYmaUjeQ9KlUVTt5Aygg5FW0NapHK9CVRTwKatSKKpIgctSrTFFSAVaRLHinCmjpThVEjqUUlLTAWlpKWmAtFFFAgooooAKKKKACiiigAooooASlFFAoGBrBhVdP1maE/6u6JkT/e7j/PoK3qzNes2urPfFxPCfMj9yO341E1dDg9bFhhkVTnXy3WUdFOG+lO066F1bo4PLAGrEkYdSD0IxWO5psA4INSSqHjIPeoIM+WFPJX5al3fLimgZzWp25SQkVlSfLljwBXUX6BwQawLi0aZvLxiM/ePr7VyzjrodMXdalbw/an5rhxh5mLfQdh+VdMkWFzUenWmADjAFXpF2jFaxjZGcpXZVYVFipyKYVp2FcYBS4p2OKAKQxuKTFPIoxRYBmKQrzUuKMU7CICtNK1Y20hWlYLlfZR5dT7aNtFguQbKAlT7aNtFguQ7KULUoWlC0WC5GFpdtS7aXbTsFyDbSFan2UbKLCuVdtJsq1sFRzvDAu6aVI19XYAfrRYdyDZSbKik1XT0/wCXqNv9z5v5VA2t2Y+75jfRf8am8e5Vpdi3spNlVI9YtpBxHMPqo/xqVdQhb+GT8h/jRdCs0TbaQimi7gPUkfUVIssT/dkU/jTSQhhWs/WL6x0iwkvdVu4LO0jxvmncIo9OTWrtryv46WUzP4T1Oexm1HQtN1IT6jbRR+YdmAFcp/EF5yPeqUbsTlY7Hw14i0XxJFNJoOp2t+sJAk8l8lM5xuHUZwceuDWjPp6PnCgofvIf5ivJfGPiaw1nw/Nd+CINStrMX9lHrOo2VjJbytZkyb/LO0OxTvgcB/QmsC41DXU0XxUfCd/4gn8JR3lksN6xle5jhIP2kwM43kA7ee3JHc1Xsxc9j2m81Cy0Oaxg1G6EX22cW1tuBJeQ8hOB14PJq3rOqafosNtLqlytulxOltEzAndI/wB1eB3xXjOvWGlaxb+FIPCuo6/e6efEkQkuZZZ2eDMRyY3kG5QMg56Ak1UurLVk0WfTJn1S+t9O8cW8dq92XlkEAOc7jyVHPPSmoIftWfREKlauR18waxf+JY/GurPqOtXel6vb6sTZQubxlltgw2JHFGhidGXqSc5znFT6zrOsyfEL7VpMmtWVxb+I47aa1ee7laS3MmCzLjyEiI6LycY571SiTKdz6gSpVryb4a6dqmoeNvFep6rrGv8AlafrdxFaWT3LC1aIpgfIR8yjdkDOAQCBnNVvihduvxR0S08Q3+u2HhNtPd4W0szr51/5mAjGEFj8mCB6/U1SRDZ6p4b1vTvEej2+q6JdLd6fcbvKmUEBtrFTwQDwVI/CtYV8u/DbWL/wfoXwnn1Y6vZ6GY9UhvIooZnVpWmfyg8SAkkk/LkH271Jp2ra5L4V8ESeLtS8SWvhue91AardRvOJ8hz9nSVl/eKh6cf0GKsTc+ln1Gyi1GHT5Ly2S/mQyR2zSqJXQdWVM5IHqKuivmfX7XRYPH/gbVpNa8VR+HJdOuIIdRaa5EpYSkohYDeA2cYIyyhc19LimIcKdTRSigBRS0UUxC0UUUAFFFFABRRRQAUUUUAFFFFABSUtJQAtBoFFAGHDH9l1G4gHCP8Avo/YH7w/Pn8a0VORVPX8wpBdr/ywcb/9w8H+n5VZjOenINc7VmbrVXFxhifWlIzT6FFIV7FKeMsc4qAW43VqMmeaj2fNS5SlIdAgji6VVmOWq5IcJiqbcmql2JXciIppFSkUxhUMsixRin4pKQxMUUuKXFMAApcUopQKdhXG7aNtPxRiiwiMrSbalxRinYRFtpdtSbaXbRYLkW2lCVLtp2KLBciC0u2nOyxoXkYKo5JJwBWPfa2oUrZgMf77dPwFKTUdxpOWxqTPHCm6V1RfVjisDV/E1vZwu1uhmYDqflX/ABrFvrl5XLzSM7epNcZ4u1LZbGKI5lc4AFclXENL3TrpYdSepqaT4u1fWby5eScRWyMVRIV2j8+p/Oubmd7zxLNLK7yFOMsSe9aehWn9m6MWlIDEFj9TWfoiedcTThcF5Dz9K4oylOXvM9BxjBPlR1VouEUVbAxUNuvyipLhikZIIz711I43uTwPhgCa04CDjFYW7Yu5uSOSRV+yulOMEkH2rSLMpI1wgI5pTCPSkhkDCrS4NbIxZDGjp9x2X6GoNR1yLS7jS4LuOR21G6+yRGMDAfy3ky2SMDEbdM84rSC1zHjmw1C4k8O3Wl2TXz6fqYupYUkRGKeRMmQXIHWRe9XFESZ0Gp6zpWkrC2ralZWAmbZGbqdYt7ei7iMn2FGo61pGlz28Op6pYWc1wcQx3FwkbS/7oYjP4Vxd7bay/iKTW38LzXkd1pv9n/YXuIN0DCRmLMS+3Y4cA7SW/djg1B4T8Paz4RkaG70lvEAudOs7Q3EUsQERhjKMj+awPl5O4FQx+Y5X10SIudzB4h0OfUbiwg1jTZL+33Ga2S6QyRbfvblByMd89Ko6F4z0fXLHTrrSphcpezCDYkse+FirsN67sjiM8DJ74xkjkLbw94lvvFWiXeqWt4TZatPcTSGe3FmIGjmVfJjT5ySHTcXGc565yJdB8K6zHovhTTJNKaxl0bUzJPdebEVmj8m5QSR7WLHBkj4YKeenBNVZCueh2muaRdXd3aWuq2E11Zgm5hjuEZ4QOu9Qcr+NS6VrWk6rcTQaZqlheTwAGWO3uEkaMHoWCkkZ968z03wlrj6b4e0uTR1sn0GxubeW98+Mpfs9u0QEe1i2HZhI28LgqOvWul8K+GL7TNb8K3EltFFBYeHH0642MvyzF7chcDqPkkORx+dOwrnV6prWlaO1uur6nY2DXDbIRdXCRGRvRdxGTz2rMfxhat46/wCEXtI0nvIoUmuWNxGnlBwxUBCdznCZIA4DKe9YvinR9Uj8Tavf2uif27b6ppSaeiebEn2ZlaUnf5jD92/mLkruPyfdPFWfAHhO90HXbmbUPLuANG0yxW7yC0ssCzLK3qM7k5PXPtTsK5v+K/FOkeFtOmudWv7OCUQySw281wkclwUUnagY/MT049adbeLdCeTT7e51bTrXUL6KOWGymuo1mbeAQAhOT17CuQ8Y6JrLaz4qksNFbVV1zR0sLedZokFqyiUFH3sCEJkVsoG5zkDANYHizwp4u1PTLzShaXskJtbNLMW1zbRWwaNI/M8/J81nDh8YyuAvQ5NMR6xceI9DttQWxudZ02G+Zii28l0iyFgAxAUnOQCDj0NRjxb4c/sltU/4SDSP7MWTyWu/tsfkiT+4X3bd3tnNcTrHgq/vdM8XRfYbeSbUvEVlfw7in7y3jNpuJJ6YEU3yn39eU1/QfElv4i1q90i3n+w32oWs0v2CSBbpoktSjGIzHYreYEBJwducGmI76fxHolto8erXGs6bFpUmAl690iwtnOMOTtPQ9+1Fz4m0G00yLUrvW9Lg06Vikd1LdxrE7AkYDk4JyCMZ7V5FY6Xe+CpNH1jWktkSHUtSdLS/1KCORhcbWSUSMwQyKEfIznDsRnnNbwt4e1m70fw34gsYNRe2Uaov2fS5rdJkWe9eVJIzcAIyMmO6kjaRkEigR7F4h8VaLoOmLe6jqlhCksbSWwluUT7ThdwEeT8xPHTPUVd0TUo9V0Kw1RVMMV3bR3IVzygdQ2CfbNeU2XhLVtAiuY9P8PXV/BfaEunQLNd25ksHEk7MkhJUbG85OYw2PLAxgA11+oeGtQvvg6PDcbRwam2jx2ZDN8nmCIKVJH8JIKkjPB70wNiHxdot4Yf7J1Gz1QPdLaObK6hkELsGI3/P/sngZb0B5xW8P+M7LV7S2uHia0hlgublpJpYwkSQS+WxbLZ75zjaADkg4BxL6y1XXpdAdfDEmjDTtStZpBNNbktEiSghfKdvlUsMZwTuPyjmuesPB/irTbG2k0+3tl1C30XVLRPNdHUTT3kcsYwcg5RWPIK5wDQB6nomu6Rr0Dz6HqlhqUKNtaSzuEmVT6EqTg1o15x8PNB1ay8Z6xq+oW+qRW13p9rArapcwSzvJHJMWyISUUAOuMfp0Ho9ABRRRQAUUUUAFFFFABSUtFAAKKQUtAEN5CtxbSRP911KmsrRHZrFUkzviYxHPXg8fpits9Kx4F8jVrqLGFlAlX3PQ/0rOa6mkH0L9KtJSioQ2SDpUbjBqRTUcvQ1UiVuRyHIquRUppprM0IyOKYQec1MRTGFJjIiKTFOI5pMUhhijFKKXFMQmKUUAU4CmAClxRS4piYlGKWloEJilxSgUoFVYQmKyfEOvWWhW2+7kBmYfu4Qfmc/4e9O1nW7bTpFt96tduMrHnoPU+g/nXkvj7Sr27vP7RhkZ7jHzZPUeg9vauTEYlU/djudeGw3tHeWiKHi/wAYapdanBcTSFbJTgQJwq+59T7n9K3dL1oXFupLY4rgA7XCm2u0McnTa39Kjtri90l2QDzIT055FeeqrbvI9KVBWtFHZ63rXko20nJ6Vl6Dp8uo34ubv5gvKrjpWZYT/wBq6kCQcL1U9jXo9v5GnaeMbfMIqZO7Go8iOb8Y3f2exMSYG4hal0GBUtol9B+tYfjCYSwMc8j5s+hrb8OybreLnsKdLcKukbHRxjApZV3xsPbtTV4qQDIrqRwsq7sx4KsD3GKsw7tgI+8KCtKOKaEy5ZTEZDAjnvWlFcYGSeKwjNt6AsfQVYVi23nHfFaKRDidDDMH6Diqup6oLLVdEsy0Q/tC4khw4bcdsLyfLgYz8nfAxnviqcUzxvuLEp3HpVXVrQ6jrnh67jnCf2bcyXBXbneGgkix7f6zP4VtGa6mMovoWfDvjbSNeurKGx+2KL63a5tJZ7Z4kuEXbu2FgMkbh/MZFXtb8T2WjX9vYSw31zfTwvPFb2ls8zMiFQx4GBguvUjrWD4b8JNpcPg5GvUl/sGzktWIjx529EXcOePu+/Wl8Q2mtyfETSr3Q0tlWPSbqF5ruN2iBaa3IXKkYY7SR6hT9RsmjJ3NO48c6VBplvqcUOo3Omy2/wBrN1b2bvHFHzkucZBGDlcZGORVVviDD/bPiDT1tJhHp1ol1FeeTI0DgwvJl2VcKuFGDzu6DmuZ1D4VSz2C2IvNOvoDp5tM6jaNL9nmLSM88KBgoZmk78rsXBOMVtnwXqMUmqQ2t/afYtU0qPT7jzIm8xGjheNXTBwQS4JB9DzzxSaJ1Ny68eaTYwq119qkWK3iubye2tZJIbRHXcGkbHyjHOOoXkgDmprjx1osGpS2bm8IgvI7Ce4W2cwQzSBNitJjb83mIMjONwziuNuvhnjUbi5hi0K/F5BBFP8A2pZNKY3jiWLcm1hlSqL8hxyOvNdPc+BjcaXr1rDexoup6za6qhEXESwm2Pl4zzn7Mee27pxVKwndEej/ABGsbm31ia/sr+0Wxv3sUP2WRhO3miJFQ7eZGZgNg5Gfxrr9F1FNUs/tCW15bYYoYruBonBHseo9xkGuQfwbqQs/EOnbtEvdL1G8kvo4b+1eT5ndXKOAwGAQdrDkHaccc73gTQLnw7ojWd3d/aXeeSZVVnZIFY8RIXYttHuepPQYAYitF4+8OPDBJ9v2rLYzaiA0bAiGI4kJGOCCD8vX5W9DWRrfxHj0yc+VaSXkTX1laCOCGUyxrPGHyy7eWweFHXpwap3/AMKIru01SH+0mR7vUmuY2EXEVq5l822xnkMLm657eYOOK09d8DXd5qGqahY31vHdT6hY6hbpNESitbqq7HwckNg8jp70xESfEeC113WrfVbW6h06za02TrZyDyVmiVszk8LhmxjAIHUcE10Hj/xIfCXhefVxaSXZikijESKxJ3yKueAemfzwO9YmpeB7vVNO8VR3V/Al1ryW28xxHZC8caq2ATkglSR7Guh8caHJ4k8LXulwXCW802x45XTcqujq65AIJGVAOD0oAyJ/G2lr/a8mrI0Wn2FvazvFNaSidPOkkjG6Mr3KDAGT1z2zZ/4WBosdreTXQv7Z7S5gtZYJbOQTB5iBFiMAsQxYYwPUdRWTqXgbUdYGuz6jf2kd3qsFhEwgiYpGbaeSTIycncHA7YIz7Vb1nwPJqWu32oLfJGtze6XdhDGTtFpLvK5z/F0z296BFpfG9ldfZRa77eY6ommXFvewvHLG7RmQDaAeSu1gT8uD1zVPwh8R7HXNOtp72zvrCW51CTT4hLbSBHcSyooDFQCSIiWH8J4NPu/A8k/iK51MXyKs2t22r+X5ZyBFarBsznqSu7P4YrOXwNrUGmRWVtqGnGPT9YbV9OaSF8sXmlkeObB6ATMAV9AcdqYHS3njXSLZZArXNxcLfNpq21vAzyyTqnmMqr3AQFiemB1rc028TULGG6jiniWVciO4iaKRfZlYZBrgZfAV/Lot/BeNoep3N5qr6m63VrIscZZFUeWVfcjrjh8nIJHGc12HhHSZ9D8N6fpt3fSX89tHse4kJy5yT/EScDOBkk4AySeaANeiiigAooooAKKKKACiiigAooooASlpKWgArM1fEMttdf8APN9rf7p4/wDr1p1BewLdWssL/ddStKSuhxdmIKXFUtMmL2wWQ5liPlvnuR3/AB6/jV4GsUzRoBTX5pxNRM1OTEkRmmnilY80wmszQWmtS5piEEEZ5U4NAARTcU/FJigBtKKUClxTEJilApcUUwACnUUuKYhKXFLilxTFcTFYni3XBomms8QEl24IiQ9M/wB4+wrU1K7SwsZrmQZEakhR1Y9hXhV3rl7fa/P/AGqw3TZKADCqOyj6Vx4zE+xjaO7OvCYf20uaWyMXRNSu38Vzy3k7Sy3Db5Gc8k/57V61cxpNpySA5O2vI9VtGtNQS7iHzKd31rtNK1zzrFMNlSPyrylNPVnrThty9Cjr+lQ3SZ4V15VvSsC3jEm6CcqZF7juK6DVp2aNmQbh6Zrkor1PtbBj5Ug4GRwaLXRSdjSsLZbO73IMZ610NxK9xBg9hxWFDchmUSoc+q8irck52fu3GPSplLlQ9zCv54rtjbzny584B7MK09IujayJFMCgHAJ6H6Vy+suBqMbkZ6qa2dOuWaBUZRNF3Vuo+laU3pdGNTsd/bTLIBhgavIMiuJsZWjk3WcjMo6wydR9DW/Y6sH+WRSrd1brXVGaZySgzZK4phojnSQDmnlc9K0M7FWEETybjyelWkIzx1ppQHqM1IgxjjFCEydTgVj+Nruew8Ia5f2Uphu7WwnmicKDtZY2YHB4PIHWtXOK5/4hv/xb/wATD10y6/8ARTVcXqiWtDV8E6tcX3gzQb28k8y6udPt5pXwF3O0aljgcDJJ6VvxakoPJrhPAcpX4f8Ahof9Qu2/9FLTtQ1B4MkZ4q3OzJULo9Fg1BX/AIqvJMrDivGR4muoQzRox9C3StbSfH8Wdl4mwjjK9KqNVClQfQ9R31Pa3PlthuUPWub0zXLW/jDW8qt+Naazg+/0rVTMnDozpVIIBByDzS1l6ZdHcIpPun7vtWrit4yUldGMlZhRRilqiQooooAWlFJSigQtFFFMBaKKKACiiigAooooAKKKKACiiigAooooAKBQaKACikpaAMK+V7HVFnQHyLjCSeit2NX0kqe8t0ubeSKQZVxg1h2c0kUjWl0f38fQ/wB9exrnmuV3NoPmRsbgaY9VxL60GTipuUlYczUwmo2kqNpKVxk++qlvP/xNJoCeqBx/Knq2TWU9w39upMo/0eAeXI3+90/UUrjSOiAoxTgMjPalxWljMjxSgU7FAFMdxuKXFOxRigQgFOxSgU4CmITFKBS4rjPil4lGgaCIIH2399mKHHVR/E34A4+pFTUmqcXN9CqcHUkorqQ+KNYiuneOKRTFGSBg8E9zXl/iG3e5CTQPGSjbgwPNQ6beTjapfcK0LmKK8ADKA3qOK+clWdWTlI9+FH2KtEFUXdsFmjZXx3Gf1qiLCW2cm1kG08lc8GpF0y8hy1tPIB6buKaz6jEmJMOB/eTNNQ7DcmTMJvL+dCKyb/TVucnaQ/ripp9SuEb5oFx/skiq769JEcNDIR7MKtKSFzFCFL2xlBRiyjqrcg1qDVbd1/0u2aJv70f+FVT4ii3HzLeQj04pTr1gy/PayMMdDiiSb3RNyre21tfTI9pdoXB+65wa17Gwu7floGI65XkVif21pcEokWxKkHnOK37HxpCXCC2k24470lzLZClctb4gAZUZG6ZIIIp32rGFYrOp4zn5hWjDr9hOg+0WzgHjla1bKXRJ1BXygfQkCq9oupg9OhlRxXXlmS1kDL12PnNSQ6vPBgXEMqj1xkV08VtYjDxAA44NS+RBzkqfrVKs0RdHPx6/btwWAb0PFWI9Vhfow/OtGXT7KT76x/lUA0jTQTwuDVe3fYVoldtSizgSLn0zXPeP79H8DeIlDgltNuR1/wCmTV07aNpOc7Bn1zWJ4/stMh8A+JTGi7xplyV+vlNitIVnzImSVmZfga+A8D+HU6kadbDr/wBMlq7eGadR5VvI2emEJq78O57GHwB4a/dpv/sy23H1PlLmt59YtohwIwPrU1Kz5mgjolocOPD2p3TD9yyof7xxVmLwOo5upGLei8VvXni61twd0qD8a5zUfiBCCwgV5G9hxUqU3sXeTNW20B9P+axnKMOx71taRrxEpt7393ID0Y9R6ivMbnxtfyKxQrFnpnmqdrLqWrOZcyzEHIboBXRTc18TFKnfc+hbedGUMGGOuc10GnXS3MX3suvB/wAa8X8N+IJUaK0v8iQcdeDXpeiXyB1dSNvQgeldtKpZnFVp2OoooByMjpRXYcoUtJS0ALQKSlFAhaKKKYC0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAJS5oNJQAtZmsaaL2JSjmK4jO6OReoP8AhWmKCMik1dWY07O6OQttQdZGt9RUQ3Ccbuit9KvMTWlqOnQXqYlT5h0YcEfjWA9jfWDERM0sX8I27hj+Y/CuWUGjojNMskmlVSTUaS3JUE2Tt67f/r4oWDUr1tqR/Y4e7scufoO1Sosd0MnuCZPs1sPMmb5eO319h3q+ulLDo08Iy8jAuzY5Zuv/ANaren6bDZKBGuW7u3LH8a0McVvCnbcylO+xkaTJ52m2799u0/Ucf0q0RVPTF+z3V7akYCv5if7rf/XBq8RRYGxlJTzSUAJS0YpaACnCgUtMQV82/FXXP7W8eSlGzb2i/ZoueDgncfxOfwAr33xTqKaXoV1cPMsLlfLjdjj524H68/hXy14jsLrT5/MuFZ0JyJVGQfrXBj5NxUEd+XxSk5s3dPbOCDW1Ync9cppdzmNWzxXUaWwYgg14vLY9hu51FjFuQcVeNirJyv6U3RkDKBiulS2BTpXVThc5J1LM4TUNLi5JjFYV1pcJPKV6PfWec4WuevLPk4FU42HGomcVNpELA4Xmse90pVHyiu4mtyM8Vi6oPLUAIXYnHH9anVGiaZwd7YkHoefSpNDRkkZJFICcg+oroSbGAF9QnTd2jj5NUb/WoI1JsrVEUD7z8saLt6JCvc27S3kuFDRRvjpknAqyLOOGQG7uoIx6K2Sa5601JrlAXlZlPOM4A/CnXV/BApJC5+lCg+pm07nZprlpZIBHJLIMdhxWde+PEh3KkZ3ds1xT3F7qDbYAyxn0rT07wrNL88/A6ln4FHJFDVPqyzP45v5T+7QL9ear/wDCV6vJ0bA/3a27bQtLgx511ET6J838qv8A2XRIh0lf/dj/AMaaprsOy6HHTeKdZHAYn/gNYviXxHqVx4d1WGd/ke1lU8dihr0rydGcECK4HuYx/jXPeN9L0w+FNbkhfDpZTMoZCORGxFXCCUloTNe69DlfDuv3UfhzSoVuMKlpEoA7AIKsSatPMPmmc/8AAqn0Dwmt14U0e4gYM0llC5CnJBMYNVn06TT5/wB9DuUdcrVyspOwoJcqGiUyMABuY9McmtLT9C1O/YCOBo1P8T8fpXQ+GdT0lWCtHEjj+8ADXoemyQzBTDtCnpilzSehEpcpxekeAYoyr6g7TtnOztn6V2dto8UFtsijAXHQCtmGKNf4hj0FXQF8s7QPrUXd9TGVRs8z1ey2uTjaQchhwRW14O1dxL9muGAkT/x4etO8SABWY4xXIyXv2UpKrbZEbI9/at6VS4OPMj6H0i48+0HOSvH4VeriPh/qX2uBJC3EgwR6V29erTd4nm1I8srBS0UVoZhQKKBQMWiilFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACUUvekoGLSFQaBS0CG7BTgAKKKACiijtQBh60/2LUbS8/gc+RJ9DyDWmwqHWrP7dp0sQ+/jcn+8OlM0uc3OnQSNw5XDA9iODWbWpotibFGKcRSYpAJilFGKWgAxS0AUtNCPE/2nb24bRtH0u0SRmkna6cpn5Qi7Vz9d5/KvLvDep6iLLytWiM1sOPmHOPWul+Ofi++g+IlxZW8oFraQxxFCMgsRvJ/8ex+FaHhZY9TsNtzGgaReCtebiPem7Hp0fcpq5x+oQLZOstqxNrLyv8As+1beg3fzKCeKivdOfN7pMvLAF4vXisnw/MQwRs7lODn1rhnHqehTldWPY9AkBCmuwtzlRXnfhu5+QAmu5s5soPpW9PY46y1LE8YIrJu7UHJxWszZqKRAw6UbshaHI31ttBOK5nU4VKkGu61OMANXFavwTilNWN6crnLvp0AdmCAsT1rE1eBUjk2qOhrqGI5zXO69IEjfPpWPU6Uc5Z3LRwgLktngCui0TQ576QSz9D69qi8HaC91OsswOOoB7V26gzP9lslKwA4LDq5/wAKpu7shJdCtCsFkBFZQiaYcbyPlB/rV230S81GQNcFpPQN90fQdK6nR9AgtIRNdEA4yAauveJEcQqAKtQS3GtfhVzJtPCYAHnOBWknhyyjX53BqObUWP3mxWdd6wEB2nJp3iug+Wo+poyaVYxg4ANcZ8RktIfBmv7cA/YJwPr5bYq5ca1IynBrmPEqXmq6NdRw8LdJLaFyAdgK4J5PfcR9BTjKLaZM4TUXci8PeRaeE/DgunMU0un27xpCNzsDGuDnIA/WtotDMqpMXkX+JZ0CuB6gjr9Kr+H4YLTRtMsNSmguFsoEgQqN0g2qBxtyO3Qk10N0kN1pyS28yyBDtVDCVcN0wef6U5JNuxinaKUtzmNe8GywnzrQHGMgis/SdevdImWG53bQcZr3aCzj/s6GK4UblQKSfpXBeK/DtjOXCSRiQ9FyMmhxcTKM1PRmt4f1mG/RTu+bqRW7dXq7RHGa8N8y90C8wC2zPGa6my8TmW235HmgYxXPKL3QnTNHxZqSq3lZ6VxUU7Xd6245VTT9ZvJJS7scu5p+iWrBRwSzcmuijHlQ9kepfDiRo7bbk8HIr1qNgyKw7jNea+D7T7PZpkfNXoli261TPYYr06G1jzK+ruT0tFFdBzhQKKBQMWgUClFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABSUtBoASiiigYZpc02igAzRmikpAOrItgbTVbi3P+qm/fR/X+If1rWFUdVgLpFcRj97btvHuO4/EUmNFg0mKEYOiupyrDIpakYmKKWigApcUUtMD4n+JF4L/x74gnPzA3sqA/7KsVH6AV2nwyu2uLELuO+M4rlNU1Dwhqd/cTFb+0mllZ2YAEEkk1u+C9Q0DSLkmLUmdWOdrLivLktbnrfZsdt4ngEU1jqMYwVcLIfY8VwN4otfEFyIxhGYMMe9egeK9RtH8Mu8UyMkmCmD15zXC+IVIvNOmH3Z4sfjXPWWuhth33Or0G6wV5rvtOusqvNeW6S5QL7V3GlT/KozWUZWNakLnZxSbsVMSAtZtlJlasSzYU1pF6nLKJnao4w1cPq/LGus1J/lauU1Abs05yuaU1YwXOM5rBubb+09Yitk5RDvf+grY1J/KjY1H4FgErzXj/APLRy2T/AHR0rJux0rY6EQJZWiW0WBLIPmx2X/69b+h2sVrB50oG7sMVh23+kXZmbnecj2XsK1Lq5IQKD0FXHQpR01LN7qDOx3Nx6VlXF+QODVK7udgJY/nXOahrEKkqWJzxjPWjcpyUdDfm1AMcGUZ9M1VNwHY7Ud/oK5wajKR/osBHvimfbNWzkKoHvSsT7V9DpzIfLy9rNj/cJ/lVC4txqFkbaOXZLFK0qRsdvmK2MjnuCDx71kx67qNqf3sRI/2TWha+JrW9xHeRAn/bGCKa0JlOTN7RcWsREFi6XB+XMowPqO5/DrXV+EdFkgaS/wBVBjiUmQCUYLN/fI7cdBWX4e1mxhZGiiRWxjdgbvzrX8SauLqwhgif5ZGy/uoHT88VomkrnPJTnLl7kl9qE2rTFLculsOAASC/uf8ACsS/02WEljHx9K1NEuo4AC3JNdDN5N9akYG7HFJR59b6nTf2L5UtDzG9gjvbdobnG/ojHr9DXEvHLpt80chOO3vXpGsWfkyMCOK5fX7UXVoX481O/t2qE+jCrTS96OxihhdX0QHKrya7Tw/b5nT5a8+0Bz/aRR/XFereHYwJUJrpgcNXQ9E0iLbCv0rqNNP7kr6Gud07HkrW5pJBMo+hrvpaM8ypqaVFFFdBiFKKSlpiClFJS0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUGiigBKKKKBiUUtJSAKSlpKAFoPNFFAEEcQiBVfu5yB6U7FSlKTZ70rDuR0YqYD1xQR6AUWFcixRUoHHSkKjFFgufny8RDEHqDTCp+nuK3des/suu6jb4wYrmSPH0YiqLRDGcV5Gx7qWlxtvdXcjRQCV2BIVVyT1r0PXmBu9PgyP8AR4ufrXKeDrD7Vr0LEZWH94QenHStO4uHmvnndiSzHBPpmsqnkXT3Oq08/KK6/SX+Va4nTJAVAzXX6Q/yrXKbvY7TT2+Wp5mqppzfKKtTjitYnNLcyNQOVaucvBnNdHeg4IrCul4NJsqJxfiQlbSZvRSa0/DMQh8NqAMFown58VmeLDssZv8AdNb+gJv0a3UDptNSzd7F2ICLGOwxUNzLgFiatNHWB4knaC3ZUPzEYH1rQblYxNSv5767NtactnBb0rX0TwaZSJJwzsepNXPA+iqAskq5cnLE16zo9gm0cDFVFOTsjnqT5dWcZZeEECDCfpVp/CkaryleiiOKJegFVZniYkZFbuiktTmVeTeh5VqPhaLnCVymq+F9pJVa9xvLeN0OMVzWpWinPArGUGjeNS54s0d5pj5jZig6g1uafrTXQjXeFlTkA9CO4rf1bT0cNlRXFalp7W8vmQ5GPSpNk+p21vc5CuhO09R6H0rqNJ1AFVUmvNNC1TzD5U/DdDn+ddTYSlXHPepTcWdWlSJ0WvxrLFvHWuIvlADZ+h+ldlLL5tsQT2rjtS++6/hVS1dyILRxZxar9l1kHszc16j4emDIhrzbVVxNHIBg5BrtfDU37tRmtqbOGstD1nSX3wiui0b78v0Fcn4dlDRAV2GkrgSH6V6VLVo8mrpc0KWiiug5woFFKKYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAYoxRRQAYpKWkoGJiilpDSAKBRRQAvXoaaSRRS5zwaAE3GgMeKCMUlIBxb0pCSaSloA+OvipY/YfiJr8JGN100w+j/P/AOzVyjJxXrn7RelfZvGsF8o+S9tlJPq6Eqf0215f5eRXk1VabR7tF81NM0fALiLXDGxx50bID7kU65tnRpEx8yMay4ZXtLqK4jHzRMGrsLvy7mNNTtsNBMP3oHJVqykupWzM7R7wqwRzyK7/AEiUFVINebXkBhm82Jsr1rrfDt+HjTntWE42NU7o9H02boK3QN8dcfYT4KkHius02YOgBog76GU9CheRdeKw7uPrXYXVvuGQKwr2168VTQRkeceLIC1nMB6GtXwVKJtKhGcnYP5VLr9oXgcY7Vh+ALsRSvaucGNiv61mzbeJ2sseFNcZ4kIN5ErdCwxXoRRZIsrzXnnjWNobmKTHCsCRVN7Ci7s7jwzGBCgXHQV6BYuIYMnrivLvCF+GWME9cV30l4sdqG6tjpW1KXLqYVoX0HajqWGOWCqPesK58QW0RP73J9jXC+LtevrnUBaWYG5vrVSDwtqU0IluJ5Sx5+U4FZupKT0N40YxWp6DF4igl+UOafJcpOuVINeWy2d5p0h2zPx2fkU+x8TzWs4ivBsPYjkEUKUluDpxex2+oRZRsVx2pjDMrCustbyO8gDoQcisPX7XILLV6SV0Qrxepxt5G0LiaHgj0rr9EulubeNwecc1zUi7lZDT/DM5hu5ID0ByKho2pysz0aF8xH6VzOqnE5rdglHl9e1c5qz5nNHQ0T945/VBuT/dJFdD4cY+Uh9hXPXpznPqa6Hw6P3KH2rWluclZHp/heQ7QK9D0of6MT6mvNvDjYUV6bpy7bKH3XP5816dA8euWaKKK6jmCloFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACUUppKQxDRS0mKACkpaKAAcjFJilpeooAbiloooA8p/aI0r7X4TtL9E3PZ3ADNj7qOMH/x4JXzwgxxX2X4j0qPW9BvtOlwFuYmjBP8JxwfwOD+FfIF9ZS2l3NbzoUmhcxup7MDgj9K4MVC0ubuepgp3g49ijNHkHA61Joeqy6RdFWHmWknDxtyCKkC8YNQzwbl9xXKdjVzrL2xi8oSWp8y2lG5CB09qxrOV9OvMEnymP5Ve8FX67m0y5bCyHMZPZqs6pYZL/LjBII9DUSjdExlZ2Oo0q9DovPauq0q8wRk15LpF89pL5UpJ9D6iu102/DAc1ytODNmuZHplvOsqDmobqANkgViabfdOa3oZVlTrWqlzHO04s5fVrHcGwO1eW6nDJo/iETKCsUp5PbNe43kAZTXDeKtHW8t5FwN3ODjoalm0JFvQr8PENzZVhVbxfpgvbFyq5YDjFcpoGovYXP2G9O1uise9d5BcLLFtfms46e6ypLld0edeGdQe0ujbTEq8ZxzXo9pqAuI9pbOVrkfE2hB3a4t/lkxkEVkaPrU1pP5N4CjDuehrQqylqjq20djrsF2FJRTzj3r07T4YTZ7WC9K4HStWilAIYGuos9QXZw3Bq6TUXcyrJzVjnPFmmL5rbV4J9K851mwGGWRfofSvV9dnWWMAckmuF8Qx8E4qm7sUNEc74S1SS2vPscrEgHA+ldzfKJbXPqK8zgQrrtuV6k816PM5SwG7ris3o9DSWxyF2AlwwrPtmKaxGV4Bq3eybpnPasu0cvqaEdFNV0FHc75JiIhz2rHvX3yZqYzfu8VnXD/AHjU9DoM+5OV+uTXVaAuIUrj5mL3McK8nIFdppIChAOwxW1JdTkrM77wyjTTRRJ1dgor1dVCqFHQDArgPhzZmWd7lh8kS4H+8f8A62a9Ar1qCtG54uId5WClpBS1uYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUlLRQAlFFFIYUmKWigQlApaKAENFLRQAo6V8+/HDw+LDxKmowx4t79dzEdBKOG/MYP1Jr6CrA8b6BH4k8PXNiwUTY8yBz/DIOn59D7Gs61PnjY3w9X2c03sfJskWKjxWvd2kkE0kM8bRyxsUdGGCpBwRWfLFivLPZKADRTLJGSGU5B969GJW/wBLtr9cYkAWUejdDXASJx05rr/h/cmaC/0xzwyGRM9jRYifcy9e010/eRdV5BHaodD1VgfLlOHBxXYtB59irkZ4w31rjNb0pllMkHyOPTvWU4KSLpzsd3pd/kLzXV6dqAIAJrxrRtYaOQQznDrxXb6bqKsB8361yWcGbSipI9HSRZVrO1C23AkVQ03UOAGattHWVOxrVNSRhZxZ5l4t0YSjzEUhh3FZmi63JaMtrf54+69en6lYrNGRtrgdd0IjcVTI+lJrubxlc3YrmOeIDIZSKx9V0OC7zgc+1czb313pkuxtzxA9D1FdLp+rxXSZVxn0zSu0O1tjANhqOlOTAzSJngGr9t4nnt8JcRsje4roDMknDYNNks7SYZkRD9QKa1FzdzJfxJ5mTnn+VZ95qa3mQDn2HNdF/Yulv9+JfwqeKzsbRf3KD9KdvMOZdEc94d0GRroX12uxcfIp61q65KFiKr0FSXmoiNSA2B9a5zUdTXaS7cduaba6Cs3uY+ov5aMSeTUWjRHmVurHIqB/Nv7kNg+XW5aWxRBxwKbfQa01JwSwqnfOI1Oe3NX2xGpJrntTmNxN5UZ69aErlOWgukqZbozN0zxXbaSC8igCuY06DywqqK9X+F2h/bdSFxOhNvbjecjgt2H9fwrrpQcnZHFXmoptnp3hTTv7M0WGJxiV/wB5J7E9vyxWvSmkr1krKyPFb5ndiiigUUxBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFJS0UAJRRRQMKKKKQAKMUUuaBAKDRRTA8f+L/hLbO2uWKfu5MC5UDo3QP9D0Pv9a8muLbjpX1ndW8V1by29wgeGVSjqehB4IrwXxx4Uk0DUCi7nspcmGQ+n90+4rhxFKz5kenhK/MuSW55rLDtJqTw1dGw8R2r5wGcIfoe1aV1bdeKxLpDDOkw6owb8jXKdb1R6zYQJ5t1booUK5YD2NZmtaWSCQtaGjXUdxc2tyh4niAI9CK6K4tFmQgihK5zuVmeJavpp370+V1/Wqlhqc1nNsmJK9jXofiDRiNzItcJf2YDkMuDWc4J7nRTqHV6TrSyBQWrqrDVMYw2RXjaNNasPKPy5ztNdBpOugFVkO1vQ1yyg47HRdSPY7W+inXDHmi5tY5l6A1xFhqivjDc10FrqTBR82aaqdGZuDWxR1bw5FcZIUA+orlb3w3PCxMOVPqK9IjvUkHzYpzLDKOcGjToWptbnlJTVbQ9d6+9A1+WL5Z7aTPqBXps2mW8o5wKzLnw1bOCV60co1OJwUnidV5WCUn6VC/iSaYARQsM+orqpvDqBsBeKdF4eQdQKViro4hpr+7bO3APrUsOjSzMGmJY9cV30WiwxjLEUOttAPlAOKpEuS6HN2mkeUoLKAKlnCQqenFW9R1KOJSSwAFcZqmrSXUhjt+h4yKpa7E6vcfq2oZPlQ8ueOKbpliQN7jLGjTdOO/fJkufWuo0+xzgYraEDOc7aD9B0iW8vIIYU3SSMFUe5r6H8O6TFoulQ2kWCwGXb+83c1gfD/wyul2qX1yn+lyL8in/AJZqf6muyr1KFLlV3ueRiK3O7LYSlPSijvXQcwCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigApDS0UAJRS0lAwooooAUUUlLQIQ1Q1rS7XWNPktL1N0bcg90PYj3rQpKTV9xptO6PnnxX4budEvmt7hdyHmOUDhx6/X1FcfqFmWjb5elfVGsaXa6vZPa3se9DyD3U+oPrXini7wpdaLMwlXzLZydkyjg+x9D7Vw1aLjqtj06GIVRWe5zPgK5ZoZbWU/vIG3IPavTdOuUnhVgc5FePRPJo+rJdoDs+649VrvrO+SJEu4PmtJuW2/wNXPsXOJ093ZpMhBAINcP4j8PAhnjXn6V3NndLIi85B71LdQLKhqnqZpuLPB7yyeGQq6nFZ09pvH8vavWta0VZCWC/pXIX2klGIxWTidEZ3ORt7m8smyrM6+hrotL8VL9yYlW9DVG7sXUHismW0O/JHNZypJm0ah6JBrsT4xIPzrQi1dT0k/WvKgJo/usR9aet9cx9efoaxdFrY0U0z11NWGPv/rTv7YUdW/WvJV1edRn95SnWpvV8+9HJIfunqsmrxnvVSbWQB94CvMv7YuCeS1Kt7PN2c0ezkF4o7i815VB/efrXO3/iBySE/nWW1vcTYzhVPvzViCxVeqlj6mtI0u5DmuhT/wBL1CQl2Kp6mtayso4cBVye5qxb2rHAAra07S5JGUKpJJwABnNbRgZSqDLC0LMOK9a8A+EwipqGoxY7wxOOv+0R/KpPBfgoWhS81VFLgZjgPOD6t/hXoFd9Ghb3pHm18Rf3YhRRRXWcYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAIaKWigBKKWkoGKKKSlzQITFQ3dtDd28kFzGssMgwysMgip6KA2PIfG3w5kije50YPcQjloTy6/T1H6/WvObC9n0aZopgWtGOGUjlf/AK1fUeK5vxR4N0rxCjG4h8m5PSeIAMfr2b8a5amHvrE7KWKt7szyq0vGtBHJC/m2TDjuU9q6exvlmjBRgynvXMah4O1/wpcM0UEmp6UxwxgUsVX1KdR+oHrRbFYx9q0xg8P/AC0hB+ZfwrjcZQdmdPuyV0zr5YVmTsaxL7S1fOBVzTtQS4TcjexHcVprtkHOKLX2I1icDd6PnPy1hXejg8qOK9Xms1cHaBmst9O+8m0HHtS5WWqh5NPpbKfumqcliw6rXqs+jrJkbMevFUptAH93j6UuVmiqnmwsx0K00aUrNk9K9Ak8PEH7v6U1dCI/h/SjlY/aI46DS0H8Ofwq7Fp+BwtdfBooB5X8xWjBpCeg/KmokuqcRHprN/DV+10ZmP3TXd2WhtOwWGFpG/2VzXW6T4SjTD3uP+uaf1P+FawouWxlOuo7nnuieFZryUJDEWPc9h9TXp3h7wtZ6QFlKiW6A++Rwp9h/Wty3t4raMRwRrGg7KMVLXZToqGpxVK8p6dAooorYxCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACjFFFABijFFFABRRRQAUUUUAFZeoaDpt/KZZ7VBP8A89U+Vz9SOv41qUUmk9GNNrVHC6l4FImE+k3Sxyd0lHyt9SP8KjGianbfft94HeNgw/x/Su+orF4eD1Whqq89nqcDtkj4lidD/tKRQ0KyEE/eHcda77r1qJreFvvQxt9VFT9X8x+28jhGgG3AHA5ppt17gV3RsrU/8u8X/fIpVs7ZekEQ/wCAij2D7j9scAbRWGNuakj0ieU/u7aQj128fnXoCRon3EVfoMU6msOurF7d9DiYvC15IPmMUIPqcn9K2bHw1aQYMxaZh2+6Pyrdoq40Yoh1ZMZFFHCgSJFRR2UYp9FFamYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the different parts of the ear. Cells in the inner ear are damaged in people with tinnitus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jenny Wang.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2549=[""].join("\n");
var outline_f2_31_2549=null;
var title_f2_31_2550="Gemistocytic astrocytoma Light";
var content_f2_31_2550=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F77661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F77661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gemistocytic astrocytoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of gemistocytic astrocytoma. The emistocytic cells are exceptionally large and densely packed with a globoid appearance (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Smith, MD, University of Massachusetts.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2550=[""].join("\n");
var outline_f2_31_2550=null;
var title_f2_31_2551="Substance abuse and addiction in HIV-infected patients";
var content_f2_31_2551=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Substance abuse and addiction in HIV-infected patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2551/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2551/contributors\">",
"     Andrew A Pieper, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2551/contributors\">",
"     Glenn J Treisman, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2551/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2551/contributors\">",
"     Jonathan M Silver, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2551/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2551/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/31/2551/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 29, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuropsychiatric disorders are common in individuals infected with the human immunodeficiency virus (HIV), based upon a wide variety of factors including: direct effects of the virus, preexisting psychiatric conditions, personality vulnerabilities, affective disorders, addictions, or responses to the social isolation and disenfranchisement that can result from the diagnosis of HIV. Adding to the complexity, many HIV-infected persons have difficulty with treatment adherence due to their behavior patterns as well as specific neuropsychiatric disorders associated with HIV disease progression [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Substance abuse and addiction in HIV-infected patients will be reviewed here. An overview of the range of neuropsychiatric conditions associated with HIV infection and more detailed reviews of other specific conditions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/44/5831?source=see_link\">",
"     \"Overview of the neuropsychiatric aspects of HIV infection and AIDS\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"     \"Dementia and delirium in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link\">",
"     \"Depression, mania, and schizophrenia in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substance abuse is defined as a maladaptive pattern of substance use that has become socially, legally, or occupationally problematic for the individual. Substance dependence refers to tolerance or the physical need for a substance. Tolerance is the need to use increasing amounts of a substance in order to achieve the desired effect.",
"   </p>",
"   <p>",
"    Dependence is divided into two components: physiological and psychological. An example that illustrates the difference between abuse and dependence is to compare the college fraternity student who becomes intoxicated at a fraternity party and behaves badly (alcohol abuse) with the retired businessman who drinks martinis on a daily basis and suffers tremors and anxiety when he stops drinking (alcohol dependence). Physiological dependence occurs when an individual has physically adapted to a substance to the point that he or she must continue using the substance in order to feel normal. If the physically dependent individual stops using the substance abruptly, he or she will experience uncomfortable physical withdrawal symptoms that could be relieved by using the substance. Psychological dependence occurs when the individual believes that he or she needs to continue using the substance to feel emotionally stable.",
"   </p>",
"   <p>",
"    Primary substance abuse disorders include both substance abuse and dependence. Secondary substance-induced disorders include substance intoxication, substance withdrawal, substance-induced psychotic disorder, substance-induced mood disorder, substance-induced anxiety disorder, substance-induced sleep disorder, substance-induced persisting dementia disorder, substance-induced amnestic disorder, and substance-induced sexual dysfunction. These secondary disorders typically resolve with elimination of the underlying substance abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SUBSTANCE ABUSE AND HIV TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substance abuse is a primary vector for the spread of HIV through engagement in a number of high-risk behaviors, either when intoxicated (disinhibited) or in order to obtain drugs. Such behaviors include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sharing of unclean needles",
"     </li>",
"     <li>",
"      Prostitution",
"     </li>",
"     <li>",
"      Sexual contact within a high-risk population of injection drug users (IDUs)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The proportion of IDUs with HIV infection markedly increased in the United States from 17 percent during the years 1981 to 1987 to 33 percent during 1993 to 1995. However, with the advent of highly active antiretroviral therapy (HAART) and needle exchange programs in some cities, determining the incidence of HIV infection among IDUs has become more complex. While some studies show that the rate of acquisition of new infection has declined with more widespread use of antiretrovirals and needle exchange [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/2-5\">",
"     2-5",
"    </a>",
"    ], high-risk sexual behaviors may in some circumstances increase with the perception that HIV may be more treatable [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Substance abuse also plays a major role in HIV transmission among non-injection drug users. For example, crack cocaine abusers are more likely to engage in prostitution in order to obtain money for drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]; men who use crack cocaine are more likely to engage in unprotected anal sex with casual male contacts [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/9\">",
"     9",
"    </a>",
"    ]; and alcohol intoxication precipitates risky sexual behaviors through cognitive impairment and disinhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     COMORBIDITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extensive psychiatric, psychological, and medical comorbidities are associated with substance abuse and addiction in HIV disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Psychiatric comorbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most significant psychiatric comorbidity with HIV and substance abuse is major depression, which is associated with HIV and substance abuse at a prevalence rate of 15 to 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/12\">",
"     12",
"    </a>",
"    ]. Depression is associated with worsening of addictions and resistance to treatment. While anhedonia in depression makes it difficult for any patient to respond to and enjoy life's rewards, potential rewards may especially pale for the HIV-infected substance abuser in comparison to the intense ephemeral charge of intoxicating drugs that stimulate the mesolimbic reward system of the brain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link\">",
"     \"Depression, mania, and schizophrenia in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depressed patients often find it more difficult to engage in, invest in, and sustain treatment due to their anergy and negativism. It is thus essential to recognize and treat depression early in order to maximize successful treatment outcomes for both substance abuse and HIV disease. Because it may be difficult to distinguish transient depressive symptoms precipitated by drug withdrawal, demoralization or grief reactions from the persistent depressive symptoms of a major affective disorder, it may be necessary to observe the substance abuse patient over a sustained period of abstinence in order to accurately diagnose depression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Personality comorbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Personality factors, as described more fully below, may lead to greater risk taking and increased sensitivity to rewards. An increased tendency to take risks subsequently precipitates greater likelihood to engage in high-risk behaviors, while greater sensitivity to rewards is associated with increased sensitivity to the reinforcing properties of drugs and decreased sensitivity to the consequences of drug use. On the other hand, personality types that are consequence- and risk-avoidant are relatively protected from addiction.",
"   </p>",
"   <p>",
"    Maladaptive personality traits, generally found in the cluster B personality disorders in DSM-IV (antisocial, borderline, narcissistic, and histrionic), are present in as many as 49 percent of all substance abusers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/13\">",
"     13",
"    </a>",
"    ]. It is critical to identify personality vulnerabilities in these patients because they have profound effects on treatment and prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Medical comorbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with concurrent drug use disorders, another psychiatric disorder, and HIV are abundant in HIV treatment settings because of their symptom severity and chronicity. In inner city Baltimore, for example, 44 percent of new entrants to the HIV medical clinic at Johns Hopkins had an active substance abuse disorder, and 24 percent of these patients had both a current substance use disorder and another nonsubstance-related Axis I diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Accumulation of medical sequelae from chronic substance abuse accelerates immunocompromise and amplifies accumulating burdens of HIV infection. IDUs, for example, have a higher risk of developing pneumonia, sepsis, soft tissue infections, and infective endocarditis. Tuberculosis, sexually transmitted diseases, viral hepatitis, and coinfection with human T-lymphotropic virus (HTLV) types I and II also occur more commonly among HIV-infected IDUs.",
"   </p>",
"   <p>",
"    Diagnosis and treatment of comorbid conditions is often difficult because there is substantial overlap between clinical manifestations of substance abuse and sequelae of HIV infection. For example, both AIDS dementia and drug intoxication can present with apathy, disorientation, aggression and altered consciousness, and both drug withdrawal and opportunistic infections of the central nervous system (CNS) can present with seizures and neurovegetative symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"     \"Dementia and delirium in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41128?source=see_link\">",
"     \"Approach to HIV-infected patients with central nervous system lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The duration of survival in HIV-infected IDUs has improved substantially since 1997 with the introduction of effective antiretroviral therapy, reaching rates similar to those in HIV-seronegative IDUs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/15\">",
"     15",
"    </a>",
"    ]. However, clinicians must be especially mindful of interactions among antiretroviral agents, drugs HIV-infected patients may take to prevent opportunistic infections, and substances that these patients may abuse. Opioid users, for example, are at particular risk for medication interactions.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     Rifampin",
"    </a>",
"    increases the rate of elimination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    from the body and may result in the rapid onset of withdrawal symptoms in patients on methadone maintenance therapy. Decreased plasma levels of methadone also occur with concurrent administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/62/19433?source=see_link\">",
"     nelfinavir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/12/18633?source=see_link\">",
"     nevirapine",
"    </a>",
"    , which necessitates adjustments in methadone maintenance if withdrawal should occur [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antiretroviral medications such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    may also cause peripheral neuropathies that can be worsened by the neurotoxic effects of alcohol and malnutrition related to chronic substance abuse. However, with the advent of newer antiretroviral agents with less mitochondrial toxicity, safer alternatives are now available.",
"   </p>",
"   <p>",
"    Of particular relevance to the HIV-infected population is coinfection with hepatitis C virus (HCV). Some clinics have reported that 50 percent of HIV-infected patients are also infected with HCV, and coinfection may be as high as 70 percent among IDUs. Underlying HIV infection appears to facilitate. HCV progression to cirrhosis and liver failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although very little is known about specific psychiatric disturbances in",
"    <span class=\"nowrap\">",
"     HIV/HCV",
"    </span>",
"    coinfected patients, neuropsychiatric complications of treatment with interferon (IFN)-alpha, a mainstay of therapy for HCV, are well known. IFN-alpha has been associated with depressive syndromes, suicide and mania. Patients with preexisting depression or bipolar disorder are more likely to develop affective symptoms while receiving IFN-alpha but may not be more likely to stop treatment than patients developing these symptoms \"de novo\" [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/17\">",
"     17",
"    </a>",
"    ]. Patients coinfected with HIV and HCV should be screened for mental illness, and mental health monitoring should be performed during the period of treatment with IFN-alpha to achieve early recognition and treatment of affective symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT OF SUBSTANCE USE DISORDERS IN HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;A simplified series of steps for substance abuse in HIV patients includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acceptance of the role as a patient",
"     </li>",
"     <li>",
"      Detoxification",
"     </li>",
"     <li>",
"      Treatment of comorbid conditions",
"     </li>",
"     <li>",
"      Maintenance treatment and relapse prevention",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Acceptance of patient role",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most daunting task in treatment of drug addiction is often initial engagement and guiding the individual to accept the role of a patient to achieve longer-term health goals. Whereas individuals who are addicted to drugs tend to present to treatment settings for comfort or crisis relief, medical care providers are focused on long-range goals of improving health and overall functioning. It is the task of the healthcare provider to guide the patient's attitudes to coincide with those of the provider's treatment plan. Here, a number of stages that a patient goes through (transtheoretical stages of change) provide a framework for viewing the recovery process [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2551/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Precontemplation &mdash; Patient has no intention of altering addictive behavior",
"     </li>",
"     <li>",
"      Contemplation &mdash; Patient has considered change, often after recognizing negative consequences of his or her drug use, but remains ambivalent to change",
"     </li>",
"     <li>",
"      Preparation &mdash; The patient shows intent to change by making initial steps to seek treatment",
"     </li>",
"     <li>",
"      Action &mdash; The patient decides to modify behavior, environment and circumstances in order to relinquish his or her addictive lifestyle",
"     </li>",
"     <li>",
"      Maintenance &mdash; The patient works to prevent relapse through consolidation of changed behavior and lifestyle",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most difficult transition in truly accepting the patient role is from contemplation to action. Using empathy and confrontation to amplify the discrepancy between current lifestyle and long-term life enhancing goals is essential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Detoxification",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is virtually impossible for intoxicated patients to understand and process the cognitive steps needed for recovery without first undergoing detoxification. Slowly tapering either the drug of dependence or using a cross-dependent drug with similar pharmacologic mechanism best accomplishes this goal.",
"   </p>",
"   <p>",
"    There is no evidence to support the notion that noxious withdrawal during detoxification improves outcome. In fact, some behavioral studies suggest that patients suffering through severe withdrawal develop conditioned withdrawal such that exposure to environments similar to the one experienced during severe withdrawal can bring back withdrawal symptoms months later. Thus, all efforts should be directed to help patients remain as comfortable as possible during drug withdrawal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link\">",
"     \"Opioid intoxication in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Benzodiazepine, barbiturate, and alcohol withdrawal can be life threatening, and patients should be slowly tapered with long-acting benzodiazepines such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/36/4679?source=see_link\">",
"     chlordiazepoxide",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/50/10022?source=see_link\">",
"     oxazepam",
"    </a>",
"    . Detoxification from opiates is accomplished through taper of long-acting opioid agonists, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    . Alternatively,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    , a partial opioid agonist, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    , an alpha-2 agonist, can provide symptomatic relief from opiate withdrawal. There are no specific guidelines for detoxification from psychomotor stimulant classes of drugs, such as cocaine or amphetamines, although some clinicians promote the use of antidepressants. This approach may work best in patients already suffering from major depression independent of their substance abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Treatment of comorbid psychiatric conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbid psychiatric conditions should be treated in order to maximize compliance and abstinence. Conditions such as major depression, bipolar disorder, and schizophrenia are best managed with the pharmacologic strategies routinely employed for other patients with these disorders. Medications should be started at low doses and titrated slowly to minimize development of adverse side effects and delirium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link\">",
"     \"Depression, mania, and schizophrenia in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Disorders of personality may manifest as staff splitting, doctor shopping, general noncompliance, and manipulative behavior. These individuals are best managed through psychotherapy with firm limit setting and consistency on the part of all their health care providers. There should be a documented treatment plan with clear goals agreed upon by all treatment staff. This treatment plan should be reviewed with patients at the initiation of treatment so that they clearly understand what is expected of them and what they can expect from the treatment providers if they are adherent to the stated goals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Maintenance treatment and relapse prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because HIV-infected patients with substance abuse problems are complicated and vulnerable to recidivism, an integrated approach to long-term treatment should include a treatment team of medical providers, psychiatrists, social workers, housing counselors, daycare workers, and substance abuse counselors. Group therapy is also important because more experienced members of the group can provide both confrontation and support for newly initiated members and a positive view of the benefits of recovery.",
"   </p>",
"   <p>",
"    Commitment to a community of recovery fosters protection from the influences of the drug community and provides new bonds that help maintain a sense of purposefulness and hopefulness. Specific HIV-positive recovery groups are also available. Although these groups specifically address HIV-related issues, they are not necessary for recovery from substance abuse.",
"   </p>",
"   <p>",
"    Individual and family therapies can enhance the treatment, but they should not replace group therapy. Successful therapy generally focuses on identifying triggers to substance use, minimizing exposure to substances, and defining a clear plan of action if relapse occurs. Relapse is often the rule rather than the exception, and prophylactic plans should be made for early intervention. Monitoring measures such as urine and serum toxicologies and Breathalyzer tests can help enforce compliance, and contingency management using positive and negative reinforcers linked to urine toxicology results are highly effective in helping patients maintain sobriety.",
"   </p>",
"   <p>",
"    Psychotherapeutic approaches to maintenance and relapse prevention are divided into aversive therapy (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/17/5397?source=see_link\">",
"     disulfiram",
"    </a>",
"    for alcohol abuse), blockade of reinforcement (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"     naltrexone",
"    </a>",
"    for opioid abuse), drive suppression (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    or naltrexone for tobacco abuse,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    for cocaine abuse) and substituted addiction (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    , LAAM, or buprenorphine for opioid abuse). Because relapse can occur impulsively in a single moment, many patients benefit from and appreciate these strategies.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/17/5397?source=see_link\">",
"     Disulfiram",
"    </a>",
"    inhibits acetaldehyde dehydrogenase, causing accumulation of acetaldehyde after alcohol ingestion, which results in nausea, flushing, headaches, and hypotension. Due to the risk of hepatotoxicity, liver enzymes should be monitored during disulfiram treatment.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"     Naltrexone",
"    </a>",
"    is an opioid antagonist with high affinity for mu receptors that is taken once daily in doses ranging from 50 to 100 mg. Naltrexone blocks the euphoric effects of opioids but also precipitates withdrawal symptoms in dependent individuals because it displaces opioids from mu receptors. As with disulfiram, liver function tests should be monitored in patients taking naltrexone due to a risk of hepatotoxicity. Naltrexone has also been shown to reduce alcohol craving. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19209?source=see_link\">",
"     \"Pharmacotherapy for alcohol abuse and dependence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     Methadone",
"    </a>",
"    is the opioid agonist most often used for maintenance treatment, in varying doses from 40 to 140 mg daily. Methadone is administered under daily supervision until the patient has established a pattern of abstinence, at which point take-home doses are allowed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=see_link\">",
"     \"Treatment of opioid abuse and dependence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The partial agonist,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    , may serve as a useful alternative to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    , and has the advantage that it can be administered by primary care physicians to opiate-dependent individuals, thereby removing the stigma associated with daily visits to drug treatment centers that can be a barrier to medication adherence. However, a primary care provider must be certified through an authorized training program, obtain a waiver from the Drug Enforcement Agency (DEA), and agree to use the drug on no more than 30 patients at a time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment of opioid abuse and dependence\", section on 'Buprenorphine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4847512\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Substance abuse is defined as a maladaptive pattern of substance use that has become socially, legally, or occupationally problematic for the individual. Substance dependence refers to tolerance or physical need for a substance. Tolerance is the need to use increasing amounts of a substance in order to achieve the desired effect. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Substance abuse is a primary vector for the spread of HIV through high-risk behaviors, either when intoxicated or in order to obtain drugs. Such behaviors include sharing unclean needles, prostitution, and sexual contact within a high-risk population of injection drug users. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Substance abuse and HIV transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Substance use disorders in HIV disease are frequently comorbid with major depression, personality disorders and maladaptive personality traits, pneumonia, sepsis, soft tissue infections, endocarditis, tuberculosis, sexually transmitted diseases, viral hepatitis, and coinfection with human T-lymphotropic virus (HTLV) types I and II. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Comorbidities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of substance abuse in HIV patients includes the patient accepting the role of the patient, detoxification, treatment of comorbid conditions, maintenance treatment, and relapse prevention. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment of substance use disorders in HIV'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Accepting the patient role involves several stages, including precontemplation, contemplation, preparation, action, and maintenance. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Acceptance of patient role'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Detoxification is best accomplished by slowly tapering either the drug of dependence or using a cross-dependent drug with a similar pharmacologic mechanism. Benzodiazepine, barbiturate, and alcohol withdrawal can be life threatening, and patients should be slowly tapered with a long-acting benzodiazepine such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/36/4679?source=see_link\">",
"       chlordiazepoxide",
"      </a>",
"      . Detoxification from opiates is often accomplished with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"       clonidine",
"      </a>",
"      . There are no specific guidelines for detoxification from psychomotor stimulants such as cocaine or amphetamines, although some clinicians promote the use of antidepressants. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Detoxification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Comorbid major depression, bipolar disorder, or schizophrenia are best managed with pharmacotherapy that is routinely employed for other patients with these disorders. Personality disorders are best managed through psychotherapy with firm limit setting and consistency on the part of all their health care providers. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment of comorbid psychiatric conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Group therapy is typically used for maintenance treatment and relapse prevention of substance use disorders in HIV disease. Other treatments include aversive therapy, blockade of reinforcement, drive suppression, and substituted addiction. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Maintenance treatment and relapse prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/1\">",
"      Cofrancesco J Jr, Scherzer R, Tien PC, et al. Illicit drug use and HIV treatment outcomes in a US cohort. AIDS 2008; 22:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/2\">",
"      Muga R, Sanvisens A, Egea JM, et al. Trends in human immunodeficiency virus infection among drug users in a detoxification unit. Clin Infect Dis 2003; 37 Suppl 5:S404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/3\">",
"      Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/4\">",
"      Maslow CB, Friedman SR, Perlis TE, et al. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health 2002; 92:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/5\">",
"      Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002; 92:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/6\">",
"      Tun W, Gange SJ, Vlahov D, et al. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis 2004; 38:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/7\">",
"      Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med 1994; 331:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/8\">",
"      Astemborski J, Vlahov D, Warren D, et al. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994; 84:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/9\">",
"      de Souza CT, Diaz T, Sutmoller F, Bastos FI. The association of socioeconomic status and use of crack/cocaine with unprotected anal sex in a cohort of men who have sex with men in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2002; 29:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/10\">",
"      Stein MD, Hanna L, Natarajan R, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat 2000; 18:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/11\">",
"      Rees V, Saitz R, Horton NJ, Samet J. Association of alcohol consumption with HIV sex- and drug-risk behaviors among drug users. J Subst Abuse Treat 2001; 21:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/12\">",
"      Ahmad B, Mufti KA, Farooq S. Psychiatric comorbidity in substance abuse (opioids). J Pak Med Assoc 2001; 51:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/13\">",
"      Kokkevi A, Stefanis N, Anastasopoulou E, Kostogianni C. Personality disorders in drug abusers: prevalence and their association with AXIS I disorders as predictors of treatment retention. Addict Behav 1998; 23:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/14\">",
"      Lyketsos CG, Hanson A, Fishman M, et al. Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med 1994; 24:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/15\">",
"      Muga R, Langohr K, Tor J, et al. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs. Clin Infect Dis 2007; 45:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/16\">",
"      Gourevitch MN, Friedland GH. Interactions between methadone and medications used to treat HIV infection: a review. Mt Sinai J Med 2000; 67:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/17\">",
"      Pariante CM, Orr&ugrave; MG, Baita A, et al. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999; 354:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2551/abstract/18\">",
"      Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol 1992; 47:1102.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3725 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-5C26F28503-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2551=[""].join("\n");
var outline_f2_31_2551=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4847512\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SUBSTANCE ABUSE AND HIV TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      COMORBIDITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Psychiatric comorbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Personality comorbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Medical comorbidity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT OF SUBSTANCE USE DISORDERS IN HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Acceptance of patient role",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Detoxification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Treatment of comorbid psychiatric conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Maintenance treatment and relapse prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4847512\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41128?source=related_link\">",
"      Approach to HIV-infected patients with central nervous system lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=related_link\">",
"      Dementia and delirium in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=related_link\">",
"      Depression, mania, and schizophrenia in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=related_link\">",
"      Opioid intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/44/5831?source=related_link\">",
"      Overview of the neuropsychiatric aspects of HIV infection and AIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19209?source=related_link\">",
"      Pharmacotherapy for alcohol abuse and dependence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=related_link\">",
"      Treatment of opioid abuse and dependence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_31_2552="Management of the infant whose mother has received group B streptococcal chemoprophylaxis";
var content_f2_31_2552=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of the infant whose mother has received group B streptococcal chemoprophylaxis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Karen M Puopolo, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Carol J Baker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2552/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/31/2552/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Group B streptococcus",
"    <em>",
"    </em>",
"    (GBS or",
"    <em>",
"     Streptococcus agalactiae",
"    </em>",
"    ) is an encapsulated gram-positive bacterium that colonizes the human gastrointestinal and genital tracts. GBS is the most frequent bacterial pathogen in neonates, and maternal colonization is the single most important risk factor for early-onset (younger than seven days of age) GBS infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Screening pregnant women for GBS colonization and administering intrapartum antibiotic prophylaxis (IAP) against GBS is the recommended approach to the prevention of early-onset infection in neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. However, this approach does not prevent all cases of early-onset GBS disease (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link&amp;anchor=H18#H18\">",
"     \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\", section on 'Missed cases'",
"    </a>",
"    ). Rapid detection and early initiation of appropriate antimicrobial therapy is necessary to minimize morbidity and mortality among the cases that continue to occur.",
"   </p>",
"   <p>",
"    The evaluation and initial management of neonates at risk for early-onset GBS is reviewed here. Chemoprophylaxis of the mother, established GBS infection in infants and pregnant women, the microbiology and epidemiology of GBS, and the status of GBS vaccines are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link\">",
"     \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43062?source=see_link\">",
"     \"Group B streptococcal infection in pregnant women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link\">",
"     \"Group B streptococcal infection in neonates and young infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9621?source=see_link\">",
"     \"Group B streptococcus: Virulence factors and pathogenic mechanisms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40984?source=see_link\">",
"     \"Vaccines for the prevention of group B streptococcal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SUMMARY OF MATERNAL IAP GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Centers for Disease Control and Prevention (CDC) in collaboration with the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Nurse-Midwives, and the American Society for Microbiology issued new guidelines for the prevention of perinatal group B streptococcal (GBS) disease in 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Guidelines for maternal screening and administration of intrapartum antibiotic prophylaxis (IAP) are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link\">",
"     \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\"",
"    </a>",
"    ). Aspects of maternal IAP that affect newborn management are summarized below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6035106\">",
"    <span class=\"h2\">",
"     Indications for maternal IAP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CDC guidelines recommend that all pregnant women be screened for GBS colonization with swabs of the lower (introitus) vagina and rectum at 35 to 37 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IAP should be administered to (",
"    <a class=\"graphic graphic_table graphicRef66582 \" href=\"UTD.htm?32/63/33788\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any pregnant woman with a positive screening culture from either vagina or rectum unless a planned cesarean delivery is performed in the absence of labor or rupture of membranes",
"     </li>",
"     <li>",
"      All pregnant women who gave birth to a previous infant with invasive GBS disease",
"     </li>",
"     <li>",
"      All pregnant women with documented GBS bacteriuria during the current pregnancy unless a planned cesarean delivery is performed in the absence of labor or rupture of membranes",
"     </li>",
"     <li>",
"      Pregnant women whose GBS culture status is unknown if delivery is at &lt;37 weeks of gestation, amniotic membranes have ruptured for &ge;18 hours, intrapartum temperature &ge;100.4&ordm;F (&ge;38&ordm;C) is documented,",
"      <strong>",
"       or",
"      </strong>",
"      intrapartum nucleic acid amplification test is positive for GBS",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Adequate IAP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2010 guidelines provide a clarification of the definition of &ldquo;adequate IAP&rdquo; for the purposes of infant management [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. Adequate IAP is defined as &ge;4 hours of intravenous (IV) penicillin,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"     cefazolin",
"    </a>",
"    . The four hour interval is usually counted from the beginning of the antibiotic infusion because it is easier to determine accurately than the end of the infusion. All other agents or durations are considered inadequate.",
"   </p>",
"   <p>",
"    The recommended doses for",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/46/14054?source=see_link\">",
"     penicillin G",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"     cefazolin",
"    </a>",
"    are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/46/14054?source=see_link\">",
"       Penicillin G",
"      </a>",
"      (initial dose of 5 million units IV followed by 2.5 to 3 million units IV every 4 hours until delivery)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       Ampicillin",
"      </a>",
"      (initial dose of 2 grams IV, followed by 1 g IV every 4 hours until delivery)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"       Cefazolin",
"      </a>",
"      (initial dose of 2 grams IV followed by 1g IV every 8 hours until delivery)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2901877\">",
"    <span class=\"h1\">",
"     OVERVIEW OF MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Caregivers should have a low threshold for evaluation and treatment of possible early-onset group B streptococcal (GBS) disease because of the potential for serious adverse consequences, including death (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H37#H37\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Outcome'",
"    </a>",
"    ). In the era of universal screening of pregnant women for GBS colonization, the majority of cases of early-onset GBS occurring in term infants occur in infants born to women who had negative prenatal GBS cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900460\">",
"    <span class=\"h2\">",
"     Diagnostic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early-onset GBS disease should be suspected in any infant who is ill-appearing (regardless of maternal GBS colonization status), infants who are born to women with chorioamnionitis (proven or suspected), and infants whose mothers had indications for intrapartum antibiotic prophylaxis (IAP) (",
"    <a class=\"graphic graphic_table graphicRef66582 \" href=\"UTD.htm?32/63/33788\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6035106\">",
"     'Indications for maternal IAP'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H11#H11\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The indications for and extent of neonatal evaluation depend upon clinical appearance, maternal chorioamnionitis, exposure to maternal IAP, gestational age, and duration of rupture of membranes before delivery (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900468\">",
"    <span class=\"h3\">",
"     Full evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The full diagnostic evaluation includes a complete blood count (CBC) with differential and platelet count, a blood culture, a lumbar puncture (unless the infant&rsquo;s clinical status precludes performing the procedure), and a chest radiograph (if respiratory abnormalities are present) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. The detection of GBS disease is increased by culturing both blood and cerebrospinal fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H21#H21\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The full diagnostic evaluation should be performed in any term or late-preterm newborn who is ill-appearing and in any premature infant in whom sepsis is strongly considered (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Ill-appearing infant'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900551\">",
"    <span class=\"h3\">",
"     Limited evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited diagnostic evaluation includes a blood culture at birth and CBC with differential and platelet count at birth",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    at 6 to 12 hours of life [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. The sensitivity of the CBC as a screen for sepsis improves if the sample is obtained or repeated at 6 to 12 hours of life, rather than at birth [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Exposure to IAP may inhibit the growth of GBS in blood or cerebrospinal fluid (CSF) cultures, but it does not change the clinical spectrum of disease or the onset of clinical signs of infection within 24 to 48 hours of birth [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Limited diagnostic evaluation should be performed in (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Well-appearing infants whose mothers have proven or suspected chorioamnionitis (see",
"      <a class=\"local\" href=\"#H6036777\">",
"       'Maternal chorioamnionitis'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Well-appearing infants whose mothers had indications for intrapartum antibiotic prophylaxis (IAP) (",
"      <a class=\"graphic graphic_table graphicRef66582 \" href=\"UTD.htm?32/63/33788\">",
"       table 1",
"      </a>",
"      ) but did not receive IAP or received inadequate IAP",
"      <strong>",
"       and",
"      </strong>",
"      (see",
"      <a class=\"local\" href=\"#H2757570\">",
"       'Mother received no or inadequate IAP'",
"      </a>",
"      below):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The gestational age is &lt;37 weeks,",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      Membranes were ruptured for &ge;18 hours",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900559\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical signs are more sensitive than hematologic tests in predicting neonatal sepsis, particularly if the neonate is well-appearing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/11,16-18\">",
"     11,16-18",
"    </a>",
"    ]. Interpretation of the CBC should consider the timing of the evaluation, as well as the gestational age of the infant. A multicenter study of infants born at &ge;34 weeks&rsquo; gestation, evaluated within the first 24 hours of life, found that low total white blood cell (WBC) count",
"    <span class=\"nowrap\">",
"     (&lt;5000/microL);",
"    </span>",
"    absolute neutropenia (&lt;1000 granulocytes); and proportion of immature polymorphonuclear leukocytes (PMNs) relative to the total PMN count",
"    <span class=\"nowrap\">",
"     (immature/total",
"    </span>",
"    ratio 0.3 or above) were associated with blood-culture-proven early-onset disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/13\">",
"     13",
"    </a>",
"    ]. However, a normal WBC count was not infrequent, and elevated WBC count",
"    <span class=\"nowrap\">",
"     (&gt;20,000/microL)",
"    </span>",
"    was not predictive of early-onset disease. Thrombocytopenia also was observed, usually in association with septic shock; platelet count did not independently predict early-onset disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900567\">",
"    <span class=\"h2\">",
"     Empirical antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for empirical antibiotic therapy include (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Signs of neonatal sepsis or ill-appearance (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Ill-appearing infant'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Mother with proven or suspected chorioamnionitis (see",
"      <a class=\"local\" href=\"#H6036777\">",
"       'Maternal chorioamnionitis'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The empirical antibiotic regimen should include agents active against GBS (including",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    ) and other organisms that cause neonatal sepsis (eg,",
"    <em>",
"     Escherichia coli",
"    </em>",
"    and other gram-negative pathogens). The combination of ampicillin and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    is generally recommended. However, local antibiotic resistance patterns must be considered. In the era of GBS IAP, up to 40 percent of early-onset sepsis is due to ampicillin-resistant gram-negative organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. The addition of a third-generation cephalosporin to the empiric treatment of early-onset sepsis may be warranted, but only among neonates with suspected meningitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and outcome of sepsis in term and late preterm infants\", section on 'Empiric antibiotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MANAGEMENT APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Centers for Disease Control and Prevention (CDC) guidelines provide an algorithm for secondary prevention of early-onset group B streptococcal (GBS) disease (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ). Branch-points in the algorithm include clinical appearance at birth or during the hospital observation period, maternal chorioamnionitis, indications for and adequacy of maternal GBS prophylaxis (",
"    <a class=\"graphic graphic_table graphicRef66582 \" href=\"UTD.htm?32/63/33788\">",
"     table 1",
"    </a>",
"    ), gestational age, and duration of rupture of membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ill-appearing infant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ill-appearance or signs of sepsis may be an indication of early-onset GBS, regardless of maternal GBS colonization status [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\", section on 'Clinical manifestations'",
"    </a>",
"    .) Infants who are ill-appearing or in whom bacterial sepsis is strongly suspected should undergo a full diagnostic evaluation and receive empirical antibiotic therapy, typically",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    and an aminoglycoside, until laboratory results are known (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2900468\">",
"     'Full evaluation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H2900567\">",
"     'Empirical antibiotic therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The subsequent management of ill-appearing infants varies depending upon the clinical syndrome (eg, sepsis, meningitis, pneumonia, etc), pathogen, and clinical course. Empirical antibiotic treatment should continue at least until laboratory results are known, typically no longer than 48 hours. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=see_link\">",
"     \"Treatment and outcome of sepsis in term and late preterm infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=see_link\">",
"     \"Treatment and outcome of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21512?source=see_link\">",
"     \"Neonatal pneumonia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H25#H25\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Well-appearing infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Well-appearing infants whose mothers do not have chorioamnionitis (proven or suspected) or indications for GBS prophylaxis (",
"    <a class=\"graphic graphic_table graphicRef66582 \" href=\"UTD.htm?32/63/33788\">",
"     table 1",
"    </a>",
"    ) should receive routine newborn care (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. A full diagnostic evaluation should be conducted and empirical antibiotic therapy initiated if the infant develops signs of sepsis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36105?source=see_link\">",
"     \"Overview of the routine management of the healthy newborn infant\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H6\">",
"     'Ill-appearing infant'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6036777\">",
"    <span class=\"h3\">",
"     Maternal chorioamnionitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chorioamnionitis is a risk factor for early-onset GBS disease and may reflect intrauterine onset of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. Consultation with obstetric providers to determine suspicion for chorioamnionitis is an important aspect of neonatal management. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H9#H9\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Well-appearing infants born to women with suspected or proven chorioamnionitis should undergo a limited diagnostic evaluation and receive empirical antibiotic therapy until laboratory results are known (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2900551\">",
"     'Limited evaluation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H2900567\">",
"     'Empirical antibiotic therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Infants with unremarkable laboratory results and a benign clinical course should have antibiotics discontinued after 48 hours of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Mother received adequate IAP",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the infant (of any gestational age) is well-appearing and the mother received intrapartum antibiotic prophylaxis (IAP) with penicillin,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"     cefazolin",
"    </a>",
"    at least four hours before delivery, no diagnostic testing is recommended (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. The infant should be observed for at least 48 hours. A full diagnostic evaluation should be conducted and empirical antibiotic therapy initiated if the infant develops signs of sepsis (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Ill-appearing infant'",
"    </a>",
"    above). This is a change from the 2002 guidelines, which recommended limited evaluation for infants born at &lt;35 weeks whose mothers received adequate IAP [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Well-appearing infants whose mothers received adequate IAP and who are &ge;37 weeks&rsquo; gestation can be considered for discharge at &gt;24 hours of age if they otherwise qualify for discharge, can be observed carefully at home, a person able to comply fully with discharge instructions will be present, and the parents have ready access to medical care [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]. This recommendation is based upon evidence from retrospective analyses that IAP does not alter the clinical spectrum of disease or the time of onset of clinical signs of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/6,7,22,23\">",
"     6,7,22,23",
"    </a>",
"    ]. Most infants with early-onset GBS present within the first 24 hours of life. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H12#H12\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Early-onset disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2757570\">",
"    <span class=\"h3\">",
"     Mother received no or inadequate IAP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of well-appearing infants born to mothers who had an indication for GBS prophylaxis (",
"    <a class=\"graphic graphic_table graphicRef66582 \" href=\"UTD.htm?32/63/33788\">",
"     table 1",
"    </a>",
"    ) but did not receive IAP or received inadequate IAP depends upon the gestational age of the infant and the duration of rupture of membranes before delivery (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the infant is &ge;37 weeks, 0 days&rsquo; gestational age",
"      <strong>",
"       and",
"      </strong>",
"      membranes were ruptured &lt;18 hours before delivery, the 2010 CDC guidelines state that no diagnostic testing is indicated [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"       4",
"      </a>",
"      ]. The infant should be observed in the hospital for at least 48 hours. A full diagnostic evaluation should be conducted and empirical antibiotic therapy initiated if the infant develops signs of sepsis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Ill-appearing infant'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      This is a change from the 2002 guidelines, which recommended limited evaluation for all infants born to mothers who received inadequate IAP [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/21\">",
"       21",
"      </a>",
"      ]. The change is supported by the documented low risk in this group of infants [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. Some experts recommend a complete blood count with differential and platelets at age 6 to 12 hours to evaluate this low-risk group [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2552/abstract/26\">",
"       26",
"      </a>",
"      ]. Laboratory evaluation does not replace&nbsp;the recommendation for observation of these infants in the hospital for at least 48 hours.",
"     </li>",
"     <li>",
"      If the infant is well-appearing but &lt;37 weeks, 0 days&rsquo; gestational age",
"      <strong>",
"       or",
"      </strong>",
"      the membranes were ruptured for &ge;18 hours before delivery, the infant should undergo a limited evaluation and be observed in the hospital for at least 48 hours. (See",
"      <a class=\"local\" href=\"#H2900551\">",
"       'Limited evaluation'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      A full diagnostic evaluation should be conducted and empirical antibiotic therapy initiated if the blood culture yields GBS or the infant develops signs of sepsis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H21#H21\">",
"       \"Group B streptococcal infection in neonates and young infants\", section on 'Evaluation'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H6\">",
"       'Ill-appearing infant'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Infants with unremarkable laboratory results and a benign clinical course should have antibiotics discontinued after 48 hours of therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/42/42657?source=see_link\">",
"       \"Patient information: Group B streptococcal disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All pregnant women should be screened for group B streptococcal (GBS) colonization with a swab or swabs of the lower vagina and rectum at 35 to 37 weeks of gestation, except women who have had GBS bacteriuria during the current pregnancy or a prior infant with GBS disease, who should always receive intrapartum antibiotic prophylaxis (IAP). (See",
"      <a class=\"local\" href=\"#H6035106\">",
"       'Indications for maternal IAP'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link\">",
"       \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The evaluation and empirical antibiotic therapy for early-onset GBS disease depend upon the newborn&rsquo;s clinical appearance, risk factors for GBS infection (including chorioamnionitis), and adequacy of maternal IAP (if IAP was indicated). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Management approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the infant is ill-appearing or sepsis is suspected, a full diagnostic evaluation should be performed. This includes a complete blood count (CBC) with differential and platelet count, a blood culture, and a lumbar puncture (unless the clinical status dictates otherwise), and a chest radiograph if there are respiratory abnormalities. Empirical antibiotic treatment (generally",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      ) should be administered until laboratory results are known. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Ill-appearing infant'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2900567\">",
"       'Empirical antibiotic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Well-appearing infants born to women with suspected or proven chorioamnionitis should undergo a limited diagnostic evaluation (blood culture at birth; CBC with differential and platelet count at birth",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      at 6 to 12 hours of life) (",
"      <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"       algorithm 1",
"      </a>",
"      ). Empirical antibiotic treatment (generally",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      ) should be administered until laboratory results are known. (See",
"      <a class=\"local\" href=\"#H6036777\">",
"       'Maternal chorioamnionitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2900567\">",
"       'Empirical antibiotic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic testing is not recommended for well-appearing infants whose mothers received",
"      <strong>",
"       adequate IAP",
"      </strong>",
"      (&ge;4 hours of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/46/14054?source=see_link\">",
"       penicillin G",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      , or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"       cefazolin",
"      </a>",
"      before delivery). Such infants should be observed for at least 48 hours. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Mother received adequate IAP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of well-appearing infants whose mothers had indications for GBS prophylaxis (",
"      <a class=\"graphic graphic_table graphicRef66582 \" href=\"UTD.htm?32/63/33788\">",
"       table 1",
"      </a>",
"      ) but received",
"      <strong>",
"       no or inadequate IAP",
"      </strong>",
"      depends upon the gestational age of the infant and the duration of rupture of membranes (",
"      <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"       algorithm 1",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H2757570\">",
"       'Mother received no or inadequate IAP'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For infants born at &ge;37 weeks, 0 days&rsquo; gestational age",
"      <strong>",
"       and",
"      </strong>",
"      rupture of membranes &lt;18 hours before delivery, no diagnostic testing is indicated, although some experts recommend a CBC with differential and platelets at age 6 to 12 hours. The infant should be observed in the hospital for 48 hours regardless of the CBC results.",
"     </li>",
"     <li>",
"      For infants born at &lt;37 weeks, 0 days&rsquo; gestational age",
"      <strong>",
"       or",
"      </strong>",
"      rupture of membranes &ge;18 hours before delivery, a limited evaluation (blood culture at birth; CBC with differential and platelet count at birth",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      at 6 to 12 hours of life) is recommended. The infants should be observed in the hospital for at least 48 hours.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of infants with established GBS infection is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H25#H25\">",
"       \"Group B streptococcal infection in neonates and young infants\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/1\">",
"      Schuchat A. Group B streptococcus. Lancet 1999; 353:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/2\">",
"      Schuchat A, Deaver-Robinson K, Plikaytis BD, et al. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. Pediatr Infect Dis J 1994; 13:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/3\">",
"      Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/4\">",
"      Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/5\">",
"      Committee on Infectious Diseases, Committee on Fetus and Newborn, Baker CJ, et al. Policy statement&mdash;Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 2011; 128:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/6\">",
"      Pulver LS, Hopfenbeck MM, Young PC, et al. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis. J Perinatol 2009; 29:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/7\">",
"      Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005; 115:1240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/8\">",
"      Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009; 360:2626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/9\">",
"      Stoll BJ, Hansen N, Fanaroff AA, et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004; 113:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/10\">",
"      Ansong AK, Smith PB, Benjamin DK, et al. Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Dev 2009; 85:S5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/11\">",
"      Greenberg DN, Yoder BA. Changes in the differential white blood cell count in screening for group B streptococcal sepsis. Pediatr Infect Dis J 1990; 9:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/12\">",
"      Christensen RD, Rothstein G, Hill HR, Hall RT. Fatal early onset group B streptococcal sepsis with normal leukocyte counts. Pediatr Infect Dis 1985; 4:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/13\">",
"      Newman TB, Puopolo KM, Wi S, et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/14\">",
"      Carbonell-Estrany X, Figueras-Aloy J, Salcedo-Abizanda S, et al. Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection. Arch Dis Child Fetal Neonatal Ed 2008; 93:F85.",
"     </a>",
"    </li>",
"    <li>",
"     Edwards MS, Nizet V, Baker CJ. Group B streptococcal infections. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington JS, Klein JO, Wilson CB, et al (Eds), Elsevier Saunders, Philadelphia 2010. p.419.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/16\">",
"      Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003; 22:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/17\">",
"      Hsu KK, Pelton SI, Shapiro DS. Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis 2003; 45:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/18\">",
"      Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants &gt;/=2000 grams at birth: A population-based study. Pediatrics 2000; 106:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/19\">",
"      Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003; 3:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/20\">",
"      Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010; 125:e1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/21\">",
"      Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/22\">",
"      Bromberger P, Lawrence JM, Braun D, et al. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000; 106:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/23\">",
"      Pinto NM, Soskolne EI, Pearlman MD, Faix RG. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems. J Perinatol 2003; 23:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/24\">",
"      Hashavya S, Benenson S, Ergaz-Shaltiel Z, et al. The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: is it justified? Pediatr Infect Dis J 2011; 30:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/25\">",
"      Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2552/abstract/26\">",
"      Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129:1006.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5981 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-E01451B0F0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2552=[""].join("\n");
var outline_f2_31_2552=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SUMMARY OF MATERNAL IAP GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6035106\">",
"      Indications for maternal IAP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Adequate IAP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2901877\">",
"      OVERVIEW OF MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2900460\">",
"      Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2900468\">",
"      - Full evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2900551\">",
"      - Limited evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2900559\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2900567\">",
"      Empirical antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MANAGEMENT APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ill-appearing infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Well-appearing infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6036777\">",
"      - Maternal chorioamnionitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Mother received adequate IAP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2757570\">",
"      - Mother received no or inadequate IAP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5981\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5981|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?5/3/5183\" title=\"algorithm 1\">",
"      Secondary prevention early-onset GBS disease among newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5981|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/63/33788\" title=\"table 1\">",
"      Indications for GBS intrapartum antibiotic prophylaxis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=related_link\">",
"      Chemoprophylaxis for the prevention of neonatal group B streptococcal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=related_link\">",
"      Clinical features and diagnosis of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=related_link\">",
"      Group B streptococcal infection in neonates and young infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43062?source=related_link\">",
"      Group B streptococcal infection in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9621?source=related_link\">",
"      Group B streptococcus: Virulence factors and pathogenic mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21512?source=related_link\">",
"      Neonatal pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36105?source=related_link\">",
"      Overview of the routine management of the healthy newborn infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/42/42657?source=related_link\">",
"      Patient information: Group B streptococcal disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=related_link\">",
"      Treatment and outcome of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=related_link\">",
"      Treatment and outcome of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40984?source=related_link\">",
"      Vaccines for the prevention of group B streptococcal disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_31_2553="Oral candidiasis - tongue";
var content_f2_31_2553=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82214%7EDERM%2F61040%7EID%2F75887&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82214%7EDERM%2F61040%7EID%2F75887&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral candidiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    White plaques are present on the tongue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral candidiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    White papules and plaques are present on the palate and tongue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oropharyngeal candidiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 237px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The buccal mucosa is involved here in the pseudomembranous form of oropharyngeal candidiasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol A Kauffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2553=[""].join("\n");
var outline_f2_31_2553=null;
var title_f2_31_2554="Overview of nerve conduction studies";
var content_f2_31_2554=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of nerve conduction studies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2554/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2554/contributors\">",
"     Steven H Horowitz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2554/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2554/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/31/2554/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/31/2554/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/31/2554/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The unique natural electrical properties of peripheral nerves can be evaluated in health and disease with externally applied stimuli and analysis of the consequent neurophysiologic responses. Nerve conduction study (NCS) techniques permit stimulation and recording of electrical activity from individual peripheral nerves with sufficient accuracy, reproducibility, and standardization to determine normal values, characterize abnormal findings, and correlate neurophysiologic-pathologic features.",
"   </p>",
"   <p>",
"    These clinical studies are used to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnose focal and generalized disorders of peripheral nerves",
"     </li>",
"     <li>",
"      Aid in the differentiation of primary nerve and muscle disorders (although NCS itself evaluates nerve and not muscle)",
"     </li>",
"     <li>",
"      Classify peripheral nerve conduction abnormalities due to axonal degeneration, demyelination, and conduction block",
"     </li>",
"     <li>",
"      Prognosticate regarding clinical course and efficacy of treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The basic anatomy, physiology, and pathophysiology of the peripheral nervous system, as reflected in the clinical study of nerve conduction, will be reviewed here. Needle electromyography is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/46/1769?source=see_link\">",
"     \"Overview of electromyography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY AND NORMAL NEUROPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most peripheral nerves are composed of nerve fibers with motor, sensory, and autonomic functions; these are \"mixed\" nerves. However, certain nerves available for clinical neurophysiologic investigation contain primarily motor fibers (eg, anterior interosseous branch of the median nerve, posterior interosseous branch of the radial nerve) or primarily sensory fibers (eg, sural, superficial peroneal, superficial radial).",
"   </p>",
"   <p>",
"    The most widely used classification of individual nerve fibers relates to their diameters, myelin properties, and conductivity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A-alpha (or A-alpha beta) are large myelinated fibers, 6 to 15 microns in diameter. The largest muscle afferent fibers are sometimes classified as 1a fibers.",
"     </li>",
"     <li>",
"      A-delta are small myelinated fibers, 3 to 5 microns in diameter",
"     </li>",
"     <li>",
"      C fibers are unmyelinated fibers, 0.5 to 2 microns in diameter",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Functionally, most efferent motor fibers are large myelinated (A-alpha). Sensory fibers mediating touch, vibration, and position senses are also large myelinated (A-alpha), while those that mediate cold and pain sensations are small myelinated (A-delta), and those that mediate warm and pain sensations are unmyelinated C fibers. Efferent postganglionic sympathetic autonomic fibers are unmyelinated C fibers.",
"   </p>",
"   <p>",
"    Clinical neurophysiologic techniques are able to study only the largest A-alpha fibers; this poses a problem in clinical situations where strength and vibration and position sense are unaffected, but pain and temperature are abnormal, a condition frequently referred to as \"small fiber neuropathy.\"",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Compound action potentials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensory nerve action potentials (SNAPs) and compound motor action potentials (CMAPs) are compound potentials that represent the summated electrical activity of individual nerve fibers simultaneously activated by nerve stimulation. For both SNAPs and CMAPs (recorded from muscle), this electrical activity is generated by A-alpha fibers. With special techniques, such as digital averaging of many stimulus responses with near-nerve recording electrodes, electrical activity of sensory A-delta fibers can be visualized [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conductivity in myelinated fibers is saltatory, ie, node-to-node (Ranvier) depolarization, and the speed of conduction is fiber-diameter dependent. The largest fibers conduct the fastest; the relationship between fiber diameter and conduction velocity of electrical impulses is roughly linear with a conversion factor of about 4.3",
"    <span class=\"nowrap\">",
"     m/s",
"    </span>",
"    in healthy people [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. Thus, 14 to 15 micron fibers conduct in the range of 65 to 70",
"    <span class=\"nowrap\">",
"     m/s,",
"    </span>",
"    whereas 6 to 7 micron fibers conduct at approximately 30 to 35",
"    <span class=\"nowrap\">",
"     m/s.",
"    </span>",
"   </p>",
"   <p>",
"    For the SNAP, the peak-to-peak amplitude and the area under the waveform of the compound potential reflects the number of nerve fibers activated, while the CMAP amplitude more accurately reflects the number of activated muscle fibers than nerve fibers.",
"   </p>",
"   <p>",
"    In acute nerve lesions, when nerve regeneration has not had time to develop, the loss of motor nerve fibers and muscle fibers capable of being activated parallel to one another, and CMAP amplitude is reduced accordingly. In chronic nerve lesions, however, CMAP amplitude is a poor estimate of motor nerve fiber number because surviving motor units reinnervate previously denervated muscle fibers via collateral sprouting of terminal motor nerve fiber branches. Subsequent to this process of reinnervation, there are reduced numbers of motor fibers, each with enlarged motor unit territories and increased numbers of muscle fibers per motor unit, and stimulation can result in a CMAP whose amplitude is normal or only mildly reduced. In this context, contributions from electromyography and motor unit number estimation techniques may be helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Temporal dispersion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Differences in conduction speed of A-alpha myelinated fibers contributing to compound evoked potentials create a temporal dispersion of electrical activities such that the largest and fastest conducting fibers contribute to the earliest part of the potential and slower conducting fibers contribute to later parts. Thus, the onset latency of a compound evoked potential is determined by the conduction speed of the fastest fibers. In addition, the potential has a measurable duration from the time it first leaves the baseline to when it returns.",
"   </p>",
"   <p>",
"    The concept of temporal dispersion can be understood by envisioning an automobile race over a distance of 120 miles; the fastest cars travel 60 miles per hour, the slowest 40 miles per hour. Shortly after the start, the cars are bunched together, and their concentration (representing CMAP amplitude) is greatest, while the spread between the fastest and slowest cars (representing duration) is shortest. However, as the race proceeds cars splay out and their concentration at any one point decreases. When the fastest cars reach the finish line at two hours, the slowest cars are 40 miles behind. There, the concentration (amplitude) of cars is less than anywhere previously and the distance (duration) between the fastest and slowest cars is greatest.",
"   </p>",
"   <p>",
"    With increasing lengths of nerve segment between stimulating and recording electrodes, temporal dispersion increases and amplitude decreases (",
"    <a class=\"graphic graphic_figure graphicRef78960 \" href=\"UTD.htm?16/0/16398\">",
"     figure 1",
"    </a>",
"    ). As an example, one study of upper extremity nerves recorded from hand muscles found that proximal stimulation at Erb's point in the supraclavicular fossa resulted in a 20 percent decline in CMAP amplitude and a 10 percent increase in CMAP negative phase duration compared with distal stimulation at the wrist [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The consensus criteria from the American Academy of Neurology (AAN), created for research purposes, define abnormal temporal dispersion as &gt;20 percent drop in CMAP amplitude and &gt;15 percent change in CMAP duration between proximal and distal sites [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/8\">",
"     8",
"    </a>",
"    ]. The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) criteria define it as &gt;30 percent increase in proximal versus distal CMAP duration [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/9\">",
"     9",
"    </a>",
"    ]. The relationship between increasing temporal dispersion and increasing length of nerve segment is approximately linear for motor conduction [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/10\">",
"     10",
"    </a>",
"    ], but not so for sensory conduction. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Sensory nerve conduction'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Phase cancellation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the recorded potential of both single motor units and single sensory fibers has both positive and negative components, phase cancellation can occur depending on the conduction velocity of individual fibers. Phase cancellation becomes more significant with greater distances between stimulating and recording electrodes.",
"   </p>",
"   <p>",
"    Individual sensory and motor nerve fibers contribute differently to compound SNAPs and CMAPs, respectively. A single large myelinated sensory fiber action potential has a much shorter duration (typically 2 msec) than a single motor unit potential (typically 5 to 15 msec). Because of this short duration, a small amount of dispersion will produce a much more dramatic reduction in SNAP amplitude than CMAP amplitude. Increasing conduction distance decreases median and ulnar SNAP amplitudes 16 to 17 times more than corresponding decreases in CMAP amplitudes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/7\">",
"     7",
"    </a>",
"    ]. However, there are no accepted criteria for the extent to which SNAP amplitude may decline with increasing distance between stimulating and recording electrodes. This issue becomes important when considering diagnostic criteria for demyelinating diseases of nerve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Saltatory conduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Saltatory conduction is the term used to describe the rapid propagation of action potentials along myelinated fibers in which nodes of Ranvier are interspersed between myelinated internodal areas along the axon. Conduction jumps from node to node along the nerve fiber by activation of inward sodium currents, which generate an outward capacitive (driving) current at the next node. The nodal membrane is depolarized to threshold, opening sodium channels and initiating another cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/11\">",
"     11",
"    </a>",
"    ]. When the driving current exceeds the threshold current of the nerve, conduction occurs. The ratio of driving current to threshold current is the safety factor, and is normally &gt;5 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/12\">",
"     12",
"    </a>",
"    ]. Because of saltatory conduction, the conduction velocity of myelinated fibers is &gt;10 times faster than what would be predicted for an unmyelinated axon of the same diameter.",
"   </p>",
"   <p>",
"    Original theories regarding saltatory conduction posited that the myelin sheath acted as an insulator, preventing current leakage along the internodal axon. However, later evidence suggested that myelin may actually leak current, and that its major role is to limit nodal capacitance to a minimum, thereby allowing the node to depolarize rapidly to threshold. In this model, the most important section of the myelin sheath responsible for maintaining saltatory conduction is the paranodal area [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Physiologic factors affecting nerve conduction",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Specific nerves and nerve segments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normative data for distal latencies, conduction velocities, and evoked potential measurements vary in regard to specific nerves and nerve segments. For instance, nerve conduction velocities are 15 to 20 percent faster in upper extremity nerves than in lower extremity nerves, and 5 to 10 percent faster in proximal segments compared with distal segments [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/13\">",
"     13",
"    </a>",
"    ]. Sensory conduction is 5 to 10 percent faster than motor conduction for each mixed nerve segment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve conduction velocities are about half normal adult values in full-term infants and increase into the adult range by age three to five years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/14\">",
"     14",
"    </a>",
"    ]. They then plateau until ages 25 to 30 and decline slowly thereafter at approximately 1 to 3 percent per decade [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/13\">",
"     13",
"    </a>",
"    ]. Decreases in median and ulnar sensory conduction velocities have been estimated at 0.13 to 0.21",
"    <span class=\"nowrap\">",
"     m/s",
"    </span>",
"    per year [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/15\">",
"     15",
"    </a>",
"    ]. Effectively, this is a change of 10",
"    <span class=\"nowrap\">",
"     m/s",
"    </span>",
"    or less even into the ninth decade.",
"   </p>",
"   <p>",
"    There is a negative correlation between age and evoked potential amplitude, probably related to loss of nerve fibers with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/16\">",
"     16",
"    </a>",
"    ]. The decline can be as much as 50 to 75 percent for the sensory nerve action potential (SNAP) in the median, ulnar, sural, and superficial peroneal nerves between the second and ninth decades [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/13\">",
"     13",
"    </a>",
"    ]. However, the decline varies from nerve to nerve, and is more pronounced for the SNAP than the compound muscle action potential (CMAP).",
"   </p>",
"   <p>",
"    The issue of absent evoked potentials in normal elderly subjects, when recording with surface electrodes, is unsettled. One study found that responses could not be recorded in &lt;1 percent of patients age 50 and younger, whereas loss of responses was common in those aged 70 and older [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/16\">",
"     16",
"    </a>",
"    ]. The sural nerve SNAP was most vulnerable, being absent in 24 percent of patients in their eighth decade and 40 percent in their ninth [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/16\">",
"     16",
"    </a>",
"    ]. However, in other studies, sural SNAPs were found in all subjects up to age 76 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/17\">",
"     17",
"    </a>",
"    ] and to age 88 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, sural SNAPs were found in all normal subjects as old as age 90 with near-nerve electrodes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Height, weight, gender",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a negative correlation between height and nerve conduction velocity, more so for lower extremity nerves, and the effect of height is greater than that of age [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/16\">",
"     16",
"    </a>",
"    ]. Conversely, age has a much greater effect than height on evoked potential amplitude [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women have faster conduction velocities than men, possibly due to height differences [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/20\">",
"     20",
"    </a>",
"    ]. The higher sural SNAP amplitudes seen in women may relate to differences in subcutaneous tissue at the ankle [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SNAP amplitudes declined with increasing body mass index in two studies but not in another [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/17,18,21\">",
"     17,18,21",
"    </a>",
"    ]. Body mass index affects specific nerve segments; ulnar conduction velocities across the elbow directly correlated with body mass index, but not ulnar forearm conduction velocities [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/20\">",
"     20",
"    </a>",
"    ]. Possible explanations are that nerve length may be overestimated in the presence of adipose tissue, or that added insulation may produce higher local nerve temperatures [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Temperature",
"    </span>",
"    &nbsp;&mdash;&nbsp;The temperature of nerve segments undergoing testing has a significant effect on nerve conductivity and evoked potential amplitude [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/23\">",
"     23",
"    </a>",
"    ]. In normal subjects, within a range that excludes very high or very low temperatures, decreased local temperature results in the following changes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased evoked potential amplitudes, by 1.76 to 2.27 percent per degree Celsius (C) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Increased distal latencies, by 2.52 percent per degree C [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Decreased conduction velocities, by 1.2 to 2.4",
"      <span class=\"nowrap\">",
"       m/s",
"      </span>",
"      per degree C [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/3,25\">",
"       3,25",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the large magnitude of these changes and their potential role in confounding result interpretation, standardization of temperature during testing is necessary. The arm should be maintained at 34 to 36 degrees C and the leg at 32 to 34 degrees C. The situation is of particular importance during cold weather and in patients with anxiety-induced sympathetic overactivity. External infrared heating elements, hot packs, and hot water baths can be effective in raising limb temperatures, but measured skin temperature may differ considerably from intramuscular or nerve temperatures [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/24\">",
"     24",
"    </a>",
"    ]. Correction factors to compensate for low limb temperatures during testing are not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     METHODOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The essential parameters evaluated during clinical peripheral nerve conduction studies are the amplitudes, areas, configurations, and durations of the sensory nerve action potential (SNAPs) and compound muscle action potentials (CMAPs) evoked by peripheral nerve stimulation, and the sensory and motor nerve conduction velocities. All measures are dependent upon the integrity of the largest myelinated fibers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral nerve activation involves placement of a stimulating cathode (negative pole) and anode (positive pole) over the nerve and generating an electrical pulse between them. Negative charges accumulate under the cathode and depolarize the nerve. Simultaneously, the nerve is hyperpolarized under the anode. Modern stimulators generate a square or rectangular wave pulse, the duration and strength of which can be varied. The most commonly used durations are 0.1 to 0.2 msec, but pulses with durations of up to 1 msec may be necessary with diseased nerves and when studying the H reflex.",
"   </p>",
"   <p>",
"    With increasing stimulus strength a threshold level is reached, the minimum stimulus at which depolarization of some individual fibers in the underlying nerve occurs with generation of a propagating action potential. &nbsp;Greater stimulus strength recruits more nerve fibers and progressively increases the compound action potential until a maximum size is reached. For motor conduction studies, a maximal stimulus strength can be reached such that all motor axons within the nerve that can be activated are activated. However, compared with motor axons, sensory fibers have a greater variability in fiber diameter and sensitivity to stimulation. Thus, a maximum response may be reached that represents activation of all large myelinated sensory fibers but that does not include smaller myelinated fibers.",
"   </p>",
"   <p>",
"    A supramaximal stimulus, 10 to 20 percent above the maximal stimulus level, is employed to ensure that variations in stimulus intensity or inadvertent minor changes in the relationship between stimulator and nerve do not affect the action potential, particularly its amplitude and onset latency. In normal nerves, stimuli of 100 to 300 V, or 10 to 30 mA, delivered through surface electrodes, are usually sufficient to provide supramaximal stimulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Recording",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surface recording electrodes are typically used to record the electrical activity resulting from nerve excitation. These electrodes are placed over a muscle, a sensory nerve, or a cutaneous nerve distribution. The parameters most often studied are the time (latency) between the stimulus artifact and the onset of the compound action potential, and the amplitude, duration, area, and configuration of the compound action potential.",
"   </p>",
"   <p>",
"    In motor nerve studies, recording occurs from muscles. The active electrode is placed over the motor point (endplate) and the reference electrode over the muscle tendon; they record summated activity from all activated muscle fibers under the active electrode. The compound muscle action potential (CMAP) is recorded by the active electrode as a near-field potential. Although the reference electrode is considered electrically silent, it does record far-field or volume-conducted electrical activity from other concurrently activated muscles (eg, with ulnar nerve stimulation and activation of multiple hand muscles), or from faster conducting sensory fibers, thereby potentially interfering with the measurement and interpretation of the CMAP and its onset latency [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For recording of sensory potentials, digital averaging of evoked responses to multiple stimuli is often employed. This technique increases the signal-to-noise ratio by the square root of the number of stimuli averaged. Small SNAPs having identical latencies after each stimulus can be differentiated from baseline, as baseline noise is reduced. This is important when studying small lower extremity sensory nerves, especially in older people and in patients with axonal degenerative peripheral nerve disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Orthodromic and antidromic recording",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a nerve is electrically stimulated, it is depolarized. Evoked electrical activity in the nerve propagates both proximally and distally from the stimulus site.",
"   </p>",
"   <p>",
"    Motor conduction studies are orthodromic, meaning that propagation of the evoked potential occurs from nerve to muscle in the direction of physiological conduction. Sensory potentials can be recorded with either orthodromic (propagation of the evoked potential away from the sensory receptor) or antidromic (propagation of the evoked potential toward the sensory receptor) methods (",
"    <a class=\"graphic graphic_figure graphicRef78960 \" href=\"UTD.htm?16/0/16398\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In clinical practice, sensory responses using antidromic recording techniques (with the stimulator placed proximal to the recording electrodes) are more frequently employed for sensory nerve conductions, mainly because the amplitude of the sensory nerve action potential (SNAP) is larger with antidromic than with orthodromic recording [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Motor nerve conduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the peripheral nervous system, efferent motor nerve fibers are part of Liddell and Sherrington's motor unit [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/28\">",
"     28",
"    </a>",
"    ], which consists of an anterior horn cell (motor neuron), its axon (motor nerve), terminal nerve branches, synapses, and all individual muscle fibers so innervated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     CMAP latency, amplitude, area, and duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the active recording electrode is properly placed over the motor point of the muscle, the compound muscle action potential (CMAP) is biphasic, beginning with negative (upward) activity as the potential leaves the baseline.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CMAP latency is the time between stimulus onset and onset of negative peak",
"     </li>",
"     <li>",
"      CMAP amplitude is the height of the negative peak from baseline or the difference between negative and positive peaks",
"     </li>",
"     <li>",
"      CMAP area is the area under the negative peak waveform [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/14\">",
"       14",
"      </a>",
"      ]. This measurement is calculated by computerized electronic integration of the CMAP negative waveform",
"     </li>",
"     <li>",
"      CMAP duration is the time from onset of the negative peak to return to baseline of the end of the potential",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the CMAP potential starts with a positive (downward) deflection, then either the active electrode is distant from the motor point, or activity is being recorded from nearby muscles [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Conduction velocity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conductivity of an electrical impulse is fastest along the main axon and slower in terminal nerve branches. At neuromuscular junctions (synapses), acetylcholine quanta are released from nerve terminals; they activate acetylcholine receptors at muscle fiber endplates. There is depolarization of the muscle membrane, development of a motor action potential, and muscle fiber contraction. These neuromuscular junction activities add an approximately 1 msec delay to motor unit conductivity, with an additional delay due to electrical transmission along muscle fiber membranes.",
"   </p>",
"   <p>",
"    Consequently, the pure conduction velocity of electrical current flowing along a motor nerve cannot be accurately measured between a single stimulating electrode placed along the nerve and a recording electrode over the muscle, because the conduction time from stimulus onset to onset of recorded electrical potential comprises not only nerve conduction, but also neuromuscular junction (NMJ) transmission and muscle fiber conduction. The conduction time involving all three components (nerve conduction, NMJ transmission, and muscle fiber conduction) is called the terminal motor latency or distal motor latency. Normal terminal motor latency values vary from nerve to nerve, being longer in lower extremity nerves.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Calculation of motor conduction velocity",
"    </span>",
"    &nbsp;&mdash;&nbsp;To measure motor conduction velocity, a motor nerve must be stimulated at two points, one proximal and one more distal. The conduction time in the terminal segments of the motor unit are identical for the resulting compound muscle action potential (CMAP) recordings from both stimulation sites.",
"   </p>",
"   <p>",
"    The pure motor conduction velocity can be calculated as follows (",
"    <a class=\"graphic graphic_figure graphicRef73171 \" href=\"UTD.htm?32/11/32948\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measuring the distance (d) between the stimulation sites in millimeters",
"     </li>",
"     <li>",
"      Subtracting the conduction time between the distal stimulus site and the recording site (distal latency) from the conduction time between the proximal stimulus site and the recording site (proximal latency)",
"     </li>",
"     <li>",
"      Dividing the distance (d) in millimeters by the difference in conduction times (proximal latency - distal latency) in milliseconds",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, motor conduction velocity =",
"    <span class=\"nowrap\">",
"     d/(proximal",
"    </span>",
"    latency - distal latency). The units are",
"    <span class=\"nowrap\">",
"     millimeters/millisecond",
"    </span>",
"    <span class=\"nowrap\">",
"     (mm/msec),",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     meters/second",
"    </span>",
"    <span class=\"nowrap\">",
"     (m/s).",
"    </span>",
"   </p>",
"   <p>",
"    Motor conduction velocity determinations are critically dependent upon accurate measurements of both distal and proximal latencies and of conduction distances between these stimulation sites. The standard consensus is that distances of at least 10 cm or more should be used to minimize measurement errors. However, with modern electrodiagnostic equipment, accurate conduction velocities can be determined with distances as short as 5 to 6 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further evaluation of conduction in the terminal segment of the motor unit may differentiate demyelinating disorders that have uniform conduction slowing along the entire length of nerve (eg, hereditary motor and sensory neuropathy type 1A), and those with multifocal conduction changes and nonuniform conduction slowing (eg, hereditary neuropathy with pressure palsy, the inflammatory demyelinating polyneuropathies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/30\">",
"     30",
"    </a>",
"    ]), from those with disproportionate distal nerve conduction slowing (eg, polyneuropathy with antibodies against myelin-associated glycoproteins). The terminal latency index (TLI) is a measure that combines distal latency and proximal conduction velocity to evaluate whether disproportionate distal slowing is present [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Sensory nerve conduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Afferent sensory fibers, which have their cells of origin in the dorsal root ganglia, do not have synapses within the peripheral nervous system. Therefore, electrical current flowing between stimulating and recording sensory electrodes in the periphery occurs solely along the nerve, and a conduction velocity can be derived by dividing conduction distance by conduction time between stimulating and recording electrodes. In routine studies, the sensory receptors are not evaluated.",
"   </p>",
"   <p>",
"    Whereas the compound muscle action potential (CMAP) is measured in millivolts (mV), the sensory nerve action potential (SNAP) is measured in microvolts (microV) (",
"    <a class=\"graphic graphic_figure graphicRef55496 \" href=\"UTD.htm?15/25/15765\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     F wave",
"    </span>",
"    &nbsp;&mdash;&nbsp;F waves are late responses generated by supramaximal nerve stimulation (",
"    <a class=\"graphic graphic_waveform graphicRef75038 \" href=\"UTD.htm?1/45/1744\">",
"     waveform 1",
"    </a>",
"    ). Electrical activity moving proximally in motor nerves activates or backfires motor neurons, which can generate an orthodromic response known as the F wave that is visible as a low amplitude late potential. F waves are useful for evaluating peripheral neuropathies with predominantly proximal involvement, such as the acute and chronic inflammatory demyelinating polyneuropathies, in which distal conduction velocities may be normal early in the disease.",
"   </p>",
"   <p>",
"    The F wave is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39251?source=see_link&amp;anchor=H2#H2\">",
"     \"Nerve conduction studies: Late responses\", section on 'F waves'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     H reflex",
"    </span>",
"    &nbsp;&mdash;&nbsp;The H reflex is a true reflex with an afferent arc mediated by large, fast-conducting group 1a fibers, and an efferent arc mediated by alpha motor neurons (",
"    <a class=\"graphic graphic_figure graphicRef81004 \" href=\"UTD.htm?29/53/30558\">",
"     figure 4",
"    </a>",
"    ). It is visible only with submaximal stimulation and is most consistently seen with tibial nerve stimulation in the popliteal fossa when recording from the soleus and plantar foot muscles. The H reflex is useful for evaluating the S1 nerve root in suspected radiculopathies and proximal conduction in polyneuropathies.",
"   </p>",
"   <p>",
"    The H reflex is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39251?source=see_link&amp;anchor=H4#H4\">",
"     \"Nerve conduction studies: Late responses\", section on 'H reflex'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three main pathologic mechanisms affecting peripheral nerve:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Axonal degeneration",
"     </li>",
"     <li>",
"      Demyelination",
"     </li>",
"     <li>",
"      Conduction block",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This pathophysiologic classification is based upon an understanding of the two predominant neural structures, the axon and its myelin sheath. Peripheral nerve disorders, both focal and generalized, can affect either of these structures alone or together.",
"   </p>",
"   <p>",
"    Electrophysiologic studies attempt to characterize abnormalities according to which mechanism predominates in a particular disorder and patient. However, this division is simplistic and not absolute; complex",
"    <span class=\"nowrap\">",
"     axon/myelin",
"    </span>",
"    interactions exist, many diseases have both axonal loss and demyelination (eg, hereditary motor and sensory neuropathy 1, severe carpal tunnel syndrome), and axonal changes can occur secondary to disorders of myelin. In some patients, the results do not allow distinction. Further, in conditions with axonal loss, nerve conduction study findings come from conduction in fibers that are still functional, and there is no contribution from the most affected degenerated fibers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/32\">",
"     32",
"    </a>",
"    ]. In demyelinating disorders, the nerve conduction study findings reflect conduction in affected nerve fibers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Axonal degeneration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary feature of axonal degeneration seen with nerve conduction studies is reduced amplitude. The conduction velocity may also be reduced to the extent that the largest axons are affected; in this setting, the measured conduction velocity reflects the velocity of the largest remaining axons. Nevertheless, the degree of conduction slowing with axonal degeneration is less than with demyelination.",
"   </p>",
"   <p>",
"    Pathologic conditions affecting peripheral nerves may produce focal or general loss of axons. The axons relevant to clinical neurophysiologic studies are A-alpha fibers with diameters of 6 to 15 microns. Loss of these fibers is manifested as a decrease in amplitude and a change in configuration (increased dispersion and increased number of phases) of the compound evoked potentials. In addition, loss of these fibers causes slowing in maximum conduction velocity.",
"   </p>",
"   <p>",
"    Since the largest fibers contribute to the earliest part of the compound evoked potential, their loss results in an increase in conduction time and a decrease in conduction velocity. As an example, if all fibers &gt;10 microns in diameter are lost, then the fastest conduction velocities of the remaining fibers would be in the 40",
"    <span class=\"nowrap\">",
"     m/s",
"    </span>",
"    range. Normally, maximum conduction velocities are in the 65 to 75",
"    <span class=\"nowrap\">",
"     m/s",
"    </span>",
"    range.",
"   </p>",
"   <p>",
"    Small A-delta fibers make little if any contribution to the sensory nerve action potential (SNAP) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/4\">",
"     4",
"    </a>",
"    ] or compound muscle action potential (CMAP) and C fibers make none. Thus, these SNAPs and CMAPs are normal in neuropathies that exclusively or predominantly affect small fibers.",
"   </p>",
"   <p>",
"    By the \"80 percent rule\", the conduction velocity should be &gt;80 percent of the lower limits of normal when the amplitude of the evoked potential is &gt;80 percent of the normal value [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/14\">",
"     14",
"    </a>",
"    ]. A greater loss of fast conducting fibers could be responsible for greater conduction slowing. However, in pure axonal loss lesions, the conduction slowing cannot go below 70 percent of the lower limits of normal [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/14\">",
"     14",
"    </a>",
"    ], or 60 percent of the normal mean for that particular nerve and segment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/33\">",
"     33",
"    </a>",
"    ]. This is amplitude-dependent slowing, ie, conduction velocity is reduced because a subpopulation of faster conducting axons have been lost, not because of demyelination of conducting axons.",
"   </p>",
"   <p>",
"    Practically, assuming the variables of height, age, and temperature are taken into account, conduction velocities &gt;30",
"    <span class=\"nowrap\">",
"     m/s",
"    </span>",
"    are compatible with axonal loss, whereas velocities &lt;30",
"    <span class=\"nowrap\">",
"     m/s",
"    </span>",
"    most likely reflect demyelination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Disorders of myelin-demyelination",
"    </span>",
"    &nbsp;&mdash;&nbsp;When myelin is disrupted (demyelination), especially in paranodal areas, nodal capacitance increases, and resistance decreases. It takes longer for the driving current to activate the next node to threshold, resulting in slowing in internodal conduction and a reduced conduction velocity along that segment of nerve.",
"   </p>",
"   <p>",
"    This slowing in conduction velocities can occur through the several patterns that follow:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uniform (seen in all segments of all nerves), as in hereditary motor and sensory neuropathy type 1",
"     </li>",
"     <li>",
"      Multifocal (seen in some but not all nerves, or only along certain nerve segments), as in the acute and chronic inflammatory demyelinating neuropathies",
"     </li>",
"     <li>",
"      Monofocal (one nerve at one site), as in compressive lesions of the median nerve at the carpal tunnel or the ulnar nerve at the ulnar groove",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Conduction block occurs (conduction fails at that point of the axon) if the driving current falls below the threshold current (ie, if the safety factor drops below unity) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/11,12,34\">",
"     11,12,34",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Conduction block'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Unfortunately, the diagnosis of primary demyelination in any particular patient or nerve can be problematic.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Slowed conduction velocities and prolonged distal latencies can occur in axonal disorders",
"     </li>",
"     <li>",
"      There is a wide range of normal values for the standard parameters of nerve conduction",
"     </li>",
"     <li>",
"      Secondary demyelination can occur with primary axonopathies [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      CMAP amplitude must be considered",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CMAP amplitude can be normal or reduced in demyelination and conduction block. With focal sites of demyelination and block, stimulation distally will result in normal CMAP amplitudes if axons remain intact. However, a definite diagnosis of primary demyelination may be impossible in the context of marked reductions in distal CMAP amplitudes. That is why the consensus criteria discussed above are, in part, dependent upon CMAP amplitude and the amplitude, in part, determines the criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. These criteria are usually considered sufficiently specific, but insufficiently sensitive to be used in clinical practice. This raises the risk of not diagnosing and hence, not treating patients who actually have inflammatory or autoimmune demyelinating disorders that may be responsive to treatments such as intravenous immunoglobulin or plasmapheresis.",
"   </p>",
"   <p>",
"    Multiple studies have attempted to refine the consensus criteria in the hopes of increasing their sensitivity and specificity. Many such studies have used the electrophysiologic findings in motor neuron disorders and axonal polyneuropathies as representative of axonal degeneration, and have defined criteria for primary demyelination in contrast. As an example, the following are one set of proposed criteria for primary demyelination [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Motor conduction velocity slowing of &lt;70 percent of the lower limit of normal",
"     </li>",
"     <li>",
"      Prolonged motor distal latency of &gt;150 percent of the upper limit of normal",
"     </li>",
"     <li>",
"      Prolonged F wave latency of &gt;120 percent of the upper limit of normal with distal CMAP negative peak amplitude of &gt;80 percent of the lower limit of normal, with findings present in at least two nerves. The F wave latency must be prolonged to &gt;150 percent of the upper limit of normal if the distal negative peak CMAP amplitude is &lt;80 percent of the lower limit of normal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Alternatively, in hereditary motor and sensory neuropathy type 1, a condition with pathologically proven demyelination, conduction velocities are &lt;60 percent of the normal mean for that particular segment of that particular nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prolongation of the distal CMAP duration, due to abnormal temporal dispersion, can be an indication of distal demyelination; this finding is not observed in axonal neuropathic disorders or in focal nerve compression syndromes (eg, carpal tunnel) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. One group of investigators determined that distal CMAP durations (from onset of the first negative deflection to return to baseline of the last negative deflection) are abnormal and indicative of demyelination when &gt;8.5 msec in acute inflammatory demyelinating polyneuropathy and &gt;9 msec in chronic inflammatory demyelinating polyneuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/36,38\">",
"     36,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, this phenomenon cannot be used to distinguish between acquired and hereditary demyelinating polyneuropathies, since one study found that distal CMAP prolongations of &gt;9 msec occur in a clinically significant proportion of patients with hereditary demyelinating neuropathies (eg, hereditary motor and sensory neuropathy type 1A) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/39\">",
"     39",
"    </a>",
"    ]. However, the same report found abnormal distal CMAP prolongation affecting multiple nerves occurred in 39 percent of patients with chronic inflammatory demyelinating polyneuropathy, but rarely in hereditary disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another study, a linear correlation between CMAP and SNAP action potential amplitude and conduction velocity was present in most nerves affected by axonal or demyelinating polyneuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/40\">",
"     40",
"    </a>",
"    ]. Thus, the relationship between amplitude reduction and conduction slowing did not seem useful for distinguishing the degree of demyelination versus axonal loss in an individual patient with polyneuropathy.",
"   </p>",
"   <p>",
"    Given the many possible electrophysiologic expressions of demyelination, it is no wonder that confusion exists. There is still no gold standard set of diagnostic criteria for the electrophysiologic identification of demyelination. Such criteria are difficult to devise because \"there is no accepted time-honored set-in-stone way to deal with multiple parameters\" [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Conduction block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conduction block can occur with acquired demyelinating nerve lesions. The key information for identifying conduction block is the amount of drop in CMAP amplitude",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    area when stimulating from more proximal, compared with distal, sites. Criteria for conduction block are specific for individual nerves, since normative data for CMAP amplitude, area, and duration vary from nerve to nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even in normal nerves, the effects of phase cancellation and temporal dispersion can affect compound potentials and lead to reductions in amplitude and area, and increases in duration, when stimulating from successively more proximal sites. These changes are more pronounced for SNAPs than CMAPs. The criteria for conduction block must account for these normal changes. The AANEM consensus criteria cite normal ranges of CMAP changes between stimulus sites distal and proximal as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For the median and ulnar nerves, with stimulation at the elbow versus the wrist, CMAP amplitude and area are reduced by no more than 25 and 20 percent respectively, while duration increases by no more than 25 percent",
"     </li>",
"     <li>",
"      For the peroneal nerve, with stimulation at the knee versus the ankle, CMAP amplitude and area are reduced by no more than 30 and 25 percent respectively, while duration increases by no more than 30 percent",
"     </li>",
"     <li>",
"      For the tibial nerve, with stimulation at the knee versus the ankle, CMAP amplitude and area are reduced by no more than 50 percent and 30 percent, while duration increases by no more than 30 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With these normal findings in mind, the AANEM consensus criteria for definite partial conduction block, assuming a minimal contribution of temporal dispersion (&lt;30 percent), are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In median and ulnar nerves, conduction block requires a reduction in CMAP amplitude of &gt;50 percent over wrist to elbow segments",
"     </li>",
"     <li>",
"      In peroneal and tibial nerves, conduction block requires a reduction in CMAP amplitude of &gt;60 percent over ankle to knee segments",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The AAN criteria require only a &gt;20 percent decline in CMAP negative peak area or peak-to-peak amplitude with &lt;15 percent change in duration [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/8\">",
"     8",
"    </a>",
"    ]. Others have proposed a 30 percent CMAP amplitude drop, except with stimulation at Erb's in the supraclavicular fossa point, for which a &gt;50 percent amplitude drop was used [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of note, any reduction in CMAP amplitude of &gt;20 to &lt;50 percent is abnormal according to the AAN criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/8\">",
"     8",
"    </a>",
"    ], but not those of the AANEM [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While temporal dispersion and its attendant desynchronization and phase cancellation contribute little to the decline in CMAP amplitude and area over distance in normal conduction, they can make a significant contribution to CMAP amplitude or area decline in segmental demyelination, giving a false impression of conduction block [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/14,43\">",
"     14,43",
"    </a>",
"    ]. Excessive CMAP desynchronization and phase cancellation, rather than conduction block, should be considered when a prominent reduction in CMAP amplitude is accompanied by good motor unit recruitment and strength [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/14\">",
"     14",
"    </a>",
"    ]. Alternatively, abnormal temporal dispersion is an intrinsic electrophysiologic feature of multifocal motor neuropathy, independent of conduction block, and, when present, should not preclude this diagnosis whether conduction block is present or not [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of conduction block is complicated when distal CMAP amplitude is reduced. The AANEM consensus criteria are valid when the negative phase of the distal CMAP is &gt;20 percent of the lower limit of normal [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/9\">",
"     9",
"    </a>",
"    ]. Reduced distal CMAP amplitudes may be due to distal axonal loss as seen in conditions with length-dependent axonal degeneration, distal demyelination, or distal conduction block, that is, a block in conduction between the distal-most stimulus site and the recording electrode over muscle. (Distal conduction block may be considered when muscle weakness exists without muscle atrophy or denervation activity on electromyography). If a reduced distal CMAP amplitude is due to axonal loss, then greater desynchronization and phase cancellation can produce further reductions in CMAP amplitude with proximal stimulation and obscure possible conduction block.",
"   </p>",
"   <p>",
"    Conduction block is significantly influenced by membrane hyperpolarization when an axon conducts a rapid train of impulses either via external stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/45\">",
"     45",
"    </a>",
"    ] or voluntary activity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/46\">",
"     46",
"    </a>",
"    ]. This activity-dependent, or frequency-dependent, hyperpolarization blocks conduction when the safety factor is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/34\">",
"     34",
"    </a>",
"    ]. Axonal membrane hyperpolarization was found distal to the site of conduction block in multifocal motor neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/47\">",
"     47",
"    </a>",
"    ]. In multifocal motor neuropathy, the electrophysiologic features of the block may change depending on disease duration; depolarizing blocks were seen in patients with shorter disease duration (two years) and hyperpolarizing blocks in patients with more chronic disease (five or more years) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/48\">",
"     48",
"    </a>",
"    ]. Frequency-dependent conduction block has also been found in patients with carpal tunnel syndrome and significantly prolonged motor latencies. It may explain grip weakness associated with this condition [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conduction block can also be caused by mechanisms other than demyelination, such as sodium channel blockade or ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/11\">",
"     11",
"    </a>",
"    ]. In multifocal motor neuropathy, antibody interference with sodium movement across the nodal membrane may play a role in conduction block [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sensory fibers are much less susceptible to conduction block than motor fibers for various physiologic reasons, including protection against hyperpolarization due to greater inward rectification, a more active sodium-potassium pump, greater expression of persistent sodium channels, and a higher safety factor for impulse transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/11,34,46\">",
"     11,34,46",
"    </a>",
"    ]. Additionally, partial sensory conduction block may be more difficult to define because of the effects of normal temporal dispersion and phase cancellation on the SNAP [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. Nonetheless, partial sensory conduction block has been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/4\">",
"     4",
"    </a>",
"    ] and can occur in multifocal acquired demyelinating sensory and motor neuropathy (MADSAM, Lewis-Sumner syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve conduction studies are invaluable in defining and determining peripheral nervous system function, dysfunction, and disease, both focally, as in entrapment neuropathies, and generally, as in polyneuropathies. Some conditions (eg, conduction block) can only be diagnosed with conduction studies. Conduction studies can also provide the electropathophysiologic diagnoses in other conditions, such as axonal damage versus demyelination.",
"   </p>",
"   <p>",
"    Nerve conduction studies may also be helpful in determining therapies, such as when to do surgery in the carpal tunnel syndrome, or when to use immunosuppressive therapy in polyneuropathies. Because they are reliable and reproducible, nerve conduction studies can provide objective evidence of efficacy with therapy and in clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While nerve conduction studies can distinguish various types of electropathophysiologic abnormalities of large myelinated fibers, they most often cannot determine specific etiologies. Since conduction studies evaluate large myelinated fiber functions, they are often normal in polyneuropathies with predominant small fiber involvement, and in neuropathic pain conditions. Nevertheless, one study found electrodiagnostic evidence that small fiber sensory neuropathy progresses to large fiber involvement 5 to 10 years after onset of pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Concurrent electromyography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve conduction studies should not be performed or interpreted in isolation. The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) recommends that nerve conduction studies and electromyography should be performed and interpreted at the same time in the majority of situations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/54\">",
"     54",
"    </a>",
"    ]. This is critically important in patients with suspected radiculopathy, plexopathy, myopathy, motor neuropathy, or motor neuron disease. In addition, the complementary information derived from electromyography is useful to ensure that an underlying disease process is not missed (eg, radiculopathy in a patient with suspected carpal tunnel syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/46/1769?source=see_link\">",
"     \"Overview of electromyography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Utility of composite scores",
"    </span>",
"    &nbsp;&mdash;&nbsp;Composite scores made up of several nerve conduction study attributes may be better diagnostic measures of nerve impairment than the individual nerve conduction study tests [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Composite scores may also be useful for the detection of subclinical nerve impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of patients with generalized peripheral neuropathies, including patients with diabetes (n = 396) and those with chronic inflammatory demyelinating polyneuropathy (n = 55), composite scores that incorporated nerve conduction velocities, distal latencies, and F waves of individual or multiple nerves were generally more sensitive and more reproducible than individual nerve conduction study tests for the detection of neuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study involving patients with diabetes but without a diagnosis of polyneuropathy at baseline, composite scores of nerve conduction study tests were the most sensitive indicator of early asymptomatic functional nerve worsening over time [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/57\">",
"       57",
"      </a>",
"      ]. In addition, composite scores demonstrated latent nerve dysfunction before nerve conduction criteria for diabetic polyneuropathy were met, and showed a statistically significant worsening over time [",
"      <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve conduction studies employing surface electrodes are noninvasive. The major risks involve possible electrical injury from stray leakage currents.",
"   </p>",
"   <p>",
"    Safety procedures are necessary to minimize electrical leaks and injury [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/58\">",
"     58",
"    </a>",
"    ]. Most important are measures to insure proper grounding. These measures include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Use of a three-hole power receptacle with a properly grounded outlet.",
"     </li>",
"     <li>",
"      Use of ground electrodes in all tests to help dissipate and minimize electrical leaks. Ground electrodes should be applied to the same limb as the active electrodes so that leakage currents will not flow through the heart. Placing the ground electrode between stimulator and recording electrodes minimizes leakage and also minimizes stimulus artifact, especially with sensory conduction studies at high amplification.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intensive care unit settings predispose to increased risk when patients are attached to multiple electrical devices plugged into different power outlets. In addition, the normal protective barrier of intact, dry skin may be breached by intravenous lines, external wires, and fluid spills [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nerve conduction studies can be safely performed in patients with implanted cardiac pacemakers and cardioverter-defibrillators [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. There is the theoretical possibility that nerve stimuli can be mistaken as arrhythmias and trigger or inhibit demand pacemakers and cardioverter-defibrillators or induce atrial or ventricular fibrillation. However, in a study of nerve conduction studies at routine sites, including the left supraclavicular fossa, electrical impulses were not detected by the bipolar sensing systems of these cardiac devices [",
"    <a class=\"abstract\" href=\"UTD.htm?2/31/2554/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The sensory nerve action potential (SNAP) and compound muscle action potential (CMAP) are compound potentials that represent the summated electrical activity of individual nerve fibers simultaneously activated by nerve stimulation. Normal differences among individual nerve fibers in action potential conduction speed and duration can affect the amplitude and duration of compound potentials via temporal dispersion and phase cancellation. Normal nerve conduction parameters also vary with regard to specific nerves, nerve segments, individual patient characteristics, and temperature. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomy and normal neurophysiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Surface recording electrodes are typically used to record the electrical activity resulting from nerve excitation. These electrodes are placed over a muscle, a sensory nerve, or a cutaneous nerve distribution. The essential parameters evaluated are the amplitudes, areas, durations, and configurations of the SNAPs and CMAPs, and the conduction velocities of sensory and motor nerves. They are dependent upon the integrity of the largest myelinated fibers. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Methodology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      F waves are late responses generated by supramaximal nerve stimulation. Electrical activity moving proximally in motor nerves activates or backfires motor neurons, which can generate an orthodromic response known as the F wave that is visible as a low amplitude late potential. F waves are useful for evaluating peripheral neuropathies with predominantly proximal involvement. The F wave is reviewed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39251?source=see_link&amp;anchor=H2#H2\">",
"       \"Nerve conduction studies: Late responses\", section on 'F waves'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The H reflex is a true reflex with an afferent arc mediated by large, fast-conducting group 1a fibers, and an efferent arc mediated by alpha motor neurons. It is visible only with submaximal stimulation and is most consistently seen with tibial nerve stimulation in the popliteal fossa when recording from the soleus and plantar foot muscles. The H reflex is useful for evaluating the S1 nerve root in suspected radiculopathies and proximal conduction in polyneuropathies. The H reflex is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39251?source=see_link&amp;anchor=H4#H4\">",
"       \"Nerve conduction studies: Late responses\", section on 'H reflex'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The three main pathologic mechanisms that affect peripheral nerve are axonal degeneration, demyelination, and conduction block (see",
"      <a class=\"local\" href=\"#H23\">",
"       'Pathophysiology'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The primary feature of axonal degeneration is reduced amplitude of SNAPs or CMAPs.",
"     </li>",
"     <li>",
"      The primary feature of demyelination is reduced conduction velocity.",
"     </li>",
"     <li>",
"      Conduction block can occur with acquired demyelinating nerve lesions. The key information is the amount of drop in CMAP amplitude",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      area when stimulating from more proximal compared with distal sites.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nerve conduction studies are invaluable in defining and determining peripheral nervous system function, dysfunction, and disease, both focally, as in entrapment neuropathies, and generally, as in polyneuropathies. In addition, they are useful to assess the degree of axonal damage versus demyelination. Because they evaluate large myelinated fiber functions, conduction studies are often normal in polyneuropathies with predominant small fiber involvement. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Clinical application'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nerve conduction studies and electromyography should be performed and interpreted at the same time in the majority of test situations. This is particularly important in patients with suspected radiculopathy, plexopathy, myopathy, motor neuropathy, or motor neuron disease. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Concurrent electromyography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The major risk of nerve conduction studies is electrical injury from stray leakage currents. Safety procedures are necessary to minimize electrical leaks and injury. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Erlanger, J, Gasser, HS. Electrical signs of nervous activity, University of Penn Press, Philadelphia, PA 1937.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/2\">",
"      Shefner JM, Logigian EL. Relationship between stimulus strength and the cutaneous silent period. Muscle Nerve 1993; 16:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/3\">",
"      Buchthal, F, Rosenfalck, A. Evoked action potentials and conduction velocity in human sensory nerves. Brain Res 1966; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/4\">",
"      Krarup C. Compound sensory action potential in normal and pathological human nerves. Muscle Nerve 2004; 29:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/5\">",
"      Hursh, JB. Conduction velocity and diameter of nerve fibers. Am J Physiol 1939; 127:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/6\">",
"      Behse F. Sensory action potentials and biopsy of the sural nerve in neuropathy. Brain 1978; 101:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/7\">",
"      Krarup C, Trojaborg W. Sensory pathophysiology in chronic acquired demyelinating neuropathy. Brain 1996; 119 ( Pt 1):257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/8\">",
"      Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/9\">",
"      American Association of Electrodiagnostic Medicine, Olney RK. Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve Suppl 1999; 8:S225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/10\">",
"      Schulte-Mattler WJ, M&uuml;ller T, Georgiadis D, et al. Length dependence of variables associated with temporal dispersion in human motor nerves. Muscle Nerve 2001; 24:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/11\">",
"      Kaji R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 2003; 27:285.",
"     </a>",
"    </li>",
"    <li>",
"     Tasaki, R. Nervous transmission, Charles C. Thomas, Springfield, IL 1953.",
"    </li>",
"    <li>",
"     Rosenfalck, P, Rosenfalck, A. Electromyography-sensory and motor conduction. Findings in normal subjects, Lab of Clin Neurophysiology, University of Copenhagen, Copenhagen, DK 1975.",
"    </li>",
"    <li>",
"     Kimura, J. Electrodiagnosis in Diseases of Nerve and Muscle, 3rd ed, Oxford University Press, Oxford 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/15\">",
"      Tong HC, Werner RA, Franzblau A. Effect of aging on sensory nerve conduction study parameters. Muscle Nerve 2004; 29:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/16\">",
"      Rivner MH, Swift TR, Malik K. Influence of age and height on nerve conduction. Muscle Nerve 2001; 24:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/17\">",
"      Overbeek BU, van Alfen N, Bor JA, Zwarts MJ. Sural/radial nerve amplitude ratio: reference values in healthy subjects. Muscle Nerve 2005; 32:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/18\">",
"      Esper GJ, Nardin RA, Benatar M, et al. Sural and radial sensory responses in healthy adults: diagnostic implications for polyneuropathy. Muscle Nerve 2005; 31:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/19\">",
"      Horowitz SH, Krarup C. Conduction studies of the normal sural nerve. Muscle Nerve 1992; 15:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/20\">",
"      Robinson LR, Rubner DE, Wahl PW, et al. Influences of height and gender on normal nerve conduction studies. Arch Phys Med Rehabil 1993; 74:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/21\">",
"      Buschbacher RM. Body mass index effect on common nerve conduction study measurements. Muscle Nerve 1998; 21:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/22\">",
"      Landau ME, Barner KC, Campbell WW. Effect of body mass index on ulnar nerve conduction velocity, ulnar neuropathy at the elbow, and carpal tunnel syndrome. Muscle Nerve 2005; 32:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/23\">",
"      Rutkove SB. Effects of temperature on neuromuscular electrophysiology. Muscle Nerve 2001; 24:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/24\">",
"      Hopf HC, Maurer K. Temperature dependence of the electrical and mechanical responses of the adductor pollicis muscle in humans. Muscle Nerve 1990; 13:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/25\">",
"      Dioszeghy P, St&aring;lberg E. Changes in motor and sensory nerve conduction parameters with temperature in normal and diseased nerve. Electroencephalogr Clin Neurophysiol 1992; 85:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/26\">",
"      Nandedkar SD, Barkhaus PE. Contribution of reference electrode to the compound muscle action potential. Muscle Nerve 2007; 36:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/27\">",
"      Phongsamart G, Wertsch JJ, Ferdjallah M, et al. Effect of reference electrode position on the compound muscle action potential (CMAP) onset latency. Muscle Nerve 2002; 25:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/28\">",
"      Liddell, EGT, Sherrington, CS. Recruitment and some other factors of reflex inhibition. Proc R Soc Lond [Biol] 1925; 97:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/29\">",
"      Landau ME, Diaz MI, Barner KC, Campbell WW. Optimal distance for segmental nerve conduction studies revisited. Muscle Nerve 2003; 27:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/30\">",
"      Lewis RA, Sumner AJ, Shy ME. Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle Nerve 2000; 23:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/31\">",
"      Simovic D, Weinberg DH. Terminal latency index in the carpal tunnel syndrome. Muscle Nerve 1997; 20:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/32\">",
"      Krarup C. Nerve conduction studies in selected peripheral nerve disorders. Curr Opin Neurol 2002; 15:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/33\">",
"      Buchthal F, Behse F. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 1977; 100 Pt 1:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/34\">",
"      Kaji R, Bostock H, Kohara N, et al. Activity-dependent conduction block in multifocal motor neuropathy. Brain 2000; 123 ( Pt 8):1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/35\">",
"      Van den Bergh PY, Pi&eacute;ret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004; 29:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/36\">",
"      Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002; 59:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/37\">",
"      Cleland JC, Logigian EL, Thaisetthawatkul P, Herrmann DN. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome. Muscle Nerve 2003; 28:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/38\">",
"      Cleland JC, Malik K, Thaisetthawatkul P, et al. Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis. Muscle Nerve 2006; 33:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/39\">",
"      Stanton M, Pannoni V, Lewis RA, et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2006; 34:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/40\">",
"      Tankisi H, Pugdahl K, Johnsen B, Fuglsang-Frederiksen A. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies. Clin Neurophysiol 2007; 118:2383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/41\">",
"      van Dijk JG. Too many solutions for one problem. Muscle Nerve 2006; 33:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/42\">",
"      Nicolas G, Maisonobe T, Le Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002; 25:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/43\">",
"      Van Asseldonk JT, Van den Berg LH, Wieneke GH, et al. Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. Brain 2006; 129:2447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/44\">",
"      Ghosh A, Virgincar A, Kennett R, et al. The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2005; 76:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/45\">",
"      Bostock H, Grafe P. Activity-dependent excitability changes in normal and demyelinated rat spinal root axons. J Physiol 1985; 365:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/46\">",
"      Vagg R, Mogyoros I, Kiernan MC, Burke D. Activity-dependent hyperpolarization of human motor axons produced by natural activity. J Physiol 1998; 507 ( Pt 3):919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/47\">",
"      Kiernan MC, Guglielmi JM, Kaji R, et al. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002; 125:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/48\">",
"      Priori A, Bossi B, Ardolino G, et al. Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy. Brain 2005; 128:1642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/49\">",
"      Watson BV, Brown WF, Doherty TJ. Frequency-dependent conduction block in carpal tunnel syndrome. Muscle Nerve 2006; 33:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/50\">",
"      Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999; 22:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/51\">",
"      Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001; 24:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/52\">",
"      Bird SJ, Brown MJ, Spino C, et al. Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial. Muscle Nerve 2006; 34:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/53\">",
"      Walk D, Zaretskaya M, Parry GJ. Symptom duration and clinical features in painful sensory neuropathy with and without nerve conduction abnormalities. J Neurol Sci 2003; 214:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/54\">",
"      American Association of Neuromuscular &amp; Electrdiagnostic Medicine (AANEM). Proper performance and interpretation of electrodiagnostic studies. Muscle Nerve 2006; 33:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/55\">",
"      Robinson LR, Micklesen PJ. Expression of nerve conduction test results. Muscle Nerve 2002; 25:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/56\">",
"      Dyck PJ, Litchy WJ, Daube JR, et al. Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve 2003; 27:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/57\">",
"      Dyck PJ, O'Brien PC, Litchy WJ, et al. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care 2005; 28:2192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/58\">",
"      Al-Shekhlee A, Shapiro BE, Preston DC. Iatrogenic complications and risks of nerve conduction studies and needle electromyography. Muscle Nerve 2003; 27:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/31/2554/abstract/59\">",
"      Schoeck AP, Mellion ML, Gilchrist JM, Christian FV. Safety of nerve conduction studies in patients with implanted cardiac devices. Muscle Nerve 2007; 35:521.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5142 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-194.187.108.93-5353394DC6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2554=[""].join("\n");
var outline_f2_31_2554=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY AND NORMAL NEUROPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Compound action potentials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Temporal dispersion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Phase cancellation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Saltatory conduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Physiologic factors affecting nerve conduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Specific nerves and nerve segments",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Height, weight, gender",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Temperature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      METHODOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Recording",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Orthodromic and antidromic recording",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Motor nerve conduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - CMAP latency, amplitude, area, and duration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Conduction velocity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Calculation of motor conduction velocity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Sensory nerve conduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      F wave",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      H reflex",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Axonal degeneration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Disorders of myelin-demyelination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Conduction block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      CLINICAL APPLICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Concurrent electromyography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Utility of composite scores",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5142\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5142|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/0/16398\" title=\"figure 1\">",
"      Temporal dispersion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/11/32948\" title=\"figure 2\">",
"      Motor nerve conduction study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/25/15765\" title=\"figure 3\">",
"      Sensory nerve conduction study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/53/30558\" title=\"figure 4\">",
"      H reflex",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5142|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?1/45/1744\" title=\"waveform 1\">",
"      F waves",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39251?source=related_link\">",
"      Nerve conduction studies: Late responses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/46/1769?source=related_link\">",
"      Overview of electromyography",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_31_2555="Risk of spine injury in children";
var content_f2_31_2555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Factors producing increased mobility and risk of injury to the pediatric spine",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Large size of head in comparison to neck and trunk, increasing flexion, extension, and shearing forces on the cervical spine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Underdevelopment of paraspinous muscles",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Shallow, horizontally oriented facet joints",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Increased elasticity of facet joint ligaments",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Incompletely ossified vertebrae",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       High water content and elasticity of intervertebral disks, increasing vertical loading effect",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Akbarnia, BA. Orthop Clin North Am 1999; 30:521; Thomas, NH, Robinson, L, Evans, A, Bullock, P. Pediatr Neurosurg 1995; 23:188; and Rooks, VJ, Sisler, C, Burton, B. Pediatr Radiol 1998; 28:193.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2555=[""].join("\n");
var outline_f2_31_2555=null;
var title_f2_31_2556="Class snake bite US";
var content_f2_31_2556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical classification of United States Crotalinae* envenomation to guide FabAV administration",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Category",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tissue effect",
"       </td>",
"       <td class=\"subtitle1\">",
"        Systemic signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Coagulopathy and bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minimal",
"       </td>",
"       <td>",
"        Swelling, pain, and ecchymosis adjacent to the bite site",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Normal coagulation parameters&bull;; no bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        Swelling, pain, and ecchymosis less than full extremity or less than 50 cm if bite on head, neck, or trunk",
"       </td>",
"       <td>",
"        Present but not life-threatening (eg, nausea, vomiting, diarrhea, oral paresthesia, unusual tastes, tachycardia, tachypnea, mild hypotension [systolic BP &gt;90 mmHg in an adult])",
"       </td>",
"       <td>",
"        Abnormal coagulation parameters&bull;; no bleeding or minor hematuria, gum bleeding, and/or epistaxis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe",
"       </td>",
"       <td>",
"        Swelling, pain, ecchymosis involving more than the entire extremity; greater than 50 cm if bite on head, neck, or trunk; threatens the airway; OR signs of compartment syndrome",
"       </td>",
"       <td>",
"        Present and life-threatening (eg, respiratory insufficiency, marked tachycardia for age with severe hypotension, obtundation, seizures)",
"       </td>",
"       <td>",
"        Markedly abnormal coagulation parameters&bull; with serious bleeding",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FabAV: polyvalent Crotalidae ovine immune Fab (Crofab&reg;, Protherics); BP: blood pressure.",
"     <br>",
"      * Includes bites by rattlesnakes, water moccasins (cottonmouths), and copperheads.",
"      <br>",
"       &bull; Coagulation parameters include platelet count, prothrombin time (PT), partial thromboplastin time (PTT), fibrinogen, and fibrin degradation products (fibrin split products [FSP]).",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Goto, CS, Feng, SY. Crotalidae polyvalent immune fab for the treatment of pediatric crotaline envenomation. Pediatr Emerg Care 2009; 25:273.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2556=[""].join("\n");
var outline_f2_31_2556=null;
var title_f2_31_2557="Antiepileptic drugs in children part II";
var content_f2_31_2557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drug therapy for seizures in children (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Blood level",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Laboratory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Starting",
"       </td>",
"       <td class=\"subtitle2\">",
"        Maintenance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxcarbazepine&nbsp;",
"       </td>",
"       <td>",
"        8-10 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        30-40 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        8-35 mcg/mL&nbsp;",
"       </td>",
"       <td>",
"        CBC/plts every 3 months for first 6 months, chemical panel prn (routine monitoring may not be necessary)&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Phenytoin, fosphenytoin (intravenous)",
"       </td>",
"       <td>",
"        5&nbsp;mg/kg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        4-8 mg/kg/day (older children, adolescents 300 mg/day)",
"       </td>",
"       <td rowspan=\"2\">",
"        10-20 mcg/mL&nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        Routine lab tests not recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Status elilepticus 20 mg/kg (fosphenytoin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Phenobarbital",
"       </td>",
"       <td rowspan=\"2\">",
"        3-4 mg/kg/day",
"       </td>",
"       <td>",
"        Infants 5-6 mg/kg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        10-40 mcg/mL",
"       </td>",
"       <td rowspan=\"2\">",
"        Routine lab tests not recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children 1-5 y.o.&nbsp;6-8 mg/kg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primidone",
"       </td>",
"       <td>",
"        1-2 mg/kg/day",
"       </td>",
"       <td>",
"        10-25 mg/kg/day",
"       </td>",
"       <td>",
"        5-12 mcg/mL (phenobarbital level 1.2 x higher)",
"       </td>",
"       <td>",
"        Routine lab tests not recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rufinamide&nbsp;",
"       </td>",
"       <td>",
"        10 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        45 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        Not established&nbsp;",
"       </td>",
"       <td>",
"        Routine lab tests not recommended&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Topiramate",
"       </td>",
"       <td>",
"        1-3 mg/kg/day",
"       </td>",
"       <td>",
"        5-9 mg/kg/day",
"       </td>",
"       <td>",
"        5-20 mcg/mL",
"       </td>",
"       <td>",
"        CBC/plts, hepatic function tests, serum K when maximum dose reached or at 3-6 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Tiagibine",
"       </td>",
"       <td>",
"        &lt;12 years 0.5 mg/kg/day",
"       </td>",
"       <td>",
"        Weekly increase 0.5-1 mg/kg/day with max 4-8 mg/kg/day (3-4 divided daily doses)",
"       </td>",
"       <td rowspan=\"2\">",
"        Not established",
"       </td>",
"       <td rowspan=\"2\">",
"        Routine lab tests not recommended&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         &gt;12 years 4 mg/day",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Increase 4 mg/week to max 32 mg/day (2-4 divided daily doses)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valproate&nbsp;",
"       </td>",
"       <td>",
"        10-15 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        30-60 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        50-150 mcg/mL&nbsp;",
"       </td>",
"       <td>",
"        Hepatic function tests every 1-2 months&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zonisamide&nbsp;",
"       </td>",
"       <td>",
"        1-2 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        5-8 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        10-40 mcg/mL&nbsp;",
"       </td>",
"       <td>",
"        Serum electrolytes&nbsp;when maximum dose is reached or at 3-6 months&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CBC: complete blood count; max: maximum; plts: platelets; y.o.: years old",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2557=[""].join("\n");
var outline_f2_31_2557=null;
var title_f2_31_2558="Contents: Eating disorders";
var content_f2_31_2558=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?41/24/42381\">",
"       Psychiatry",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Eating disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Eating disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/62/38890\">",
"           Anorexia nervosa in adults and adolescents: Medical complications and their management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/16/30982\">",
"           Anorexia nervosa in adults and adolescents: The refeeding syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/56/21385\">",
"           Anorexia nervosa in adults: Cognitive-behavioral therapy (CBT)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/7/3194\">",
"           Anorexia nervosa in adults: Diagnosis, associated clinical features, and assessment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/10/16550\">",
"           Anorexia nervosa in adults: Evaluation for medical complications and criteria for hospitalization to manage these complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/18/7463\">",
"           Anorexia nervosa in adults: Pharmacotherapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/28/8646\">",
"           Binge-eating disorder: Cognitive-behavioral therapy (CBT)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/1/34841\">",
"           Binge-eating disorder: Overview of treatment in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/1/33816\">",
"           Bulimia nervosa and binge eating disorder in adults: Medical complications and their management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/50/33577\">",
"           Bulimia nervosa in adults: Clinical features, diagnosis, and assessment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/24/7560\">",
"           Bulimia nervosa in adults: Cognitive-behavioral therapy (CBT)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/62/7145\">",
"           Bulimia nervosa in adults: Pharmacotherapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/38/7781\">",
"           Eating disorders in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/2/23593\">",
"           Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/63/44023\">",
"           Eating disorders: Treatment",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-28537C68FF-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f2_31_2558=[""].join("\n");
var outline_f2_31_2558=null;
var title_f2_31_2559="Vitreous bleed in Eales disease";
var content_f2_31_2559=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50653&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50653&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vitreous hemorrhage in Eale's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 339px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Funduscopy in a patient with Eale's disease shows vitreous hemorrhage.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Tolentino, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_31_2559=[""].join("\n");
var outline_f2_31_2559=null;
